A1BG response element gene transcriptions: Difference between revisions
(807 intermediate revisions by the same user not shown) | |||
Line 17: | Line 17: | ||
==Response element testing== | ==Response element testing== | ||
{| class="wikitable sortable" | {| class="wikitable sortable" | ||
|+ Response element | |+ Response element | ||
|- | |- | ||
! Name of elements !! Consensus sequences !! Testing !! | ! Name of elements, Abbreviations, Authors !! Consensus sequences, Variations !! Testing !! Order !! Resource !! nucleotides for one occurrence or likelihood found | ||
|- | |||
|1. ABA-response element-like, (ABRE-like) || ACGTGTCC || Absent || 27 || [[ABA-response element gene transcriptions|ABA-response elements]] 13:07, 8 October 2020 || 4<sup>8</sup> | |||
|- | |- | ||
|2. ABA-response elements, novel, (ABREN, novel ABRE) | |||
|| GATCGATC, CGATCGAT, GATCGAT || Absent || 28 || [[ABA-response element gene transcriptions|ABA-response elements]] 13:07, 8 October 2020 || 4<sup>7</sup>-4<sup>8</sup> | |||
|- | |- | ||
|3. ABA responsive elements (ABREs) || ACGTG(G/T)C || Present || 29 || [[ABA-response element gene transcriptions|ABA-response elements]] 05:53, 9 October 2020 || likely active or activable | |||
|- | |- | ||
| | |4. Abf1 regulatory factors || CGTNNNNNACGAT || Absent || 31 || [[Abf1 regulatory factor gene transcriptions|Abf1 regulatory factors]] 18:32, 10 October 2020 || 4<sup>13</sup> | ||
|| | |||
|- | |- | ||
| | |5. A-boxes || TACGTA || Present || 26 || [[A box gene transcriptions|A-boxes]] 21:24, 7 October 2020 || likely active or activable | ||
|| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |6. Abscisic acid-responsive elements (Pho4s), G boxes || CACGTG || Present || 126 || [[Phosphate starvation-response transcription factor gene transcriptions|Abscisic acid-responsive elements (Pho4s)]], [[G box gene transcriptions|G boxes]] 06:38, 10 May 2022 || likely active or activable | ||
| | |||
|- | |- | ||
| | |7. ACGT-containing elements || ACGT || Present || 182 || [[ACGT-containing element gene transcriptions|ACGT-containing elements]] 03:02, 25 September 2022 || cores, proximals likely active or activable, few UTRs, distals may be random | ||
|- | |- | ||
| | |8. Activated B-cell Factor-1s (ABFs, Abfms) || CGTNNNNN(A/G)(C/T)GA(C/T) || Present || 30 || [[Abf1 regulatory factor gene transcriptions|Abf1 regulatory factors]] 17:47, 10 October 2020 || likely active or activable | ||
| | |- | ||
| | |9. Activating proteins (APs), (Murata) || GCCCACGGG || Absent || 275 || [[Activating protein gene transcriptions|Activating proteins]] 05:32, 15 December 2022 || 4<sup>9</sup> | ||
| | |- | ||
| | |10. Activating protein 2 alpha (AP2a) || GCCNNNGGC || Present || 184 || [[Activating protein gene transcriptions|Activating protein 2 alpha]] 00:57, 29 September 2022 || likely active or activable, positive strand, positive direction within randoms | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |11. Activating protein 2 (AP2), (Cohen1) || GCCTGGCC || Present || 187 || [[Activating protein gene transcriptions|Activating protein 2]] 06:54, 30 September 2022 || likely active or activable | ||
|- | |- | ||
| | |12. Activating protein 2, (Cohen2) || TCCCCCGCCC || Present || 188 || [[Activating protein gene transcriptions|Activating protein 2]] 07:41, 30 September 2022 || likely active or activable | ||
|- | |- | ||
| | |13. Activating protein 2, (Murata) || (C/G)CCN(3)GG(C/G) || Present || 183 || [[Activating protein gene transcriptions|Activating protein 2]] 23:47, 28 September 2022 || likely active or activable | ||
| | |||
| | |||
| | |||
|- | |- | ||
| | |14. Activating protein 2, (Murata) || (C/G)CCN(4)GG(C/G) || Present || 186 || [[Activating protein gene transcriptions|Activating protein 2]] 19:10, 29 September 2022 || likely active or activable | ||
|- | |- | ||
| | |15. Activating protein 2, (Yao1) || TCTTCCC || Present || 189 || [[Activating protein gene transcriptions|Activating protein 2]] 08:11, 30 September 2022 || likely active or activable | ||
|- | |- | ||
| | |16. Activating protein 2, (Yao2) || CTCCCA || Present || 190 || [[Activating protein gene transcriptions|Activating protein 2]] 19:00, 30 September 2022 || likely active or activable | ||
|- | |- | ||
| | |17. Activating protein 2, (AP-2), (Yao3) || GGCCAA || Present || 191 || [[Activating protein gene transcriptions|Activating proteins]] 22:23, 30 September 2022 || likely active or activable | ||
|- | |- | ||
| | |18. Activating protein 2, (AP-2), (Roesler) || CCCCACC(A/C) || Present || 353 || [[CAT box gene transcriptions|AP-2 (Roesler) samplings]] 19:31, 21 April 2023 || likely active or activable | ||
( | |||
|| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |19. Activating transcription factors, (ATF), (Burton) || (A/C/G)TT(A/G/T)C(A/G)TCA || Present || 192 || [[Activating transcription factor gene transcriptions|Activating transcription factors]] 01:48, 1 October 2022 || likely active or activable | ||
|- | |- | ||
| | |20. Activating transcription factors, (ATF), (Kilberg) || (A/G/T)TT(A/G/T)CATCA || Present || 193 || [[Activating transcription factor gene transcriptions|Activating transcription factors]] 02:21, 1 October 2022 || likely active or activable | ||
|- | |||
( | |21. Adenylate–uridylate rich elements, (AUREs), (Bakheet) || (A/T)(A/T)(A/T)TATTTAT(A/T)(A/T) || Present || 116 || [[Adenylate–uridylate rich element gene transcriptions|Adenylate–uridylate rich elements]] 02:16, 3 October 2021 || likely active or activable | ||
|| | |- | ||
|22. Adenylate–uridylate rich elements, (AREs), (Chen and Shyu, Class I) || ATTTA || Present || 273 || [[Adenylate–uridylate rich element gene transcriptions|Adenylate–uridylate rich elements]] 04:44, 15 December 2022 || likely active or activable, UTRs at the lower end of the randoms | |||
|- | |||
|23. Adenylate–uridylate rich elements, (AREs), (Chen and Shyu, Class II) || TTATTTA(A/T)(A/T) || Present || 272 || [[Adenylate–uridylate rich element gene transcriptions|Adenylate–uridylate rich elements]] 04:31, 15 December 2022 || likely active or activable | |||
|- | |||
|24. Adenylate–uridylate rich elements, (AREs), (Chen and Shyu, Class III) || ATTT || Present || 271 || [[Adenylate–uridylate rich element gene transcriptions|Adenylate–uridylate rich elements]] 04:06, 15 December 2022 || likely active or activable, low negative direction proximals overlap randoms | |||
|- | |||
|25. Adr1ps, (ADR), (Tang 2020) || TTGG(A/G)G || Present || 268 || [[Adr1p gene transcriptions|Adr1ps]] 01:36, 15 December 2022 || likely active or activable | |||
|- | |||
|26. Aft1s, (AFT) || (C/T)(A/G)CACCC(A/G) || Present || 194 || [[Aft1p gene transcriptions|Aft1s]] 15:48, 3 October 2022 || likely active or activable | |||
|- | |- | ||
| | |27. AGC boxes || AGCCGCC (Leubner-Metzger 1998) || Present || 8 || [[AGC box gene transcriptions|AGC boxes]] 14:40, 2 May 2014 || likely active or activable | ||
( | |||
|| | |||
|- | |- | ||
| | |28. AhR DNA-binding consensus sequence, (AhRY), (Yao) || GCGTGNN(A/T)NNN(C/G) || Present || 234 || [[Xenobiotic response element gene transcriptions|AhR DNA-binding consensus sequence]] 05:37, 5 November 2022 || likely active or activable for ZNF497 | ||
( | |||
(Yao) | |||
|| ( | |||
|- | |- | ||
| | |29. AhR-responsive elements (AHRE) (Yao 1992) || (G/T)NGCGTG(A/C)(C/G)A || Absent || 84 || [[Xenobiotic response element gene transcriptions|AhR/ARNT complex]] 20:45, 17 February 2021 || 2<sup>3</sup>*4<sup>6</sup> | ||
( | |||
|| ( | |||
|- | |- | ||
| | |30. Alpha-amylase conserved elements (Sharma 2020) || TATCCATCCATCC || Absent || 36 || [[Alpha-amylase conserved element gene transcriptions|Alpha-amylase conserved elements]] 04:22, 13 October 2019 || 4<sup>13</sup> | ||
|| | |||
|- | |- | ||
| | |31. Alpha-amylase conserved elements portion || TATCCA || Present || 347 || [[Alpha-amylase conserved element gene transcriptions|Alpha-amylase conserved elements portion]] 05:39, 11 April 2023 || likely active or activable | ||
|- | |- | ||
| | |32. Amino acid response elements, (AARE1), (Maruyama) || ATTGCATCA || Absent || 110 || [[Amino acid response element gene transcriptions|Amino acid response elements]] 01:32, 22 May 2021 || 4<sup>9</sup> | ||
|- | |- | ||
| | |33. Amino acid response elements, (AARE), (Broer) || TTTGCATCA<ref name=Broer/><ref name=Garaeva/> || Absent || 38 || [[Amino acid response element gene transcriptions|Amino acid response elements]] 01:59, 1 November 2020 || 4<sup>9</sup> | ||
|- | |- | ||
| | |34. Amino acid response element-like, (AARE-like), (AARE3), (Maruyama) || TGGTGAAAG || Absent || 39 || [[Amino acid response element gene transcriptions|Amino acid response element-like]] 02:27, 2 November 2020 || 4<sup>9</sup> | ||
|| | |||
|- | |- | ||
| | |35. Androgen response elements, (AREs), (Kouhpayeh) || GGTACANNNTGTTCT || Absent || 40 || [[Androgen response element gene transcriptions|Androgen response elements]] 17:01, 2 November 2020 || 4<sup>12</sup> | ||
| | |- | ||
| | |36. Androgen response element1s, (Kouhpayeh) || GGTACA of GGTACAnnnTGTTCT || Present || 196 || [[Androgen response element gene transcriptions|Androgen response element1s]] 17:22, 4 October 2022 || likely active or activable | ||
| | |- | ||
| | |37. Androgen response element2s, (Kouhpayeh) || TGTTCT of GGTACAnnnTGTTCT || Present || 197 || [[Androgen response element gene transcriptions|Androgen response element2s]] 17:01, 5 October 2022 || likely active or activable | ||
| | |- | ||
| | |38. Androgen response elements, (AREs), (Wilson) || AGAACANNNTGTTCT || Absent || 117 || [[Androgen response element gene transcriptions|Androgen response elements]] 16:21, 11 November 2021 || 4<sup>12</sup> | ||
| | |- | ||
| | |39. Androgen response elements, (Wilson) || AGAACANNNTGTTCT || Present || 198 || [[Androgen response element gene transcriptions|Androgen response elements]] 18:53, 5 October 2022 || the two portions AGAACA and TGTTCT occurring separately are likely active or activable | ||
| | |- | ||
| | |40. Angiotensinogen core promoter elements (AGCE) || (A/C)T(C/T)GTG || Present || 256 || [[AGCE gene transcriptions|Angiotensinogen core promoter elements]] 20:01, 5 December 2022 || likely active or activable, positive direction distal low occurrences overlap randoms | ||
| | |- | ||
| | |41. Antioxidant-electrophile responsive elements, (ARE), (Otsuki) || GTGAGGTCGC<ref name=Otsuki/> or GCTGAGT, GCAGGCT of GC(A/C/T)(A/G/T)(A/G/T)(C/G/T)T(A/C)A<ref name=Lacher/> || Absent || 41 || [[Antioxidant-electrophile responsive element gene transcriptions|Antioxidant-electrophile responsive elements]] 06:06, 4 November 2020 || (4/3)*2*4<sup>5</sup>-4<sup>10</sup> | ||
| | |- | ||
| | |42. Antioxidant-electrophile responsive elements, (Lacher) || GC(A/C/T)(A/G/T)(A/G/T)(C/G/T)T(A/C)A || Present || 199 || [[Antioxidant-electrophile responsive element gene transcriptions|Antioxidant-electrophile responsive elements]] 23:22, 5 October 2022 || likely active or activable | ||
|- | |||
|43. Aryl hydrocarbon responsive element II, (AHRE-II) || CATGN<sub>6</sub>C(A/T)TG || Present || 257 || [[Xenobiotic responsive element gene transcriptions|AhR responsive element or Aryl hydrocarbon responsive element II]] 18:04, 6 December 2022 || likely active or activable | |||
|- | |- | ||
| | |44. ATA boxes || AATAAA || Present || 267 || [[ATA box gene transcriptions|ATA boxes]] 19:59, 14 December 2022 || likely active or activable | ||
|- | |- | ||
| | |45. ATTTA elements, (Siegel) || (A/T)(A/T)(A/T)(A/T)(A/T)(A/T)(A/T)(A/T)(A/T) || Present || 270 || [[Adenylate–uridylate rich element gene transcriptions|ATTTA elements]] 04:04, 15 December 2022 || likely active or activable | ||
|- | |||
( | |46. Auxin response factors, (ARF), (Stigliani) || (C/G/T)(A/C/T)(G/T)G(C/T)(C/T)(G/T)(C/G)(A/C/T)(A/G/T) || Present || 235 || [[Auxin response factor gene transcriptions|Auxin response factors]] 05:55, 5 November 2022 || likely active or activable, positive direction proximals overlap high randoms, positive direction cores within randoms | ||
|- | |||
( | |47. Auxin response factors, (ARF), (Ulmasov) || TGTCTC || Present || 236 || [[Auxin response factor gene transcriptions|Auxin response factors]] 06:02, 5 November 2022 || likely active or activable | ||
|| | |- | ||
| | |48. Auxin response factors, (ARF), (Boer) || TGTCGG || Present || 200 || [[Auxin response factor gene transcriptions|Auxin response factors]] 17:03, 7 October 2022 || likely active or activable | ||
| | |- | ||
| | |49. Auxin response factors, (ARF5) || (C/G/T)N(G/T)GTC(G/T) || Present || 201 || [[Auxin response factor gene transcriptions|Auxin response factors]] 04:15, 10 October 2022 || likely active or activable, negative direction proximals ≥ randoms | ||
| | |- | ||
| | |50. B-boxes, (Johnson) || TGGGCA || Present || 203 || [[B box gene transcriptions|B-boxes]] 18:05, 10 October 2022 || likely active or activable, positive direction distals ≥ randoms | ||
| | |- | ||
| | |51. boxes A || TGACTCT || Present || 125 || [[A box gene transcriptions|Box A]] 06:50, 9 May 2022 || likely active or activable | ||
| | |- | ||
| | |52. boxes B, (Sanchez) || TGTCTCA || Present || 202 || [[B box gene transcriptions|Box B]] 15:26, 10 October 2022 || likely active or activable | ||
| | |- | ||
| | |53. B recognition elements, (BRE<sup>u</sup>) || (G/C)(G/C)(G/A)CGCC || Present || 255 || [[Factor II B recognition element gene transcriptions|B recognition elements]] 20:39, 4 December 2022 || likely active or activable | ||
| | |- | ||
| | |54. CAACTC regulatory elements, (CAREs), (Fan) || CAACTC || Present || 122 || [[CARE gene transcriptions|CARE (Fan)]] 17:45, 7 May 2022 || likely active or activable | ||
| | |- | ||
| | |55. CAAT boxes || (C/T)(A/G)(A/G)CCAATC(A/G) || Absent || 14 || [[CAAT box gene transcriptions|CAAT boxes]] 02:41, 22 March 2019 || 4<sup>8</sup>, consensus sequence for the CCAAT-enhancer-binding site (C/EBP) is TAGCATT. | ||
| | |- | ||
| | |56. CACA elements (Orlando 2019) || CACA || Present || 108 || [[Hypoxia response element gene transcriptions|CACA elements]] 05:04, 7 May 2021 || likely active or activable | ||
| | |- | ||
| | |57. CadC binding domains || TTANNNNT || Present || 204 || [[CadC binding domain gene transcriptions|CadC binding domains]] 22:14, 12 October 2022 || likely active or activable, negative direction proximals within randoms | ||
| | |- | ||
| | |58. Calcineurin-responsive transcription factors || TG(A/C)GCCNC || Present || 265 || [[Calcineurin-responsive transcription factor gene transcriptions|Calcineurin-responsive transcription factors]] 19:14, 12 December 2022 || likely active or activable | ||
| | |- | ||
| | |59. Calcium-response elements, (CaRE1s), (Tao 2002) || CTATTTCGAG || Absent || 42 || [[Calcium-response element gene transcriptions|Calcium-response elements]] 19:43, 7 November 2020 || 4<sup>10</sup> | ||
| | |- | ||
| | |60. Carbohydrate response elements, (ChREs), (ChoRE1, ChoRE2), (Long 2020) || CACGTGACCGGATCTTG, TCCGCCCCCATCACGTG || Absent || 43 || [[Carbohydrate response element gene transcriptions|Carbohydrate response elements]] 20:50, 10 November 2020 || 4<sup>17</sup> | ||
| | |- | ||
| | |61. Carbohydrate response elements, (ChoRE1), (Carb) || ACCGG || Present || 143 || [[Carbohydrate response element gene transcriptions|Carbohydrate response elements]] 18:56, 18 June 2022 || likely active or activable | ||
| | |- | ||
| | |62. Carbohydrate response elements, (ChoRE2), (Carb1) || CCCAT || Present || 205 || [[Carbohydrate response element gene transcriptions|Carbohydrate response elements]] 06:01, 13 October 2022 || likely active or activable | ||
| | |- | ||
| | |63. Carbohydrate response elements, (Carb E1) || ATCTTG || Present || 206 || [[Carbohydrate response element gene transcriptions|Carbohydrate response elements]] 18:45, 13 October 2022 || proximals likely active or activable | ||
| | |- | ||
| | |64. Carbohydrate response elements, (Carb E2) || CACGTG || Present || 207 || [[Carbohydrate response element gene transcriptions|Carbohydrate response elements]] 21:30, 13 October 2022 || likely active or activable | ||
| | |||
| | |||
| | |||
|- | |- | ||
| | |65. Carbohydrate response elements, (Carb E3) || TCCGCC || Present || 208 || [[Carbohydrate response element gene transcriptions|Carbohydrate response elements]] 01:21, 14 October 2022 || likely active or activable, low positive direction distals overlap high randoms | ||
|- | |||
( | |66. Carbon source-responsive elements, (CSREs) || CATTCATCCG || Absent || 105 || [[Carbon source-responsive element gene transcriptions|Carbon source-responsive elements]] 17:08, 19 March 2021 || 4<sup>10</sup>, confers carbon source-dependent regulation | ||
|| | |- | ||
| | |67. Carbon source-responsive elements, (TCCGs) || TCCG || Present || 209 || [[Carbon source-responsive element gene transcriptions|TCCG elements]] 02:41, 16 October 2022 || likely active or activable | ||
| | |- | ||
| | |68. Carbon source-responsive elements, (CATTs) || CATTCA || Present || 210 || [[Carbon source-responsive element gene transcriptions|CATTCA elements]] 17:05, 18 October 2022 || likely active or activable | ||
| | |- | ||
| | |69. CArG boxes, (Kamada 1992), (McDonald 2006) || CC(A/T)<sub>6</sub>GG || Absent || 211 || [[CArG box gene transcriptions|CArG boxes]] 19:08, 18 October 2022 || 2<sup>6</sup>*4<sup>4</sup> | ||
| | |- | ||
| | |70. CArG boxes, (Deng 2011) || CCAAAAAT(G/A)G || Absent || 212 || [[CArG box gene transcriptions|CArG boxes]] 19:08, 18 October 2022 || 2*4<sup>9</sup> | ||
| | |- | ||
| | |71. CArG boxes, (suggested more general motif), (Deng 2011) || C(C/A/T)(A/T)<sub>6</sub>(A/G)G from two different CArG-box motifs at 502 bp (CTAAATATGG) and 287 bp (CAATAATTGG) upstream || Present || 213 || [[CArG box gene transcriptions|CArG boxes]] 19:08, 18 October 2022 || likely active or activable, positive strand, negative direction: CATTAAAAGG at 3441 and CAAAAAAAAG at 1399 | ||
| | |- | ||
| | |72. Cat8ps, (Tang 2020) || CGG(A/C/G/T)(C/G/T)(A/C/G/T)(A/C/G)(A/C)(A/C/T)GGA || Present || 214 || [[Cat8p gene transcriptions|Cat8ps]] 22:21, 18 October 2022 || likely active or activable | ||
| | |- | ||
| | |73. CAT boxes, (Saitoh 1993) || CATTCCT || Present || 215 || [[CAT box gene transcriptions|CAT boxes]] 23:56, 18 October 2022 || likely active or activable | ||
| | |||
| | |||
| | |||
|- | |- | ||
| | |74. CAT-box-like elements, (Berberich 1993) || GCCATT || Present || 216 || [[CAT box gene transcriptions|CAT-box-like elements]] 19:38, 20 October 2022 || likely active or activable | ||
|- | |||
|75. Cbf1 regulatory factors || TCACGTGA || Absent || 112 || [[Cbf1 regulatory factor gene transcriptions|Cbf1 regulatory factors]] 15:57, 11 June 2021 || 4<sup>8</sup> | |||
|- | |||
|76. C-boxes, (Johnson) || GAGGCCATCT || Absent || 33 || [[C box gene transcriptions|C-boxes]] 02:51, 22 October 2020 || 4<sup>10</sup> | |||
|| | |- | ||
| | |77. C boxes, (Samarsky) || AGTAGT || Present || 217 || [[C box gene transcriptions|C boxes]] 02:22, 21 October 2022 || likely active or activable | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |78. C-boxes, (Song) || GACGTC || Present || 218 || [[C box gene transcriptions|C-boxes]] 06:22, 21 October 2022 || likely active or activable | ||
( | |||
|| | |||
|- | |- | ||
| | |79. C/A hybrid boxes, (Song) || TGACGTAT || Absent || 32 || [[C box gene transcriptions|C/A hybrid boxes]] 16:18, 20 October 2020 || 4<sup>8</sup> | ||
|- | |||
( | |80. C/G hybrid boxes, (Song) || TGACGTGT || Present || 244 || [[C box gene transcriptions|CG hybrid boxes]] 18:35, 15 November 2022 || likely active or activable | ||
|| | |- | ||
| | |81. C/T hybrid boxes, (Song) || TGACGTTA || Absent || 34 || [[C box gene transcriptions|C/T hybrid boxes]] 01:51, 24 October 2020 || 4<sup>8</sup> | ||
| | |- | ||
| | |82. C boxes, (Voronina) || GGTGATG || Present || 243 || [[C box gene transcriptions|C boxes]] 18:28, 15 November 2022 || likely active or activable | ||
| | |- | ||
| | |83. CCAAT-enhancer-binding site (C/EBP) activating transcription factor (ATF), or C/EBP-ATF responsive elements, (CAREs), (Garaeva) || (A/G/T)TT(A/G/T)CATCA || Present || 123 || [[CARE gene transcriptions|CARE (Garaeva)]] 01:10, 8 May 2022 || likely active or activable | ||
| | |- | ||
| | |84. CCAAT-enhancer-binding site (C/EBP), C/EBP boxes || TTAGGACAT,<ref name=Misra/> or TAGCATT.<ref name=Yao/> || Absent || 44 || [[C-EBP box gene transcriptions|C/EBP boxes]] 23:21, 18 November 2020 || 4<sup>7</sup>-4<sup>9</sup> | ||
| | |- | ||
| | |85. CCCTC-binding factors, (CTCF), (Hashimoto 2017) || NCA-NNA-G(A/G)N-GGC-(A/G)(C/G)(C/T) || Absent || 35 || [[CCCTC-binding factor gene transcriptions|CCCTC-binding factors]] 23:02, 24 October 2020 || 4<sup>9</sup> | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |86. CCCTC-binding factors, (CTCF), (Lobanenkov 1990) || CCCTC || Present || 370 || [[CCCTC-binding factor gene transcriptions|CCCTC-binding factors]] 23:44, 12 May 2023 || likely active or activable | ||
( | |||
( | |||
|| | |||
|- | |- | ||
| | |87. C clamp, (HMG DBD), (Cadigan 2012) || (C/G)CTTTGAT(C/G) || Absent || 367 || [[HMG box gene transcriptions|C clamp]] 06:03, 10 May 2023 || 4<sup>8</sup> | ||
( | |||
|| | |||
|- | |- | ||
| | |88. Cell-cycle boxes, (CCBs) || CACGAAAA || Absent || 107 || [[Cell-cycle box gene transcriptions|Cell-cycle boxes]] 22:13, 19 April 2021 || 4<sup>8</sup>, "cell cycle box" is functional in either orientation, acting as an enhancer | ||
|- | |||
( | |89. Cell-cycle box variants, (CCBs) || CACGAAA, ACGAAA and C-CGAAA || Present || 219 || [[Cell-cycle box gene transcriptions|Cell-cycle box variants]] 05:54, 23 October 2022 || likely active or activable | ||
|| | |- | ||
| | |90. Cell cycle regulation, (Sharma 2020) || CCCAACGGT || Absent || 45 || [[Cell cycle regulation gene transcriptions|Cell cycle regulation]] 20:53, 25 November 2020 || 4<sup>9</sup> | ||
| | |- | ||
| | |91. CENP-B boxes || TTTCGTTGGAAGCGGGA || Absent || 16 || [[CENP-B box gene transcriptions|CENP-B boxes]] 15:05, 16 October 2019 || 4<sup>17</sup>, specifically localized at the centromere | ||
| | |- | ||
| | |92. CGCG boxes, (Yang 2002) || (A/C/G)CGCG(C/G/T) || Present || 264 || [[CGCG box gene transcriptions|CGCG boxes]] 07:14, 12 December 2022 || likely active or activable, probably for zinc fingers | ||
| | |- | ||
| | |93. Circadian control elements || CAANNNNATC || Present || 263 || [[Circadian control element gene transcriptions|Circadian control elements]] 00:33, 12 December 2022 || likely active or activable but overlaps highest randoms | ||
| | |- | ||
| | |94. Class C DNA binding sites, (Leal) || CACGNG || Present || 164 || [[N box gene transcriptions|Class C DNA binding sites]] 06:16, 5 August 2022 || likely active or activable, distals may be random | ||
| | |- | ||
| | |95. Cold-responsive elements || CCGAC || Present || 220 || [[Cold-responsive element gene transcriptions|Cold-responsive elements]] 05:34, 24 October 2022 || likely active or activable | ||
| | |- | ||
|96. Constitutive decay elements, (CDEs), (Siegel) || TTC(C/T)(A/G)(C/T)GAA || Present || 269 || [[Adenylate–uridylate rich element gene transcriptions|Constitutive decay elements]] 03:50, 15 December 2022 || likely active or activable possibly for ZNF497 | |||
| | |- | ||
| | |97. Copper response elements, (CuREs), (Quinn) || TTTGC(T/G)C(A/G) || Present || 221 ||[[Copper response element gene transcriptions|Copper response elements]] 07:57, 24 October 2022 || likely active or activable | ||
| | |- | ||
| | |98. Copper response elements, (CuREs), (Park) || TGTGCTCA || Present || 222 || [[Copper response element gene transcriptions|Copper response elements]] 05:45, 25 October 2022 || likely active or activable | ||
| | |- | ||
| | |99. Coupling elements, (CE1), (Watanabe) || TGCCACCGG || Absent || 46 || [[Coupling element gene transcriptions|Coupling elements]] 01:51, 1 December 2020 || 4<sup>9</sup> | ||
| | |- | ||
| | |100. Coupling elements, (CE3s), (Watanabe) || GCGTGTC || Present || 118 || [[Coupling element gene transcriptions|Coupling elements]] 15:47, 12 February 2022 || likely active or activable | ||
| | |- | ||
| | |101. Coupling elements, (CE3s), (Ding) || CACGCG || Present || 119 || [[Coupling element gene transcriptions|Coupling elements]] 02:59, 15 February 2022 || likely active or activable | ||
| | |- | ||
| | |102. cyclic-AMP-responsive elements, (CREs), Aca1ps, Sko1ps, (Montminy 1986) || TGACGTCA || Present || 274 || [[CRE box gene transcriptions|cAMP-responsive elements]] 05:05, 15 December 2022 || likely active or activable, same as [[Root specific element gene transcriptions|Root specific elements]] | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |103. Cytokinin response regulators, (ARR1s) || AGATT(C/T) || Present || 227 || [[Cytokinin response regulator gene transcriptions|Cytokinin response regulators]] 16:21, 31 October 2022 || likely active or activable | ||
|- | |- | ||
| | |104. Cytokinin response regulators, (ARR10s) || (A/G)GATA(A/C)G || Present || 223 || [[Cytokinin response regulator gene transcriptions|Cytokinin response regulators]] 17:47, 27 October 2022 || likely active or activable or may be random | ||
|- | |- | ||
| | |105. Cytokinin response regulators, (ARR12s) || (A/G)AGATA || Present || 224 || [[Cytokinin response regulator gene transcriptions|Cytokinin response regulators]] 06:09, 28 October 2022 || likely active or activable | ||
|- | |- | ||
| | |106. Cytokinin response regulators, (ARRs), (Ferreira) || (G/A)GGAT(T/C) || Present || 225 || [[Cytokinin response regulator gene transcriptions|Cytokinin response regulators]] 03:25, 31 October 2022 || likely active or activable | ||
|- | |- | ||
| | |107. Cytokinin response regulators, (ARRs), (Rashotte1) || GATCTT || Present || 226 || [[Cytokinin response regulator gene transcriptions|Cytokinin response regulators]] 16:21, 31 October 2022 || likely active or activable | ||
|- | |- | ||
| | |108. Cytokinin response regulators, (ARRs), (Rashotte2) || (G/A)GAT(T/C) || Present || 228 || [[Cytokinin response regulator gene transcriptions|Cytokinin response regulators]] 20:24, 1 November 2022 || likely active or activable | ||
|- | |||
( | |109. Cytoplasmic polyadenylation elements, (CPEs) || TTTTTAT || Present || 160 || [[Cytoplasmic polyadenylation element gene transcriptions|Cytoplasmic polyadenylation elements]] 06:10, 25 July 2022 || likely active or activable | ||
|| (G/ | |- | ||
|110. DAF-16-associated elements, (DAE), (Li) || TGATAAG || Absent || 47 || [[DAF-16-associated element gene transcriptions|DAF-16-associated elements]] 22:51, 3 December 2020 || 4<sup>7</sup> | |||
|- | |||
|111. DAF-16 binding elements || (A/G)(C/T)AAA(C/T)A || Present || 229 || [[DAF-16 binding element gene transcriptions|DAF-16 binding elements]] 19:54, 2 November 2022 || likely active or activable | |||
|- | |||
|112. D-boxes, (Mracek1) || GTTGTATAAC || Absent || 49 || [[D box gene transcriptions|D-boxes]] 02:46, 10 December 2020 || 4<sup>10</sup> | |||
|- | |||
|113. D-boxes, (Mracek2) || CTTATGTAAA || Absent || 50 || [[D box gene transcriptions|D-boxes]] 02:20, 12 December 2020 || 4<sup>10</sup> | |||
|- | |- | ||
| | |114. D-boxes, (Johnson) || TCTCACATT(A/C)AATAAGTCA || Absent || 48 || [[D box gene transcriptions|D-boxes]] 04:12, 8 December 2020 || 2*4<sup>18</sup> | ||
|- | |- | ||
| | |115. D boxes, (Samarsky) || AGTCTG || Present || 262 || [[D box gene transcriptions|D boxes]] 00:16, 12 December 2022 || likely active or activable | ||
|- | |- | ||
| | |116. D boxes, (Voronina) || TCCTG || Present || 230 || [[D box gene transcriptions|D boxes]] 02:28, 4 November 2022 || likely active or activable | ||
|- | |- | ||
| | |117. D-boxes, (Motojima) || TGAGTGG || Present || 261 || [[D box gene transcriptions|D-boxes]] 00:11, 12 December 2022 || likely active or activable | ||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |118. Defense and stress-responsive elements, (Sharma) || ATTTTCTTCA || Absent || 51 || [[Defense and stress-responsive element gene transcriptions|Defense and stress-responsive elements]] 21:02, 13 December 2020 || 4<sup>10</sup> | ||
|- | |||
( | |119. Destruction box, (D box), (Pfleger and Kirschner 2000) || CGN(C/T)TNAAN || Present || 371 || [[D box gene transcriptions|Destruction boxes]] 17:39, 15 May 2023 || likely active or activable | ||
|| | |- | ||
| | |120. Dioxin-responsive elements, (DREs) || TNGCGTG || Present || 231 || [[Xenobiotic response element gene transcriptions|Dioxin-responsive elements]] 20:43, 4 November 2022 || likely active or activable | ||
| | |- | ||
| | |121. DNA damage response elements, (DREs), (Smith) || TTTCAAT || Absent || 52 || [[DNA damage response element gene transcriptions|DNA damage response elements]] 12:25, 17 December 2020 || 4<sup>7</sup> | ||
| | |- | ||
| | |122. DNA damage response elements, (DREs), (Sumrada) || TAGCCGCCG of TAGCCGCCGRRRR || Absent || 276 || [[DNA damage response element gene transcriptions|DNA damage response elements]] 06:31, 17 December 2022 || 4<sup>9</sup>-2<sup>4</sup>*4<sup>9</sup> | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |123. DNA replication-related elements, (DREs), (Hirose) || TATCGATA || Absent || 53 || [[DNA replication-related element gene transcriptions|DNA replication-related elements]] 02:56, 20 December 2020 || 4<sup>8</sup> | ||
|| | |||
|- | |- | ||
| | |124. Downstream B recognition elements || (A/G)T(A/G/T)(G/T)(G/T)(G/T)(G/T) || Present || 278 || [[Downstream TFIIB recognition element gene transcriptions|Downstream B recognition elements]] 22:45, 20 December 2022 || likely active or activable, negatives > randoms, positives overlap or outside randoms | ||
|- | |- | ||
| | |125. Downstream core elements, (DCESIs) || CTTC of CTTC...CTGT...AGC || Present || 279 || [[Downstream core element gene transcriptions|Downstream core elements]] 21:36, 22 December 2022 || likely active or activable, depending on overlaps | ||
|- | |- | ||
| | |126. Downstream core elements, (DCESIIs) || CTGT of CTTC...CTGT...AGC || Present || 280 || [[Downstream core element gene transcriptions|Downstream core elements]] 06:59, 26 December 2022 || likely active or activable, depending on overlaps | ||
|- | |- | ||
| | |127. Downstream core elements, (DCESIIIs) || AGC of CTTC...CTGT...AGC || Present || 281 || [[Downstream core element gene transcriptions|Downstream core elements]] 02:54, 28 December 2022 || likely active or activable, depending on overlaps | ||
|- | |- | ||
| | |128. Downstream promoter elements, (DPEs), (Juven-Gershon 2010) || RGWYVT, (A/G)G(A/T)(C/T)(A/C/G)T || Present || 157 || [[Downstream promoter element gene transcriptions|Downstream promoter elements]] 05:18, 17 July 2022 || most or all of the real DPE (Juven-Gershon)s are likely active or activable | ||
|- | |- | ||
| | |129. Downstream promoter elements, (DPEs), (Butler 2002) || RGWYV or (A/G)G(A/T)(C/T)(A/C/G) || Present || 3 || [[Downstream promoter element gene transcriptions|Downstream promoter elements]] 00:22, 13 October 2019 || likely active or activable | ||
|- | |||
( | |130. Downstream promoter elements, (DPEs) (Butler 2002) || RGWYV or (A/G)G(A/T)(C/T)(A/C/G) || Present || 376 || [[Downstream promoter element gene transcriptions|Downstream promoter elements]] 19:59, 15 June 2023 || likely active or activable | ||
|| | |- | ||
| | |131. Downstream promoter elements, (DPEs), (Kadonaga) || (A/G)G(A/T)CGTG || Present || 155 || [[Downstream promoter element gene transcriptions|Downstream promoter elements]] 20:16, 16 July 2022 || likely active or activable | ||
| | |- | ||
| | |132. Downstream promoter elements, (DPEs), (Matsumoto) || AGTCTC || Present || 156 || [[Downstream promoter element gene transcriptions|Downstream promoter elements]] 21:32, 16 July 2022 || likely active or activable | ||
| | |- | ||
| | |133. Downstream TFIIB recognition elements (BRE<sup>d</sup>, dBRE) (Deng 2005) || (A/G)T(A/G/T)(G/T)(G/T)(G/T)(G/T) || Present || 6 || [[Downstream TFIIB recognition element gene transcriptions|Downstream TFIIB recognition elements]] 23:26, 26 December 2019 || likely active or activable | ||
| | |- | ||
| | |134. DREB boxes (CRT/DREB box) || TACCGACAT || Absent || 21 || [[DREB box gene transcriptions|DREB boxes]] 17:03, 28 December 2019 || 4<sup>9</sup> | ||
| | |- | ||
| | |135. E2 boxes || (A/G)CAGNTGN || Present || 195 || [[E2 box gene transcriptions|E2 boxes]] 17:04, 3 October 2022 || likely active or activable | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |136. EIF4E basal elements (poly(C) motif) || TTACCCCCCCTT || Absent || 15 || [[EIF4E basal element gene transcriptions|EIF4E basal elements]] 05:11, 13 October 2019 || 4<sup>12</sup> | ||
|- | |- | ||
| | |137. EIN3 binding sites || A(C/T)G(A/T)A(C/T)CT || Present || 282 || [[EIN3 binding site gene transcriptions|EIN3 binding sites]] 01:44, 29 December 2022 || likely active or activable | ||
( | |||
|| | |||
|- | |- | ||
| | |138. Endoplasmic reticulum stress response elements, (ERSE) || CCAAT-N9-CCACG || Absent || 284 || [[Endoplasmic reticulum stress response element gene transcriptions|Endoplasmic reticulum stress response elements]] 01:58, 31 December 2022 || 4<sup>10</sup> | ||
|- | |||
| | |139. Endoplasmic reticulum stress response elements, (ESRE2) || CCACG, for part 1 (CCAAT) see Hap motif || Present || 283 || [[Endoplasmic reticulum stress response element gene transcriptions|Endoplasmic reticulum stress response elements]] 01:57, 31 December 2022 || likely active or activable | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |140. Endosperm expressions || TGTGTCA || Present || 285 || [[Endosperm expression gene transcriptions|Endosperm expressions]] 03:16, 31 December 2022 || likely active or activable | ||
|- | |- | ||
| | |141. Enhancer boxes (E-box), (Massari 2000) || CANNTG || Present || 7 || [[Enhancer box gene transcriptions|Enhancer boxes]] 00:09, 13 October 2019 || likely active or activable | ||
|- | |- | ||
| | |142. Estrogen response elements, (EREs), (Matsumoto) || AGGTTA or GGTCAGGAT of AGGTTATTGCCTCCT or GGTCAGGATGAC || Absent || 335 || [[Estrogen response element gene transcriptions|Estrogen response elements]] 05:34, 9 March 2023 || 4<sup>6</sup>-4<sup>12</sup> | ||
|- | |- | ||
| | |143. Estrogen response elements, (EREs), (Yasar) || GGTCAGGATGAC || Absent || 336 || [[Estrogen response element gene transcriptions|Estrogen response elements]] 05:37, 9 March 2023 || 4<sup>12</sup> | ||
|- | |- | ||
| | |144. Estrogen response elements, (ERE1s), (Driscoll) || GGTCA || Present || 338 || [[Estrogen response element gene transcriptions|Estrogen response elements]] 03:27, 14 March 2023 || likely active or activable | ||
|- | |||
|145. Estrogen response elements, (ERE2s), (Driscoll) || TGACC || Present || 339 || [[Estrogen response element gene transcriptions|Estrogen response elements]] 03:37, 14 March 2023 || likely active or activable | |||
| | |- | ||
| | |146. Ethylene responsive elements, (EtREs) || ATTTCAAA || Present || 237 || [[Ethylene responsive element gene transcriptions|Ethylene responsive elements]] 18:06, 5 November 2022 || likely active or activable | ||
| | |- | ||
| | |147. F boxes, (Rose) || TGATAAG || Absent || 67 || [[I box gene transcriptions|F boxes]] 05:52, 28 January 2021 || 4<sup>7</sup>, F-box overlaps the I-box | ||
| | |- | ||
| | |148. Forkhead boxes, (FOXO1), (Yoshihara) || GTAAACAA || Absent || 351 || [[Forkhead box gene transcriptions|Forkhead boxes]] 04:33, 20 April 2023 || 4<sup>8</sup> | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |149. Forkhead boxes, (FOXA2), (Li 2017) || (A/G)(C/T)AAA(C/T)A || Present || 286 || [[Forkhead box gene transcriptions|Forkhead boxes]] 03:54, 1 January 2023 || likely active or activable | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |150. GAAC elements || GAACT || Present || 287 || [[GAAC element gene transcriptions|GAAC elements]] 22:49, 1 January 2023 || likely active or activable | ||
|- | |- | ||
| | |151. Galactose-inducible transcription activator 4s, (Gal4s), (Tang) || CGG(A/G)NN(A/G)C(C/T)N(C/T)NCNCCG || Absent || 54 || [[Gal4p gene transcriptions|Gal4ps]] 22:28, 31 December 2020 || 4<sup>10</sup> | ||
|- | |- | ||
| | |152. γ-interferon activated sequences, (GAS) || TTCCTAGAA || Absent || 352 || [[Γ-interferon activated sequence gene transcriptions|γ-interferon activated sequences]] 18:24, 20 April 2023 || 4<sup>9</sup> | ||
|- | |- | ||
| | |153. Γ-interferon activated sequences, (GAS) || TTNCNNNAA || Present || 288 || [[Γ-interferon activated sequence gene transcriptions|Γ-interferon activated sequences]] 01:56, 3 January 2023, see STAT5 || likely active or activable | ||
|| | |||
|- | |- | ||
| | |154. GATA boxes || GATA || Present || 258 || [[GATA gene transcriptions|GATA boxes]] 06:29, 8 December 2022 || likely active or activable, may be random in proximals | ||
|- | |- | ||
| | |155. GATA (GATAAG, GATAAH, GATTA) motifs, (Staschke) || GAT(A/T)A || Present || 259 || [[GATA gene transcriptions|GATA (GATAAG, GATAAH, GATTA) motifs]] 20:11, 9 December 2022 || likely active or activable | ||
|- | |- | ||
| | |156. GATC repeats, (ABREN), (Watanabe ''et al''. 2017) | ||
|| GATC || Present || 369 || [[ABA-response element gene transcriptions|GATC samplings]] 20:08, 11 May 2023 || GATC UTRs, proximals and positive strand, negative direction distals greater than randoms, negative strand, negative direction distals, positive direction distals likely randoms. GATCs are likely active or activable | |||
( | |||
(Watanabe) | |||
|| | |||
|- | |- | ||
| | |157. G boxes, (Song) || (G/T)CCACGTG(G/T)C || Absent || 115 || [[G box gene transcriptions|G boxes]] 03:20, 25 July 2021 || 4<sup>9</sup> | ||
|- | |||
( | |158. G-box motif, (Oeda) || GCCACGTGGC || Absent || 114 || [[G box gene transcriptions|G boxes]] 04:25, 20 July 2021 || 4<sup>10</sup>, no "perfect palindrome" G boxes in either promoter | ||
|- | |||
( | |159. GC boxes, (Briggs 1986), (Rroji 2021) || (G/T)(G/A)GGCG(G/T)(G/A)(G/A)(C/T) || Present || 289 || [[GC box gene transcriptions|GC boxes]] 16:57, 3 January 2023 || likely active or activable | ||
|| | |- | ||
|160. GC boxes, (Ye 2019) || GGGCGG || Present || 290 || [[GC box gene transcriptions|GC boxes]] 08:28, 4 January 2023 || likely active or activable | |||
|- | |- | ||
| | |161. GCC boxes, (Sato 1996) || GCCGCC || Present || 291 || [[AGC box gene transcriptions|GCC boxes]] 06:52, 5 January 2023 || likely active or activable | ||
|- | |- | ||
| | |162. GCN4 motifs, (Zhang 2014) || TGA(C/G)TCA || Absent || 185 || [[GLM box gene transcriptions#GCN4 motifs|GCN4 motifs]] 05:52, 30 September 2022 || 4<sup>7</sup> | ||
|- | |- | ||
| | |163. General control nonderepressible 4 protein binding sites, (Staschke 2010), (GCRE, GCN4) || TGA(C/G/T)T(A/C/G)(A/T) || Present || 292 || [[Gcn4p gene transcriptions|General control nonderepressible 4 protein binding site]] 07:05, 5 January 2023 || likely active or activable | ||
( | |||
|| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |164. Gcn4ps, (Tang) || ATGACTCTT || Absent || 245 || [[Gcn4p gene transcriptions|Gcn4ps]] 22:17, 15 November 2022 || 4<sup>9</sup> | ||
|- | |||
( | |165. GGCGGC triplet || GGCGGC || Present || 293 || [[GGC triplet gene transcriptions|GGCGGC triplet]] 00:32, 7 January 2023 || likely active or activable | ||
|| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |166. GGC triplets || GGC || Present || 295 || [[GGC triplet gene transcriptions|GGC triplets]] 19:40, 7 January 2023 || likely active or activable | ||
|- | |- | ||
| | |167. Gibberellic acid responsive elements-like 1, (GAREL1s) || TAACA(A/G)A || Present || 238 || [[GARE gene transcriptions|Gibberellic acid responsive elements-like 1]] 19:12, 5 November 2022 || likely active or activable | ||
|- | |- | ||
| | |168. Gibberellin responsive element-like 2, (GARE-like 2), (Fan) || TAACGTA || Absent || 55 || [[GARE gene transcriptions|Gibberellin responsive element-like 2]] 06:39, 2 January 2021 || 4<sup>7</sup> | ||
|| | |||
|- | |- | ||
| | |169. Gibberellin responsive elements, (GREs), (Sharma) || AAACAGA || Present || 296 || [[Gibberellin responsive element gene transcriptions|Gibberellin responsive elements]] 01:19, 8 January 2023 || likely active or activable | ||
|- | |- | ||
| | |170. GLM boxes, (GCN4-like motif) || (G/A)TGA(G/C)TCA(T/C) || Absent || 20 || [[GLM box gene transcriptions|GLM boxes]] 04:17, 13 October 2019 || 2<sup>3</sup>*4<sup>6</sup> | ||
|- | |||
( | |171. Glucocorticoid response elements, (GlRE), (Parsonnet 2019) || AGAACA || Present || 260 || [[Glucocorticoid response element gene transcriptions|Glucocorticoid response elements]] 05:34, 10 December 2022 || likely active or activable | ||
|| | |- | ||
|172. Glucose transporter gene repressor, (Rgt1), (Kim 2019) || CGG(A/G)(A/T)N(A/T)(A/T) || Present || 311 ||[[Rgt1p gene transcriptions|Glucose transporter gene repressor]] 20:06, 21 January 2023 || likely active or activable | |||
|- | |- | ||
| | |173. G-protein-coupled receptors,(GCR1s), CT boxes || CTTCC || Present || 297 || [[Gcr1p gene transcriptions|G-protein-coupled receptors]] 03:36, 8 January 2023 || likely active or activable | ||
|- | |- | ||
| | |174. Grainy head transcription factor binding sites || AACCGGTT || Absent || 56 || [[Grainy head transcription factor gene transcriptions|Grainy head transcription factor binding sites]] 23:33, 6 January 2021 || 4<sup>8</sup> | ||
|- | |- | ||
| | |175. Grainy head transcription factor binding sites || GACTGGTT || Absent || 354 || [[Grainy head transcription factor gene transcriptions|Grainy head transcription factor binding sites]] 07:13, 22 April 2023 || 4<sup>8</sup> | ||
|| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |176. GT boxes, (Motojima) || TGGGTGGGGCT || Absent || 57 || [[TC element gene transcriptions|GT boxes]] 00:39, 11 January 2021 || (-78 to -69) 4<sup>11</sup> | ||
|- | |- | ||
| | |177. GT boxes, (Sato) || GGGG(T/A)GGGG || Present || 298 || [[TC element gene transcriptions|GT boxes]] 04:33, 8 January 2023 || likely active or activable | ||
|- | |||
|178. Hac1, ''KAR2'' || CAGCGTG || Present || 299 || [[Hac1p gene transcriptions|Hac1]] 05:27, 8 January 2023 || likely active or activable | |||
|- | |||
( | |179. H and ACA boxes || AGAGGA || Present || 301 || [[H and ACA box gene transcriptions|H and ACA boxes]] 04:33, 9 January 2023 || likely active or activable, negative distals likely random | ||
|| | |- | ||
| | |180. Hapless motifs (Ozsarac 1997) || CCAATCA || Absent || 150 || [[Middle sporulation element gene transcriptions|Hapless motifs]] 02:33, 30 June 2022 || heterotrimeric transcription factor, HAP2/3/4 4<sup>7</sup> | ||
| | |- | ||
| | |181. Hap motif (Hap4p) || CCAAT || Present || 302 || [[CAAT box gene transcriptions|Hap motif]] 20:38, 9 January 2023 and [[Endoplasmic reticulum stress response element gene transcriptions#CCAAT samplings|ESRE CCAAT]] || likely active or activable | ||
| | |- | ||
| | |182. H-boxes, (Grandbastien) || CC(A/T)ACCNNNNNNN(A/C)T || Present || 121 || [[H box gene transcriptions|H-boxes]] 16:34, 7 May 2022 || likely active or activable | ||
| | |- | ||
| | |183. H-boxes, (Lindsay) || CCTACC || Present || 124 || [[H box gene transcriptions|H-boxes]] 14:39, 8 May 2022 || likely active or activable, equal to or greater than the randoms for the negative direction distals | ||
| | |- | ||
| | |184. H box, (Mitchell) || ANANNA || Present || 266 || [[H box gene transcriptions|H box]] 20:03, 12 December 2022 || likely active or activable | ||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |185. H box, (Rozhdestvensky) || ACACCA || Present || 120 || [[H box gene transcriptions|H box]] 05:46, 5 May 2022 || likely active or activable | ||
|- | |||
( | |186. Heat-responsive elements || AAAAAATTTC || Absent || 58 || [[Heat-responsive element gene transcriptions|Heat-responsive elements]] 02:10, 14 January 2021 || four nGAAn motifs 4<sup>10</sup> | ||
|| | |- | ||
| | |187. Heat shock elements, (HSE1), (Eastmond) || nGAAnnTTCnnGAAn || Absent || 59 || [[Hsf1p gene transcriptions|Heat shock elements]] 04:13, 20 January 2021 || HSE1 4<sup>9</sup> | ||
| | |- | ||
| | |188. Heat shock elements, (HSE2), (Eastmond) || nTTCnnGAAnnTTCn || Absent || 127 || [[Hsf1p gene transcriptions|Heat shock elements]] 16:30, 10 May 2022 || HSE2 is the inverse complement of HSE1 4<sup>9</sup> | ||
| | |- | ||
| | |189. Heat shock elements, (HSE3s), (Eastmond) || nGAAn-(5-bp)-nGAAnnTTCn || Present || 130 || [[Hsf1p gene transcriptions|Heat shock elements]] 17:47, 13 May 2022 || likely active or activable | ||
| | |- | ||
| | |190. Heat shock elements, (HSEs), (Eastmond) || nGA(A/G)n-(5-bp)-nGAAnnTTCn (GAP1) || Present || 132 || [[Hsf1p gene transcriptions|Heat shock elements]] 16:28, 16 May 2022 || same result as HSE3, likely active or activable | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |191. Heat shock elements, (HSEs), (Eastmond) || nGAAn-(5-bp)-nGA(A/G)nnTTCn (GAP2) || Present || 133 || [[Hsf1p gene transcriptions|Heat shock elements]] 06:36, 17 May 2022 || same result as HSE3, likely active or activable | ||
|- | |- | ||
| | |192. Heat shock elements, (HSE4s), (Eastmond) || nGAAn-(5-bp)-nGAAn-(5-bp)-nGAAn || Present || 131 || [[Hsf1p gene transcriptions|Heat shock elements]] 05:14, 14 May 2022 || likely active or activable | ||
|- | |- | ||
| | |193. Heat shock elements, (HSE5), (Eastmond) || nTTCn-(5-bp)-nTTCnnGAAn || Absent || 60 || [[Hsf1p gene transcriptions|Heat shock elements]] 02:49, 23 January 2021 || HSE5 4<sup>9</sup> | ||
|| | |||
|- | |- | ||
| | |194. Heat shock elements, (HSE6), (Eastmond) || nTTCn-nnGAAn-(5-bp)-nGAAn || Absent || 61 || [[Hsf1p gene transcriptions|Heat shock elements]] 18:05, 23 January 2021 || HSE6 4<sup>9</sup> | ||
|- | |- | ||
| | |195. Heat shock elements, (HSE7), (Eastmond) || nGA(A/G)nnTTCnnGAAn || Absent || 62 || [[Hsf1p gene transcriptions|Heat shock elements]] 22:36, 23 January 2021 || HSE7 PFT1 2*4<sup>8</sup> | ||
|- | |- | ||
| | |196. Heat shock elements, (HSE), (Eastmond) || nGAAnnTTCnnGA(A/G)n || Absent || 63 || [[Hsf1p gene transcriptions|Heat shock elements]] 05:45, 24 January 2021 || HSE7 PFT2 2*4<sup>8</sup> | ||
|- | |- | ||
| | |197. Heat shock elements, (HSE10), (Eastmond) || nTTCn-(11-bp)-nGAAn-(5 bp)-nGAAn || Absent || 64 || [[Hsf1p gene transcriptions|Heat shock elements]] 22:33, 26 January 2021 || HSE10 4<sup>9</sup> | ||
|- | |- | ||
| | |198. Heat shock factors, (Hsfs), (Tang) || NGAAN || Present || 128 || [[Hsf1p gene transcriptions|Heat shock factors]] 06:01, 11 May 2022 || likely active or activable | ||
|| | |||
|- | |- | ||
| | |199. Helper site, (Atcha et al. 2007), (Cadigan and Waterman 2012) || (C/G)C(C/G)G(C/G) || Present || 368 || [[HMG box gene transcriptions|Helper site]] 10:54, 10 May 2023 || likely active or activable | ||
|- | |- | ||
| | |200. Hepatic nuclear factors (HNFs) || (A/G/T)(A/T)(A/G)T(C/T)(A/C/G)AT(A/C/G/T)(A/G/T) || Present || 135 || [[HNF gene transcriptions|HNF6s]] 17:53, 20 May 2022 || likely active or activable, although the negative direction distals are at or less than randoms | ||
|- | |- | ||
| | |201. Hex sequences || TGACGTGGC || Present || 134 || [[Hex sequence gene transcriptions|Hex sequences]] 19:57, 17 May 2022 || likely active or activable | ||
|- | |- | ||
| | |202. High Mobility Group boxes, (HMG boxes) || (A/T)(A/T)CAAAG || Present || 358 || [[HMG box gene transcriptions|High Mobility Group boxes]] 22:01, 30 April 2023 || likely active or activable | ||
|- | |- | ||
| | |203. Homeoboxes || CAAG || Present || 253 || [[Homeobox gene transcriptions|Homeoboxes]] 04:28, 4 December 2022 || likely active or activable, occurs in Rox1ps | ||
|- | |- | ||
| | |204. Homeodomains || TAAT || Present || 254 || [[Homeobox gene transcriptions|Homeodomains]] 19:46, 4 December 2022 || likely active or activable, low occurrence UTRs and negative direction distals overlap high randoms, occurs in CArG boxes and Pribnow boxes | ||
| | |- | ||
| | |205. HY boxes || TG(A/T)GGG || Present || 136 || [[HY box gene transcriptions|HY boxes]] 12:43, 25 May 2022 || likely active or activable | ||
| | |- | ||
| | |206. Hypoxia-inducible factors, (HIF-1), (Li 2020) || GCCCTACGTGCTGTCTCA || Absent || 65 || [[Hypoxia-inducible factor gene transcriptions|Hypoxia-inducible factors]] 16:43, 27 January 2021 || composed of HIF-1α and HIF-1β 4<sup>18</sup> | ||
| | |- | ||
| | |207. Hypoxia-inducible factors (HIF) (Orlando 2019), ABA-response element (ABRE) (Asad 2019) || ACGTG || Present || 37 || [[Hypoxia-inducible factor gene transcriptions|Hypoxia-inducible factors]] 06:03, 7 May 2021, [[ABA-response element gene transcriptions|ABA-response element (ABRE)]] 03:06, 8 October 2020 || likely active or activable | ||
| | |- | ||
| | |208. Hypoxia response elements (HRE) (Orlando 2019) || CACGC || Present || 109 || [[Hypoxia response element gene transcriptions|Hypoxia response elements]] 05:04, 7 May 2021 || likely active or activable | ||
| | |- | ||
| | |209. I boxes || GATAAG of GGATGAGATAAGA || Absent || 66 || [[I box gene transcriptions|I boxes]] 05:49, 28 January 2021 || 4<sup>13</sup> | ||
| | |||
| | |||
| | |||
|- | |- | ||
| | |210. Initiator element (Inr) (Liston 1999) || YYA<sub>+1</sub>NWYY || Present || 2 || [[Initiator element gene transcriptions|Initiator elements]] 04:01, 13 October 2019 || likely active or activable | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |211. Initiator element (Inr) (Juven-Gershon 2008) || YYR<sub>+1</sub>NWYY || Present || 24 || [[Initiator element gene transcriptions|Initiator elements]] 17:44, 27 September 2020 || likely active or activable | ||
|- | |- | ||
| | |212. Initiator element (Inr) (Ngoc 2017) || BBCA<sub>+1</sub>BW || Present || 13 || [[Initiator element gene transcriptions|Initiator elements]] 14:57, 5 June 2022 || likely active or activable | ||
|- | |- | ||
| | |213. Initiator element (Inr), ''Drosophila melanogaster'' (Butler 2002) || TCA<sub>+1</sub>(G/T)T(C/T) || Present || 375 || [[Initiator element gene transcriptions|Initiator elements]] 06:40, 21 June 2023 || likely active or activable, UTRs are likely random | ||
| | |- | ||
| | |214. Initiator element-like (Inr-like) (Matsumoto 2020) || TTCTCT || Present || 25 || [[Initiator-like element gene transcriptions|Initiator-like elements]] 01:25, 29 September 2020 || likely active or activable | ||
| | |- | ||
| | |215. Initiator element-like (TCT) (Parry 2010) || (C/T)CT(C/T)T(C/T)(C/T) || Present || 346 || [[Initiator-like element gene transcriptions|Initiator-like elements]] 22:06, 10 April 2023 || likely active or activable | ||
| | |- | ||
| | |216. Inositol/choline-responsive elements, (ICRE), (Case) || CANNTGAAAT || Absent || 68 || [[Inositol, choline-responsive element gene transcriptions|Inositol/choline-responsive elements]] 21:43, 29 January 2021 || version of Lopes, see below 4<sup>8</sup> | ||
| | |- | ||
| | |217. Inositol/choline-responsive elements, (ICRE), (Case, Lopes) || CATGTGAAAT includes the canonical basic helix-loop-helix (bHLH) binding site CANNTG || Present || 139 || [[Inositol, choline-responsive element gene transcriptions|Inositol/choline-responsive elements]] 23:14, 9 June 2022 || likely active or activable | ||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |218. Inositol/choline-responsive elements, (ICRE), (Lopes) || ATGTGAAAT || Absent || 137 || [[Inositol, choline-responsive element gene transcriptions|Inositol/choline-responsive elements]] 23:01, 7 June 2022 || 4<sup>9</sup>, using ANNTGAAAT, likely active or activable | ||
|- | |- | ||
| | |219. Inositol/choline-responsive elements, (ICREs), (Schwank) || TYTTCACATGY contains the core sequence CANNTG || Present || 138 || [[Inositol, choline-responsive element gene transcriptions|Inositol/choline-responsive elements]] 05:39, 9 June 2022 || likely active or activable | ||
|- | |- | ||
| | |220. Interferon regulatory factor, (IRF3) || GCTTTCC || Present || 359 || [[Interferon regulatory factor gene transcriptions|Interferon regulatory factor]] 03:07, 2 May 2023 || likely active or activable | ||
|- | |- | ||
|106 | |221. Interferon-stimulated response elements, (ISREs), (Michalska) || AGTTTCN<sub>2</sub>TTTCN || Absent || 106 || [[Interferon regulatory factor gene transcriptions|Interferon-stimulated response elements]] 15:43, 28 March 2021 || 4<sup>10</sup> | ||
|- | |- | ||
| | |222. Interferon-stimulated response elements, (ISREs), (Lu) || GAAANNGAAA || Present || 140 || [[Interferon regulatory factor gene transcriptions|IFN-stimulated response elements]] 06:41, 12 June 2022 || likely active or activable | ||
|| | |||
|- | |- | ||
| | |223. IRS consensus, (Fujii) || AANNGAAA || Present || 141 || [[Interferon regulatory factor gene transcriptions|IRS consensus]] 03:16, 14 June 2022 || likely active or activable | ||
( | |||
|| | |||
|- | |- | ||
| | |224. Jasmonic acid-responsive elements, (JAREs) || TGACG || Present || 144 || [[Jasmonic acid-responsive element gene transcriptions|Jasmonic acid-responsive elements]] 23:12, 20 June 2022 || likely active or activable | ||
|- | |- | ||
| | |225. K-boxes, (Saito 2020) || GTTCGG-NNAN-CCNNAC || Absent || 104 || [[K-box gene transcriptions|K-boxes]] 22:22, 17 March 2021 || 4<sup>11</sup> | ||
|| | |||
|- | |- | ||
| | |226. K-box1s, (Saito 2020) || GTTCGG || Present || 366 || [[K-box gene transcriptions|K-boxes]] 20:59, 4 May 2023 || likely active or activable | ||
|- | |- | ||
| | |227. KEN box, (Pfleger and Kirschner 2000) || AA(A/G)GA(A/G)AA(C/T) || Present || 372 || [[D box gene transcriptions|KEN boxes]] 20:13, 15 May 2023 || likely active or activable | ||
|- | |- | ||
| | |228. Kozak sequences, (Kozak 1987) || GCCGCC(A/G)CCATGG || Absent || 103 || [[Kozak sequence gene transcriptions|Kozak sequences]] 18:12, 17 March 2021 || 2*4<sup>12</sup> | ||
|- | |- | ||
| | |229. Kozak sequences, (Matsumoto) || GAAAATGG || Absent || 69 || [[Kozak sequence gene transcriptions|Kozak sequences]] 01:16, 2 February 2021 || 4<sup>8</sup> | ||
|- | |||
( | |230. Krüppel-like factors || GGGNN(G/T)(G/T)(G/T) || Present || 145 || [[Krüppel-like factor gene transcriptions|Krüppel-like factors]] 18:25, 23 June 2022 || likely active or activable | ||
|- | |||
( | |231. L boxes (Donald) || AAATTAACCAA || Absent || 70 || [[L box gene transcriptions|L boxes]] 04:21, 2 February 2021 || 4<sup>11</sup> | ||
|| | |- | ||
| | |232. Leu3 transcription factors, (Leu3), (Reddy 2020) || (C/G)C(G/T)NNNN(A/C)G(C/G) || Present || 294 || [[Leu3 gene transcriptions|Leu3 transcription factors]] 04:52, 7 January 2023 || likely active or activable | ||
| | |- | ||
| | |233. M3 motif || (C/G)CGGAAG(C/T) or SCGGAAGY || Present || 373 || [[TATA box gene transcriptions|M3 motif]] 05:47, 6 June 2023 || likely active or activable | ||
| | |- | ||
| | |234. M22 || TGCGCAN(G/T) or TGCGCANK || Present || 374 || [[TATA box gene transcriptions|M22 samplings]] 00:52, 11 June 2023 || likely active or activable | ||
| | |- | ||
| | |235. M35 or -35 sequence || TTGACA || Present || 146 || [[M35 box gene transcriptions|-35 sequence]] 16:16, 25 June 2022 || likely active or activable, the UTR does overlap the randoms at the random's upper end | ||
| | |- | ||
| | |236. Maf recognition element, (MAREs), (Kyo) || TGCTGA(G/C)TCAGCA || Absent || 71 || [[Maf recognition element gene transcriptions|Maf recognition element]] 03:29, 3 February 2021 || 2*4<sup>12</sup> | ||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |237. M boxes, (Bertolotto) || GTCATGTGCT or AGTCATGTGCT || Absent || 72 || [[M box gene transcriptions|M boxes]] 16:05, 3 February 2021 || 4<sup>10</sup>-4<sup>11</sup> | ||
|- | |||
|238. M-CAT boxes, (Berberich 1993) || GCGGCCTC || Absent || 349 || [[CAT box gene transcriptions|M-CAT boxes]] 18:06, 18 April 2023 || 4<sup>8</sup> | |||
|| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |239. Mcm1 regulatory factors, (Rossi) || TT(A/T)CCNN(A/T)TNGG(A/T)AA || Absent || 73 || [[Mcm1 regulatory factor gene transcriptions|Mcm1 regulatory factors]] 03:17, 4 February 2021 || 2<sup>3</sup>*4<sup>9</sup> | ||
( | |||
( | |||
|| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |240. Mcm1 regulatory factors, (Rossi) || TTNCCNNNTNNGGNAA || Absent || 111 || [[Mcm1 regulatory factor gene transcriptions|Mcm1 regulatory factors]] 04:32, 9 June 2021 || 4<sup>9</sup> | ||
|- | |- | ||
| | |241. Met3s, (Blaiseau) || TCACGTG || Absent || 148 || [[Met31p box gene transcriptions|Met3s]] 08:09, 27 June 2022 || 4<sup>7</sup> | ||
|- | |- | ||
| | |242. Met31ps, (Blaiseau) || AAACTGTG || Present || 147 || [[Met31p box gene transcriptions|Met31ps]] 07:26, 27 June 2022 || likely active or activable | ||
|- | |- | ||
| | |243. Metal responsive elements, (MRE) || TGC(A/G)C(A/C/G/T)C || Present || 149 || [[Metal responsive element gene transcriptions|Metal responsive elements]] 02:25, 30 June 2022 || likely active or activable | ||
|- | |- | ||
| | |244. Middle sporulation element, (MSE), (Branco) || ACACAAA || Present || 151 || [[Middle sporulation element gene transcriptions|Middle sporulation element]] 05:04, 2 July 2022 || likely active or activable | ||
|| | |||
|- | |- | ||
| | |245. Midsporulation element, (MSE), (Ozsarac) || C(A/G)CAAA(A/T) || Present || 169 || [[Middle sporulation element gene transcriptions|Midsporulation element]] 15:07, 14 August 2022 || likely active or activable | ||
( | |||
|| | |||
|- | |- | ||
| | |246. MITF E-box, (''MITF'') || CA(C/T)(A/G)TG, (CAYRTG) || Present || 360 || [[Enhancer box gene transcriptions|MITF E-box (CAYRTG)]] 16:09, 2 May 2023 || likely active or activable, negative distals overlap randoms at low end | ||
|- | |- | ||
| | |247. Motif ten elements (MTE) (Lim 2004) || C(C/G)A(A/G)C(C/G)(C/G)AACG(C/G), CSARCSSAACGS || Absent || 5 || [[Motif ten element gene transcriptions|Motif ten elements]] 06:49, 13 October 2019 || 2<sup>5</sup>*4<sup>7</sup> | ||
|- | |- | ||
| | |248. Multicopy inhibitor of the ''GAL1'' promoter, (''MIG1''), (Gancedo 1998) || (C/G)(C/T)GGGG || Present || 361 || [[Mig1p gene transcriptions|Multicopy inhibitor of the ''GAL1'' promoter]] 16:09, 2 May 2023 || likely active or activable, UTRs may be random | ||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |249. Musashi binding elements, (MBE1s) || (G/A)U<sub>1</sub>AGU || Present || 152 || [[Musashi binding element gene transcriptions|Musashi binding elements]] 15:31, 10 July 2022 || likely active or activable | ||
|- | |- | ||
| | |250. Musashi binding elements, (MBE2s) || (G/A)U<sub>2</sub>AGU || Present || 153 || [[Musashi binding element gene transcriptions|Musashi binding elements]] 06:37, 14 July 2022 || likely active or activable, negative direction distals may be random | ||
|- | |- | ||
| | |251. Musashi binding elements, (MBE3s) || (G/A)U<sub>3</sub>AGU || Present || 154 || [[Musashi binding element gene transcriptions|Musashi binding elements]] 19:37, 16 July 2022 || likely active or activable | ||
|- | |- | ||
| | |252. Myeloblastosis (MYB) ACGT-containing elements, (ACEs) || CACGT || Present || 159 || [[MYB recognition element gene transcriptions|MYB ACGT-containing elements]] 17:07, 22 July 2022 || likely active or activable, positive strand UTR is likely random, negative strand, positive direction distals are likely random | ||
|- | |- | ||
| | |253. Myeloblastosis recognition element, (MRE) || A(A/C)C(A/T)A(A/C)C || Present || 161 || [[MYB recognition element gene transcriptions|Myeloblastosis recognition element]] 15:36, 25 July 2022 || likely active or activable | ||
( | |||
( | |||
|| | |||
|- | |- | ||
| | |254. Myocyte enhancer factors, (MEFs) || (C/T)TA(A/T)(A/T)(A/T)(A/T)TA(A/G) || Present || 162 || [[Myocyte enhancer factor gene transcriptions|Myocyte enhancer factors]] 05:44, 28 July 2022 || likely active or activable | ||
( | |||
( | |||
|- | |- | ||
| | |255. Nanos/Pumilio response elements, (PREs) || TGTAAAT || Present || 163 || [[UTR promoter gene transcriptions|Nanos/Pumilio response elements]] 15:29, 31 July 2022 || likely active or activable | ||
|- | |- | ||
| | |256. N-boxes, (Lee) || CCGGAA || Present || 168 || [[N box gene transcriptions|N-boxes]] 05:07, 14 August 2022 ||likely active or activable | ||
|| | |||
|- | |- | ||
| | |257. N-boxes, (Bai) || CACGAG || Present || 167 || [[N box gene transcriptions|N-boxes]] 17:10, 10 August 2022 || likely active or activable | ||
|- | |- | ||
| | |258. N-boxes, (Gao) || CACGGC or CACGAC, CACG(A/G)C || Present || 166 || [[N box gene transcriptions|N-boxes]] 05:54, 7 August 2022 || likely active or activable | ||
( | |||
( | |||
|| | |||
|- | |- | ||
| | |259. N-boxes, (Leal) || CACNAG || Present || 165 || [[N box gene transcriptions|N-boxes]] 06:16, 5 August 2022 || likely active or activable | ||
|- | |- | ||
| | |260. Non-DiTyrosine 80 transcription factor DNA binding domain, (Ndt80) || (A/G/T)NC(A/G)CAAA(A/T) || Present || 170 || [[Ndt80p gene transcriptions|Non-DiTyrosine 80 transcription factor DNA binding domain]] 20:36, 17 August 2022 || likely active or activable | ||
( | |||
( | |||
|| | |||
|- | |- | ||
| | |261. Nuclear factor of activated T cells, (NFATs) || GGAAAA || Present || 171 || [[Nuclear factor of activated T cell gene transcriptions (NFAT)|Nuclear factor of activated T cells]] 22:08, 19 August 2022 || likely active or activable, negative direction distals likely random, complement and inverse of the [[Pyrimidine box gene transcriptions|Pyrimidine boxes]] | ||
|| | |||
|- | |- | ||
| | |262. NF‐κB/Rel family of eukaryotic transcription factors, (NF-κB) || CCCCTAAGGGG || Absent || 74 || [[Nuclear factor gene transcriptions|NF‐κB/Rel family of eukaryotic transcription factors]] 02:53, 9 February 2021 || 4<sup>11</sup> | ||
|- | |||
( | |263. NF𝜿B (Sato)(NF𝜿BSs) || GAATTC || Present || 323 || [[Nuclear factor gene transcriptions|NF𝜿B (Sato)]] 07:30, 8 February 2023 || likely active or activable | ||
( | |||
|| | |||
|- | |- | ||
| | |264. Nuclear factor 1, (NF-1) || TTGGCNNNNNGCCAA || Absent || 75 || [[Nuclear factor gene transcriptions|Nuclear factor 1]] 03:51, 9 February 2021 || palindromic sequence 4<sup>10</sup> | ||
|- | |- | ||
| | |265. Nuclear factor Ys || CCAATGG(A/C)(A/G) || Absent || 76 || [[Nuclear factor Y gene transcriptions|Nuclear factor Ys]] 04:48, 9 February 2021 || NF-Y is a trimeric complex 4<sup>8</sup> | ||
|- | |- | ||
| | |266. Nutrient-sensing response element 1, (NSRE) || GTTTCATCA || Present || 172 || [[Nutrient-sensing response element gene transcriptions|Nutrient-sensing response element 1]] 04:29, 21 August 2022 || likely active or activable | ||
|- | |- | ||
| | |267. Oaf1 transcription factor || CGGN<sub>3</sub>TNAN<sub>9-12</sub>CCG || Present || 173 || [[Oaf1p gene transcriptions|Oaf1 transcription factor]] 05:57, 31 August 2022 || likely active or activable | ||
|- | |- | ||
| | |268. Oresara1, (ORE1), (Matallana) || (A/C/G)(A/C)GT(A/G)N<sub>5,6</sub>(C/T)AC(A/G) || Present || 174 || [[ORE1 binding site gene transcriptions|ORESARA1]] 05:42, 4 September 2022 || likely active or activable | ||
|- | |- | ||
| | |269. Oresara1, (ORE1), (Olsen) || T(A/G/T)(A/G)CGT(A/G)(A/C/T)(A/G/T) || Present || 175 || [[ORE1 binding site gene transcriptions|ORESARA1]] 23:53, 7 September 2022 || likely active or activable | ||
|- | |- | ||
| | |270. p53 response elements || (A/G)(A/G)(A/G)C(A/T)(A/T)G(C/T)(C/T)(C/T) || Present || 176 ||[[P53 response element gene transcriptions|p53 response elements]] 18:30, 8 September 2022 || likely active or activable | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |271. p53 response elements, (Long1) || CAGGCCC || Present || 177 || [[P53 response element gene transcriptions|p53 response elements]] 03:26, 11 September 2022 || likely active or activable | ||
|- | |- | ||
| | |272. p53 response elements, (Long2) || GGGCGTG || Present || 178 || [[P53 response element gene transcriptions|p53 response elements]] 20:10, 13 September 2022 || likely active or activable | ||
|- | |- | ||
| | |273. p63 DNA binding sites, (Perez 2007) || (A/G)(A/G)(A/G)C(A/G)(A/T)G(C/T)(C/T)(C/T)(A/G)(A/G)(A/G)C(A/T)(C/T)G(C/T)(C/T)(C/T), RRRC(A/G)(A/T)GYYYRRRC(A/T)(C/T)GYYY || Absent || 78 || [[P63 DNA-binding site gene transcriptions|p63 DNA binding sites]] 04:14, 14 February 2021 || 4<sup>12</sup> | ||
( | |||
|| | |||
|- | |- | ||
| | |274. P-box (Mena) || (A/T)AAAG || Present || 180 || [[P box gene transcriptions|P-box (Mena)]] 22:30, 21 September 2022 || likely active or activable, the positive direction proximals overlap the randoms | ||
|- | |||
( | |275. P-box, (Motojima) || TGAGTTCA || Present || 181 || [[P box gene transcriptions|P-box]] 18:27, 24 September 2022 || likely active or activable | ||
|| | |- | ||
|276. P-box, (Yu) || GTAA(T/C) || Present || 179 || [[P box gene transcriptions|P-box]] 02:46, 18 September 2022 || likely active or activable with some overlapping the randoms | |||
|- | |||
|277. Pleiotropic drug resistance 1p (Pdr1p), (Tang 2020) || TCCGCGGA || Absent || 79 || [[Pdr1,3p gene transcriptions|Pdr1p/Pdr3ps]] 04:07, 15 February 2021 || Pdr1p/Pdr3p response elements (PDREs) 4<sup>8</sup> | |||
|- | |||
|278. Pleiotropic drug resistance 1p (Pdr1p), (Salin 2008) || TCCG(C/T)GG(A/G) || Present || 363 || [[Pdr1,3p gene transcriptions|Pdr1p/Pdr3ps]] 03:11, 4 May 2023 || likely active or activable | |||
|- | |- | ||
| | |279. Peroxisome proliferator-activated receptor alpha || CGACCCC || Present || 80 || [[Peroxisome proliferator hormone response element gene transcriptions|Peroxisome proliferator-activated receptor alpha]] 18:37, 15 February 2021 || likely active or activable, positive direction distal overlaps upper end of randoms | ||
|- | |- | ||
| | |280. Peroxisome proliferator hormone response elements, (PPREs) || AGGTCANAGGTCA || Absent || 81 || [[Peroxisome proliferator hormone response element gene transcriptions|Peroxisome proliferator hormone response elements]] 18:37, 15 February 2021 || PPARs/RXRs heterodimers bind to PPRE 4<sup>12</sup> | ||
|| | |||
|- | |- | ||
| | |281. Phosphate starvation-response transcription factor (Pho4) || CAC(A/G)T(T/G) || Present || 129 || [[Phosphate starvation-response transcription factor gene transcriptions|Pho4ps]] 16:20, 12 May 2022 || likely active or activable, positive strand of the UTRs is in the random range but the negative direction distals are outside the randoms | ||
( | |||
|| | |||
|- | |- | ||
| | |282. Pollen1 element with TCCACCATA || AGAAANNNNTCCACCATA || Absent || 303 || [[Pollen1 element gene transcriptions|Pollen1 with TCCACCATA]] 23:24, 9 January 2023 || adjacent co-dependent regulatory element TCCACCATA 4<sup>9</sup>-4<sup>14</sup> | ||
|| | |||
|- | |- | ||
| | |283. Pollen1 elements || AGAAA || Present || 304 || [[Pollen1 element gene transcriptions|Pollen1 elements]] 21:40, 10 January 2023 || likely active or activable | ||
|- | |- | ||
| | |284. Pollen1 element || TCCACCATA || Absent || 305 || [[Pollen1 element gene transcriptions|TCCACCATA]] 08:30, 11 January 2023 || no regulatory element TCCACCATA was found, nor its ci. 4<sup>9</sup> | ||
|| | |||
|- | |- | ||
| | |285. Polycomb response elements || CGCCAT(A/T)TT || Absent || 82 || [[Polycomb response element gene transcriptions|Polycomb response elements]] 06:52, 16 February 2021 || 2*4<sup>8</sup>-4<sup>9</sup> | ||
|- | |- | ||
| | |286. Polycomb response elements, (PRE) || GCCAT || Present || 306 || [[Polycomb response element gene transcriptions|Polycomb response elements]] 22:28, 13 January 2023 || likely active or activable | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |287. Pribnow boxes || TATAAT || Present || 307 || [[Pribnow box gene transcriptions|Pribnow boxes]] 03:43, 15 January 2023 || likely active or activable | ||
|| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |288. Prolamin boxes || TG(A/T)AAAG, TGTAAAG || Present || 308 || [[Prolamin box gene transcriptions|Prolamin boxes]] 06:14, 18 January 2023 || likely active or activable | ||
|- | |- | ||
| | |289. Q elements || AGGTCA || Present || 309 || [[Q element gene transcriptions|Q elements]] 20:23, 18 January 2023 See [[Retinoic acid response element gene transcriptions|Retinoic acid response element]] || likely active or activable | ||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |290. Quinone reductase response element, (QRDRE), (Yao) || TCCCCT of TCCCCTTGCGTG || Present || 232 || [[Xenobiotic response element gene transcriptions|Quinone reductase response element]] 05:08, 5 November 2022 || likely active or activable | ||
|- | |- | ||
| | |291. Rap1 regulatory factors || ACCC(A/G)N(A/G)CA || Absent || 85 || [[Rap1 regulatory factor gene transcriptions|Rap1 regulatory factors]] 05:04, 20 February 2021 || "(ACCCRnRCA), less than half of the sites were detectably bound"<ref name=Rossi/> 4<sup>7</sup> | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |292. Rap1 reduced consensus || (A/G)(A/C)ACCC(A/G)N(A/G)C(A/C)(C/T)(A/C) || Present || 240 || [[Rap1 regulatory factor gene transcriptions|Rap1 reduced consensus]] 03:47, 15 November 2022 || likely active or activable | ||
| | |- | ||
| | |293. Reb1 extended, (Rossi) || ATTACCCGAA || Absent || 113 || [[Reb1 general regulatory factor gene transcriptions|Extended Reb1]] 00:07, 20 June 2021 || 4<sup>10</sup> | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |294. Reb1 bound and exact occurrences || TTACCC(G/T) || Present || 241 || [[Reb1 general regulatory factor gene transcriptions|Reb1 bound and exact occurrences]] 16:38, 15 November 2022 || likely active or activable | ||
|- | |- | ||
| | |295. Retinoic acid response element || AG(A/G)TCA || Present || 310 || [[Retinoic acid response element gene transcriptions|Retinoic acid response element]] 19:56, 19 January 2023 || likely active or activable, positive direction distals appear random | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |296. Ribophorin (RPN) (Rpn4), PACE (proteasome associated control element) || GGTGGCAAA || Absent || 88 || [[Rpn4p gene transcriptions|Rpn4ps]] 03:15, 23 February 2021 || 4<sup>9</sup> | ||
( | |||
|- | |- | ||
| | |297. Rlm1ps || CTA(A/T)(A/T)(A/T)(A/T)TAG || Absent || 86 || [[Rlm1p gene transcriptions|Rlm1ps]] 05:55, 22 February 2021 || <sub>4</sub>TAG 2<sup>4</sup>*4<sup>6</sup> | ||
|- | |||
( | |298. RORE motif, (RORE) || A(A/T)NTAGGTCA || Present || 312 || [[ROR-response element gene transcriptions|classic RORE motif]] 05:51, 22 January 2023 || likely active or activable | ||
( | |||
|| | |||
|- | |- | ||
| | |299. RORE motif, variant || C(T/A)(G/A)GGNCA || Present || 313 || [[ROR-response element gene transcriptions|variant RORE motif]] 03:04, 24 January 2023 || likely active or activable | ||
|| C(A | |||
|- | |- | ||
| | |300. Rox1ps (Tang 2020) || RRRTAACAAGAG || Absent || 87 || [[Rox1p gene transcriptions|Rox1ps]] Heme-dependent repressor of hypoxic genes 21:50, 22 February 2021 || 2<sup>3</sup>*4<sup>9</sup> | ||
|| | |||
|- | |- | ||
| | |301. R response elements (RRE) || CATCTG || Present || 158 || [[MYB recognition element gene transcriptions|R response elements]] 16:04, 19 July 2022 || likely active or activable | ||
|- | |- | ||
| | |302. Seed-specific elements (SRE) || CATGCATG || Absent || 89 || [[Seed-specific element gene transcriptions|Seed-specific elements]] 20:18, 23 February 2021 || 4<sup>8</sup>-4<sup>12</sup> | ||
|| | |||
|- | |- | ||
| | |303. Serum response elements, (SRE) || ACAGGATGT || Present || 314 || [[Serum response element gene transcriptions|Serum response elements]] 16:38, 25 January 2023 || likely active or activable | ||
|| | |||
|- | |- | ||
| | |304. Servenius sequences || GGACCCT || Present || 315 || [[Servenius sequence gene transcriptions|Servenius sequences]] 03:07, 28 January 2023 || likely active or activable | ||
|- | |- | ||
| | |305. Shoot specific elements, (SREs) || GATAATGATG || Absent || 90 || [[Shoot specific element gene transcriptions|Shoot specific elements]] 15:13, 24 February 2021 || 4<sup>10</sup> | ||
|- | |- | ||
| | |306. Shue box element, (Crowder 1988) || CCCTG(C/G) || Present || 348 || [[CAT box gene transcriptions|Shue box elements]] 05:24, 18 April 2023 || likely active or activable | ||
|- | |- | ||
| | |307. Sip4ps (Tang) || CC(C/G)T(C/T)C(C/G)TCCG || Absent || 91 || [[Sip4p gene transcriptions|Sip4ps]] 02:55, 25 February 2021 || 2<sup>3</sup>*4<sup>8</sup> | ||
( | |||
|| | |||
|- | |- | ||
| | |308. Smp1ps (Tang) || ACTACTA(T/A)<sub>4</sub>TAG || Absent || 92 || [[Smp1p gene transcriptions|Smp1ps]] 23:43, 25 February 2021 || 2*4<sup>10</sup> | ||
|- | |- | ||
| | |309. SP1, (Long) || GGGGCGGGCC || Absent || 355 || [[Sp1 gene transcriptions|SP1]] 19:43, 25 April 2023 || 4<sup>10</sup> | ||
|- | |- | ||
| | |310. Sp1 element, (Berberich 1993) || GGGGCGGGT || Absent || 350 || [[CAT box gene transcriptions|Sp1 elements]] 21:03, 18 April 2023 || 4<sup>9</sup> | ||
|- | |- | ||
| | |311. SP1, (Zhang) || (G/T)GGGCGG(G/A)(G/A)(C/T) || Present || 319 || [[Specificity protein gene transcriptions|SP1]] 05:57, 2 February 2023 || likely active or activable | ||
( | |||
|| ( | |||
|- | |- | ||
| | |312. SP-1, (Sato) || CCGCCCC || Present || 318 || [[Specificity protein gene transcriptions|SP-1]] 05:54, 2 February 2023 || likely active or activable | ||
|- | |||
( | |313. SP1, (Yao) || GCGGC || Present || 320 || [[Specificity protein gene transcriptions|SP1]] 05:57, 4 February 2023 || likely active or activable | ||
|| | |||
|- | |- | ||
| | |314. SP1-box 1, (Motojima) || GGGGCT || Present || 316 || [[Specificity protein gene transcriptions|SP1-box 1]] 05:46, 29 January 2023|| likely active or activable | ||
|- | |- | ||
| | |315. SP1-box 2, (Motojima) || CTGCCC || Present || 317 || [[Specificity protein gene transcriptions|SP1-box 2]] 19:30, 30 January 2023|| likely active or activable | ||
|- | |- | ||
| | |316. STAT5 || TTCNNNGAA || Present || 321 || [[STAT5 gene transcription laboratory|STAT5]] 03:41, 5 February 2023 || likely active or activable, positive distal likely random | ||
|- | |- | ||
| | |317. Sterile12, (STE12), (Tang 2020) || TGAAAC || Present || 356 || [[Ste12p gene transcriptions|Sterile12 encodes a transcription factor (Ste12)]] 05:53, 27 April 2023 || likely active or activable | ||
|- | |- | ||
| | |318. Sterol response elements, (Branco) || TCGTATA || Absent || 93 || [[Sterol response element gene transcriptions|Sterol response elements]] 19:00, 28 February 2021 || perhaps plant specific 4<sup>7</sup> | ||
|| | |||
|- | |- | ||
| | |319. Sterol response elements, (Yao) || AGCAGATTGCG || Absent || 94 || [[Sterol response element gene transcriptions|Sterol response elements]] 03:22, 1 March 2021 || liver specific 4<sup>11</sup> | ||
|- | |- | ||
| | |320. Stress-response elements, (STREs) || CCCCT || Present || 322 || [[Msn2,4p gene transcriptions|Stress-response elements]] 07:49, 7 February 2023 || likely active or activable, positive cores overlap randoms | ||
|- | |- | ||
| | |321. Sucrose boxes || NNAATCA || Present || 324 || [[Sucrose box gene transcriptions|Sucrose boxes]] 08:03, 10 February 2023 || likely active or activable | ||
|- | |- | ||
| | |322. TACTAAC boxes || TACTAA(C/T) || Present || 325 || [[TACTAAC box gene transcriptions|TACTAAC boxes]] 06:05, 12 February 2023 || likely active or activable | ||
|- | |- | ||
| | |323. TAGteams || CAGGTAG || Present || 326 || [[TAGteam gene transcriptions|TAGteams]] 04:15, 14 February 2023 || likely active or activable | ||
|- | |- | ||
| | |324. Tapetum boxes || TCGTGT || Present || 327 || [[Tapetum box gene transcriptions|Tapetum boxes]] 08:10, 16 February 2023 || likely active or activable | ||
|- | |- | ||
| | |325. TATA boxes || TATAAAA (Carninci 2006) TAT box (Yang 2006) || Present || 1 || [[TATA box gene transcriptions|TATAAAA boxes]] 03:53, 2 April 2023 || likely active or activable | ||
|- | |- | ||
| | |326. TATA boxes || TATAAA (Butler 2002) || Present || 4 || [[TATA box gene transcriptions|TATA boxes (Butler 2002)]] 07:05, 3 April 2023 || likely active or activable | ||
( | |||
|| | |||
|- | |- | ||
| | |327. TATA boxes (Watson 2014) || TATA(A/T)A(A/T) (Watson 2014) || Present || 10 || [[TATA box gene transcriptions|TATA boxes (Watson 2014)]] 04:32, 4 December 2017 || likely active or activable | ||
|- | |- | ||
| | |328. TATA boxes (Yang 2007) || TATA(A/T)AA(A/G) (Juven-Gershon 2010) || Present || 17 || [[TATA box gene transcriptions|metazoan TATA box]] 01:05, 13 October 2019 || likely active or activable | ||
|- | |- | ||
| | |329. TATA boxes (Yang 2007) || TATA(A/T)A(A/T)(A/G) (Basehoar 2004) || Present || 9 || [[TATA box gene transcriptions|TATA boxes]] 04:16, 13 June 2024 || likely active or activable | ||
|- | |- | ||
| | |330. TAT boxes (Fan 2007) || TATCCAT || Present || 239 || [[TAT box gene transcriptions|TAT box (Fan) samplings]] 06:17, 13 November 2022 || likely active or activable | ||
|- | |- | ||
| | |331. TATCCAC boxes || TATCCAC || Absent || 18 || [[TATC box gene transcriptions|TATCCAC boxes]] 03:59, 13 October 2019 || GA responsive complex component 4<sup>7</sup> | ||
|- | |- | ||
| | |332. TATCCAC boxes (Yang 2007) || TATCCAC || Absent || 19 || [[TATC box gene transcriptions]] 03:59, 13 October 2019 || 4<sup>7</sup> | ||
|- | |- | ||
| | |333. Tbf1 regulatory factors || A(A/G)CCCTAA || Present || 242 || [[Tbf1 regulatory factor gene transcriptions|Tbf1 regulatory factors]] 17:38, 15 November 2022 || ''Saccharomyces cerevisiae'', likely active or activable | ||
|- | |- | ||
| | |334. T boxes, (Conlon) || TCACACCT || Present || 246 || [[T box gene transcriptions|T boxes]] 23:28, 18 November 2022 || likely active or activable | ||
|- | |- | ||
| | |335. T boxes, (Zhang) || AACGTT || Present || 247 || [[T box gene transcriptions|T boxes]] 17:21, 20 November 2022 || likely active or activable | ||
|- | |- | ||
| | |336. TCCACCATA elements || TCCACCATA || Absent || 77 || [[TCCACCATA element gene transcriptions|TCCACCATA elements]] 05:10, 13 February 2021 || adjacent co-dependent regulatory element of POLLEN1 4<sup>9</sup> | ||
|- | |- | ||
| | |337. TEA consensus sequences || CATTCY || Present || 328 || [[TEA consensus sequence gene transcriptions|TEA consensus sequences]] 06:35, 24 February 2023 || likely active or activable | ||
|- | |- | ||
| | |338. Telomeric repeat DNA-binding factors, (TRFs) || TTAGGG || Present || 330 || [[Telomeric repeat DNA-binding factor gene transcriptions|Telomeric repeat DNA-binding factors]] 06:35, 2 March 2023 || likely active or activable | ||
|- | |- | ||
| | |339. Tetradecanoylphorbol-13-acetate response elements, (TREs) || TGA(G/C)TCA || Absent || 23 || [[Tetradecanoylphorbol-13-acetate response element gene transcriptions|Tetradecanoylphorbol-13-acetate response elements]] 15:07, 24 August 2020 || ''cis''-regulatory element of the human metallothionein IIa (hMTIIa) promoter and SV40 2*4<sup>6</sup> | ||
|| | |||
|- | |- | ||
| | |340. TGF-β control elements, (TCEs) || GCGTGGGGGA || Absent || 95 || [[TC element gene transcriptions|TGF-β control elements]] 17:38, 5 March 2021 || GCGTGGGGGA in humans 4<sup>10</sup> | ||
|- | |- | ||
| | |341. TGF-β inhibitory elements, (TIEs) || GAGTGGTGA || Absent || 22 || [[TC element gene transcriptions|TGF-β inhibitory elements]] 01:57, 23 August 2020 || in the rat transin/stromelysin promoter 4<sup>9</sup> | ||
|- | |- | ||
| | |342. Thyroid hormone response elements, (TREs)(THRs) || AGGTCA || Present || 331 || [[Thyroid hormone response element gene transcriptions|Thyroid hormone response elements]] 23:06, 3 March 2023 || likely active or activable | ||
|- | |- | ||
| | |343. Transcription factor 3, (TCF3) || GTCTGGT || Present || 332 || [[Transcription factor 3 gene transcriptions|Transcription factor 3]] 19:21, 5 March 2023 || likely active or activable | ||
|- | |||
( | |344. Translational control sequences, (TCSs) || (A/T)TT(A/G)TCT || Present || 333 || [[Translational control sequence gene transcriptions|Translational control sequences]] 20:33, 7 March 2023 || likely active or activable | ||
|| | |||
|- | |- | ||
| | |345. Transposon enhancement control (TEC) or Tec1 || GAATGT || Present || 329 || [[Tec1p gene transcriptions|Tec1ps]] 22:49, 26 February 2023 || likely random, Ste12p cofactor | ||
|- | |- | ||
| | |346. Tryptophan residues, (Lu) || GAAA || Present || 142 || [[Interferon regulatory factor gene transcriptions|Tryptophan residues]] 03:55, 18 June 2022 || likely active or activable, the tryptophan residues occur in the IRS, IFN, ICRE, Cell-cycle box variants, V-box, Pollen1, and β-Scaffold response elements | ||
( | |||
|| | |||
|- | |- | ||
| | |347. Unfolded protein response element, (URE), (UPRE-1) || CANCNTG || Present || 300 || [[Hac1p gene transcriptions|Unfolded protein response element]] 18:24, 8 January 2023 || likely active or activable | ||
|- | |- | ||
| | |348. Unfolded protein response elements, (UPREs) || TGACGTG(G/A) || Present || 334 || [[Unfolded protein response element gene transcriptions|Unfolded protein response elements]] 21:02, 7 March 2023 || likely active or activable | ||
|- | |- | ||
| | |349. Upstream repressor site 1, (URS1, core), (Sumrada) || CCGCC || Present || 277 || [[DNA damage response element gene transcriptions|Upstream repressor site 1]] 06:31, 17 December 2022 || likely active or activable | ||
|- | |- | ||
| | |350. Upstream stimulating factors, (USFs) || GCC(A/T)NN(C/G/T)(A/G) || Present || 337 || [[Upstream stimulatory factor gene transcriptions|Upstream stimulating factors]] 05:51, 11 March 2023 || likely active or activable | ||
|- | |- | ||
| | |351. V boxes || (A/G)TT(A/T)(C/T) || Present || 340 || [[V box gene transcriptions|V boxes]] 20:50, 16 March 2023 || likely active or activable | ||
|| (G | |||
|| | |||
|- | |- | ||
| | |352. Vhr1ps, (VHR1), (Weider 2016), (Tang 2020) || AATCA-N<sub>8</sub>-TGA(C/T)T || Absent || 96 || [[Vhr1p gene transcriptions|Vhr1ps]] 01:26, 9 March 2021 || Response to low biotin concentrations 2*4<sup>9</sup> | ||
( | |||
|| | |||
|- | |- | ||
| | |353. Vitamin D response elements, (VDRE2s) || A/GGG/TTCAnnnA/GGG/TTCA || Absent || 97 || [[Vitamin D response element gene transcriptions|Vitamin D response elements]] 03:48, 10 March 2021 || 4<sup>10</sup> | ||
|- | |- | ||
| | |354. Vitamin D response elements (VDRE) (Kakhki 2018) || (A/G)G(G/T)TCA, RGKTCA || Present || 341 || [[Vitamin D response element gene transcriptions|Vitamin D response elements]] 04:37, 19 March 2023 || likely active or activable | ||
( | |||
|| | |||
|- | |- | ||
| | |355. W boxes (W-boxes) (WRKY) || (C/T)TGAC(C/T) || Present || 342 || [[W box gene transcriptions|W boxes]] 20:46, 20 March 2023 || likely active or activable | ||
( | |||
|| | |||
|- | |- | ||
| | |356. X1a boxes (Ferstl 2004) || TCTGCC || Present || 364 || [[X box gene transcriptions|X-boxes]] 04:29, 4 May 2023 || likely active or activable | ||
|- | |- | ||
| | |357. X1b boxes (Ferstl 2004) || AGAGACAGAT || Absent || 357 || [[X box gene transcriptions|X-boxes]] 17:57, 30 April 2023 || 4<sup>10</sup> | ||
|- | |- | ||
| | |358. X2 boxes (Ferstl 2004) || AGGTCCA || Present || 362 || [[X box gene transcriptions|X-boxes]] 01:41, 4 May 2023 || likely active or activable | ||
|- | |- | ||
| | |359. X boxes (Zhang 1993) || GTTGGCATGGCAAC || Absent || 12 ||[[X box gene transcriptions|X boxes]] 16:03, 27 April 2023 || X2 box is AGGTCCA 4<sup>14</sup> | ||
( | |||
|| | |||
|- | |- | ||
| | |360. X-boxes (Moreno) || GT(A/C/T)N(C/T)(C/T)AT(A/G)(A/G)NAAC || Absent || 98 || [[X box gene transcriptions|X-boxes]] 16:43, 10 March 2021 || includes GTTNCCATGGNAAC (4/3)*2<sup>4</sup>*4<sup>7</sup>-4<sup>12</sup> | ||
|- | |- | ||
| | |361. X core promoter elements (XCPE1) || (A/G/T)(C/G)G(C/T)GG(A/G)A(C/G)(A/C) || Present || 343 || [[X core promoter element gene transcriptions|X core promoter elements]] 19:37, 22 March 2023 || likely active or activable | ||
|- | |- | ||
| | |362. Xenobiotic response elements, (XREs) || (T/G)NGCGTG(A/C)(G/C)A || Absent || 83 || [[Xenobiotic response element gene transcriptions|Xenobiotic response elements]] 20:45, 17 February 2021 || contains the core sequence GCGTG, see AHRE above 2*4<sup>7</sup> | ||
|- | |- | ||
| | |363. Xenobiotic response elements (XREs) (Shen 1992) || GCGTG || Present || 233 || [[Xenobiotic response element gene transcriptions|Xenobiotic response elements]] 05:22, 5 November 2022 || likely active or activable | ||
|- | |- | ||
| | |364. XhoI site-binding protein 1 protein (Xbp1p), (Mai 1997), (Tang 2020) || GcCTCGA(G/A)G(C/A)g(a/g) || Absent || 99 || [[Xbp1p gene transcriptions|Xbp1ps]] 14:40, 11 March 2021 || Transcriptional repressor 2*4<sup>10</sup> | ||
|- | |- | ||
| | |365. Yap response elements (Salin 2008) || T(G/T)ACT(A/C)A || Present || 365 || [[Yap1p,2p gene transcriptions|Yap response elements]] 05:18, 4 May 2023 || likely active or activable | ||
|- | |- | ||
| | |366. Yap recognition sequences (Tang 2020) || TTACTAA || Present || 344 || [[Yap1p,2p gene transcriptions|Yap recognition sequences]] 19:57, 24 March 2023 || likely active or activable | ||
|- | |- | ||
| | |367. Y boxes, (Koike 1997) || (A/G)CTAACC(A/G)(A/G)(C/T) || Absent || 11 || [[Y box gene transcriptions|Y boxes]] 00:44, 13 October 2019 || inverted CAAT box, 4<sup>8</sup> | ||
|- | |||
|368. YY1 binding sites || CCATTTA || Absent || 100 || [[YY1 gene transcriptions|YY1 binding sites]] 06:23, 12 March 2021 || 4<sup>7</sup> | |||
|- | |||
|369. YY1 binding sites || CCATCTT || Present || 345 || [[YY1 gene transcriptions|YY1 binding sites]] 22:07, 25 March 2023 || likely active or activable | |||
|- | |||
|370. Z-box (ZboxN) samplings, (ZboxNs) || ATACGGT || Absent || 251 || [[Z box gene transcriptions|Z-box (ZboxN) samplings]] 19:47, 2 December 2022 || 4<sup>7</sup> | |||
|- | |||
|371. Z-box (ZboxSo) samplings, (ZboxNs) || ATACGTGT || Absent || 252 || [[Z box gene transcriptions|Z-box (ZboxSo) samplings]] 20:21, 3 December 2022 || 4<sup>8</sup> | |||
|- | |||
|372. Z boxes, NSoSp form || A(C/T)A(C/G)G(G/T)(A/G/T)T || Present || 249 || [[Z box gene transcriptions|Z boxes]] 17:23, 28 November 2022 || likely active or activable, negative direction distals within randoms | |||
|- | |||
|373. Z boxes, ZboxG || A(C/T)A(C/G)GT(A/G)T || Present || 250 || [[Z box gene transcriptions|Z boxes]] 03:00, 1 December 2022 || likely active or activable | |||
|- | |||
|374. Z boxes, ZboxSp || CAGGT(A/G) || Present || 248 || [[Z box gene transcriptions|Z boxes]] 05:10, 24 November 2022 || likely active or activable | |||
|- | |||
|375. Zinc-responsive elements, (Zhao 1998), (Tang 2020) (ZREs) || ACCYYNAAGGT or ACC(C/T)(C/T)NAAGGT || Absent || 101 || [[Zap1p gene transcriptions|Zap1ps]] 15:52, 15 March 2021 || 4<sup>9</sup> | |||
|- | |||
|376. Zinc responsive elements, (ZREs), (Nicola 2007) || MHHAACCBYNMRGGT or (A/C)(A/C/T)(A/C/T)AACC(C/G/T)(C/T)N(A/C)(A/G)GGT || Absent || 102 || [[Zinc responsive element gene transcriptions|Zinc responsive elements]] 19:02, 15 March 2021 || (4/3)<sup>3</sup>*4<sup>9</sup> | |||
|} | |||
( | ==Response element testing (Absent)== | ||
|| | {{main|A1BG regulatory elements and regions}} | ||
{| class="wikitable sortable" | |||
|+ Response element | |||
|- | |||
! Name of elements !! Consensus sequences !! Response element class !! Testing !! Activity | |||
|- | |- | ||
! Abbreviations !! Variations !! !! Absent (N) !! Notes | |||
( | |||
|- | |- | ||
! Authors !! !! !! !! | |||
|- | |- | ||
| | |1. [[ABA-response element gene transcriptions|novel ABA-response elements]] | ||
( | (ABREN, novel ABRE) | ||
|| | || GATCGATC, CGATCGAT, GATCGAT || WD40 repeat family || N || ABREN, CGATCGAT motif, and core of ABREN and CGATCGAT motif.<ref name=Watanabe>{{ cite journal | ||
|author=Kenneth A. Watanabe | |||
|author2=Arielle Homayouni | |||
|author3=Lingkun Gu | |||
|author4=Kuan‐Ying Huang | |||
|author5=Tuan‐Hua David Ho | |||
|author6=Qingxi J. Shen | |||
|title=Transcriptomic analysis of rice aleurone cells identified a novel abscisic acid response element | |||
|journal=Plant, Cell & Environment | |||
|date=18 June 2017 | |||
|volume=40 | |||
|issue=9 | |||
|pages=2004-2016 | |||
|url=https://onlinelibrary.wiley.com/doi/full/10.1111/pce.13006 | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1111/pce.13006 | |||
|pmid= | |||
|accessdate=5 October 2020 }}</ref> | |||
|- | |||
|2. [[ABA-response element gene transcriptions|ABA-response element-like]] | |||
(ABRE-like) | |||
|| ACGTGTCC || WD40 repeat family || N || third highest scoring motif.<ref name=Watanabe/> | |||
|- | |- | ||
| | |3. [[Abf1 regulatory factor gene transcriptions|Abf1 regulatory factors]] || CGTCCTCTACGAT || General Regulatory Factors || N || CGTNNNNNACGAT.<ref name=Rossi>{{ cite journal | ||
|author=Matthew J. Rossi | |||
|author2=William K.M. Lai | |||
|| | |author3=B. Franklin Pugh | ||
| | |title=Genome-wide determinants of sequence-specific DNA binding of general regulatory factors | ||
| | |journal=Genome Research | ||
|date=21 March 2018 | |||
|volume=28 | |||
|| | |issue= | ||
|- | |pages=497-508 | ||
| | |url=https://genome.cshlp.org/content/28/4/497.full | ||
|arxiv= | |||
( | |bibcode= | ||
|| | |doi=10.1101/gr.229518.117 | ||
|pmid=29563167 | |||
|accessdate=31 August 2020 }}</ref> | |||
| | |- | ||
| | |4. [[Activating protein gene transcriptions|Activating proteins]] | ||
(Murata) | |||
|| GCCCACGGG || bHSH || N || Activating protein 2.<ref name=Murata>{{ cite journal | |||
|author=Takayuki Murata | |||
|author2=Chieko Noda | |||
|author3=Yohei Narita1 | |||
|author4=Takahiro Watanabe | |||
|author5=Masahiro Yoshida | |||
|author6=Keiji Ashio | |||
|author7=Yoshitaka Sato | |||
|author8=Fumi Goshima | |||
|author9=Teru Kanda | |||
|author10=Hironori Yoshiyama | |||
|author11=Tatsuya Tsurumi | |||
|author12=Hiroshi Kimura | |||
|title=Induction of Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 (LMP1) by Transcription Factors Activating Protein 2 (AP-2) and Early B Cell Factor (EBF) | |||
|journal=Journal of Virology | |||
|date=27 January 2016 | |||
|volume= | |||
|issue= | |||
|pages= | |||
|url=https://jvi.asm.org/content/jvi/early/2016/01/21/JVI.03227-15.full.pdf | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1128/JVI.03227-15 | |||
|pmid= | |||
|accessdate=4 October 2020 }}</ref> | |||
|- | |||
|5. [[Xenobiotic response element gene transcriptions|AhR-responsive elements]] | |||
(AHRE) | |||
(Yao) | |||
|| (G/T)NGCGTG(A/C)(C/G)A || bHLH || N || in the promoter region of AhR responsive genes | |||
|- | |||
|6. [[Alpha-amylase conserved element gene transcriptions|Alpha-amylase conserved elements]] || TATCCA || ? || N || TATCCATCCATCC.<ref name=Sharma>{{ cite journal | |||
|author=Bhaskar Sharma | |||
|author2=Joemar Taganna | |||
|title=Genome-wide analysis of the U-box E3 ubiquitin ligase enzyme gene family in tomato | |||
|journal=Scientific Reports | |||
|date=12 June 2020 | |||
|volume=10 | |||
|issue=9581 | |||
|pages= | |||
|url=https://www.nature.com/articles/s41598-020-66553-1 | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1038/s41598-020-66553-1 | |||
|pmid=32533036 | |||
|accessdate=27 August 2020 }}</ref> | |||
|- | |||
|7. [[Amino acid response element gene transcriptions|Amino acid response elements]] | |||
(AARE) | |||
(Maruyama) | |||
|| ATTGCATCA || ? || N || AARE1 (ATTGCATCA)<ref name=Maruyama/> | |||
|- | |||
|8. [[Amino acid response element gene transcriptions|Amino acid response elements]] | |||
(AARE) | |||
(Broer) | |||
|| TTTGCATCA || ? || N || TTTGCATCA.<ref name=Broer>{{ cite journal | |||
|author=Angelika Bröer | |||
|author2=Gregory Gauthier-Coles | |||
|author3=Farid Rahimi | |||
|author4=Michelle van Geldermalsen | |||
|author5=Dieter Dorsch | |||
|author6=Ansgar Wegener | |||
|author7=Jeff Holst | |||
|author8=Stefan Bröer | |||
|title=Ablation of the ASCT2 (SLC1A5) gene encoding a neutral amino acid transporter reveals transporter plasticity and redundancy in cancer cells | |||
|journal=Journal of Biological Chemistry | |||
|date=March 15, 2019 | |||
|volume=294 | |||
|issue=11 | |||
|pages=4012-4026 | |||
|url=https://www.jbc.org/content/294/11/4012.full.pdf | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1074/jbc.RA118.006378 | |||
|pmid= | |||
|accessdate=4 October 2020 }}</ref><ref name=Garaeva>{{ cite journal | |||
|author=Alisa A. Garaeva | |||
|author2=Irina E. Kovaleva | |||
|author3=Peter M. Chumakov | |||
|author4=Alexandra G. Evstafieva | |||
|title=Mitochondrial dysfunction induces ''SESN2'' gene expression through Activating Transcription Factor 4 | |||
|journal=Cell Cycle | |||
|date=15 January 2016 | |||
|volume=15 | |||
|issue=1 | |||
|pages=64-71 | |||
|url=https://www.tandfonline.com/doi/full/10.1080/15384101.2015.1120929 | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1080/15384101.2015.1120929 | |||
|pmid=26771712 | |||
|accessdate=5 September 2020 }}</ref> | |||
|- | |||
|9. [[Amino acid response element gene transcriptions|Amino acid response element-like]] | |||
(AARE-like) | |||
|| TGGTGAAAG || ? || N || AARE-like sequence (TGGTGAAAG, named AARE3).<ref name=Maruyama>{{ cite journal | |||
|author=Ryuto Maruyama | |||
|author2=Makoto Shimizu | |||
|author3=Juan Li, Jun Inoue | |||
|author4=Ryuichiro Sato | |||
|title=''Fibroblast growth factor 21'' induction by activating transcription factor 4 is regulated through three amino acid response elements in its promoter region | |||
|journal=Bioscience, Biotechnology, and Biochemistry | |||
|date=24 March 2016 | |||
|volume=80 | |||
|issue=5 | |||
|pages=929-934 | |||
|url=https://www.tandfonline.com/doi/pdf/10.1080/09168451.2015.1135045 | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1080/09168451.2015.1135045 | |||
|pmid= | |||
|accessdate=4 October 2020 }}</ref> | |||
|- | |||
|10. [[Androgen response element gene transcriptions|Androgen response elements]] | |||
(AREs) | |||
(Kouhpayeh) | |||
|| GGTACANNNTGTTCT || Zinc finger DNA-binding domain || N || GGTACACGGTGTTCT.<ref name=Kouhpayeh>{{ cite journal | |||
|author=S Kouhpayeh | |||
|author2=AR Einizadeh | |||
|author3=Z Hejazi | |||
|author4=M Boshtam | |||
|author5=L Shariati | |||
|author6=M Mirian | |||
|author7=L Darzi | |||
|author8=M Sojoudi | |||
|author9=H Khanahmad | |||
|author10=A Rezaei | |||
|title=Antiproliferative effect of a synthetic aptamer mimicking androgen response elements in the LNCaP cell line | |||
|journal=Cancer Gene Therapy | |||
|date=1 July 2016 | |||
|volume=23 | |||
|issue= | |||
|pages=254-257 | |||
|url=https://www.researchgate.net/profile/Mina_Mirian/publication/304707422_Antiproliferative_effect_of_a_synthetic_aptamer_mimicking_androgen_response_elements_in_the_LNCaP_cell_line/links/59ffed00458515d0706e4f27/Antiproliferative-effect-of-a-synthetic-aptamer-mimicking-androgen-response-elements-in-the-LNCaP-cell-line.pdf | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1038/cgt.2016.26 | |||
|pmid= | |||
|accessdate=3 October 2020 }}</ref> | |||
|- | |||
|11. [[Androgen response element gene transcriptions|Androgen response elements]] | |||
(AREs) | |||
(Wilson) | |||
|| TGATTCGTGAG || Zinc finger DNA-binding domain || N || AGAACANNNTGTTCT.<ref name=Wilson>{{ cite journal | |||
|author=Stephen Wilson, Jianfei Qi & Fabian V. Filipp | |||
|title=Refinement of the androgen response element based on ChIP-Seq in androgen-insensitive and androgen-responsive prostate cancer cell lines | |||
|journal=Scientific Reports | |||
|date=14 September 2016 | |||
|volume=6 | |||
|issue= | |||
|pages=32611 | |||
|url=https://www.nature.com/articles/srep32611 | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1038/srep32611 | |||
|pmid= | |||
|accessdate=3 October 2020 }}</ref> | |||
|- | |||
|12. [[Antioxidant-electrophile responsive element gene transcriptions|Antioxidant-electrophile responsive elements]] | |||
(Otsuki) | |||
|| GTGAGGTCGC || bHLH || N || GTGAGGTCGC.<ref name=Otsuki>{{ cite journal | |||
|author=Akihito Otsuki | |||
|author2=Mikiko Suzuki | |||
|author3=Fumiki Katsuoka | |||
|author4=Kouhei Tsuchida | |||
|author5=Hiromi Suda | |||
|author6=Masanobu Morita | |||
|author7=Ritsuko Shimizu | |||
|author8=Masayuki Yamamoto | |||
|title=Unique cistrome defined as CsMBE is strictly required for Nrf2-sMaf heterodimer function in cytoprotection | |||
|journal=Free Radical Biology and Medicine | |||
|date=February 2016 | |||
|volume=91 | |||
|issue= | |||
|pages=45-57 | |||
|url=https://www.sciencedirect.com/science/article/abs/pii/S0891584915011478 | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1016/j.freeradbiomed.2015.12.005 | |||
|pmid=26677805 | |||
|accessdate=21 August 2020 }}</ref> or GCTGAGT, GCAGGCT of GC(A/C/T)(A/G/T)(A/G/T)(C/G/T)T(A/C)A<ref name=Lacher>{{ cite journal | |||
|author=Sarah E. Lacher | |||
|author2=Daniel C. Levings | |||
|author3=Samuel Freeman | |||
|author4=Matthew Slattery | |||
|title=Identification of a functional antioxidant response element at the HIF1A locus | |||
|journal=Redox Biology | |||
|date=October 2018 | |||
|volume=19 | |||
|issue= | |||
|pages=401-411 | |||
|url=https://www.sciencedirect.com/science/article/pii/S2213231718305391 | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1016/j.redox.2018.08.014 | |||
|pmid= | |||
|accessdate=6 October 2020 }}</ref>, an antioxidant response element (ARE) | |||
|- | |||
|13. [[CAAT box gene transcriptions|CAAT boxes]] || (C/T)(A/G)(A/G)CCAATC(A/G) || bZIP || N || consensus sequence for the CCAAT-enhancer-binding site (C/EBP) is TAGCATT. | |||
|- | |||
|14. [[Calcium-response element gene transcriptions|Calcium-response elements]] || CTATTTCGAG || ? || N || CaRE1 CTATTTCGAG.<ref name=Tao>{{ cite journal | |||
|author=Xu Tao | |||
|author2=Anne E. West | |||
|author3=Wen G. Chen | |||
|author4=Gabriel Corfas | |||
|author5=Michael E. Greenberg | |||
|title=A calcium-responsive transcription factor, CaRF, that regulates neuronal activity-dependent expression of BDNF | |||
|journal=Neuron | |||
|date=2002 | |||
|volume=33 | |||
|issue= | |||
|pages=383-95 | |||
|url=https://www.cell.com/neuron/fulltext/S0896-6273(01)00561-X?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS089662730100561X%3Fshowall%3Dtrue | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1016/S0896-6273(01)00561-X | |||
|pmid=11832226 | |||
|accessdate=2 September 2020 }}</ref> | |||
|- | |||
|15. [[Carbohydrate response element gene transcriptions|Carbohydrate response elements]] | |||
(ChREs) | |||
|| CACGTGACCGGATCTTG, TCCGCCCCCATCACGTG || ? || N || ChoRE1, ChoRE2.<ref name=Long>{{ cite journal | |||
|author=Jianyin Long | |||
|author2=Daniel L. Galvan | |||
|author3=Koki Mise | |||
|author4=Yashpal S. Kanwar | |||
|author5=Li Li | |||
|author6=Naravat Poungavrin | |||
|author7=Paul A. Overbeek | |||
|author8=Benny H. Chang | |||
|author9=Farhad R. Danesh | |||
|title=Role for carbohydrate response element-binding protein (ChREBP) in high glucose-mediated repression of long noncoding RNA Tug1 | |||
|journal=Journal of Biological Chemistry | |||
|date=28 May 2020 | |||
|volume=5 | |||
|issue=28 | |||
|pages= | |||
|url=https://www.jbc.org/content/early/2020/05/28/jbc.RA120.013228.full.pdf | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1074/jbc.RA120.013228 | |||
|pmid= | |||
|accessdate=6 October 2020 }}</ref> | |||
|- | |||
|16. [[Carbon source-responsive element gene transcriptions|Carbon source-responsive elements]] | |||
(CSREs) | |||
|| CATTCATCCG || ? || N || confers carbon source-dependent regulation | |||
|- | |||
|17. [[Cbf1 regulatory factor gene transcriptions|Cbf1 regulatory factors]] || TCACGTGA || ? || N || strongly bound Cbf1 motifs enriched at both ends with a "T" on the 5′ and "A" on the 3′ end. | |||
|- | |||
|18. [[C box gene transcriptions|C-boxes]] | |||
(Johnson) | |||
|| GAGGCCATCT || bZIP || N || GAGGCCATCT.<ref name=Johnson>{{ cite journal | |||
|author=PA Johnson | |||
|author2=D Bunick | |||
|author3=NB Hecht | |||
|title=Protein Binding Regions in the Mouse and Rat Protamine-2 Genes | |||
|journal=Biology of Reproduction | |||
|date=1991 | |||
|volume=44 | |||
|issue=1 | |||
|pages=127-134 | |||
|url=https://academic.oup.com/biolreprod/article-pdf/44/1/127/10536199/biolreprod0127.pdf | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1095/biolreprod44.1.127 | |||
|pmid=2015343 | |||
|accessdate=6 April 2019 }}</ref> | |||
|- | |||
|19. [[C box gene transcriptions|C/A hybrid boxes]] || TGACGTAT || bZIP || N || TGACGTAT.<ref name=Song>{{ cite journal | |||
|author=Young Hun Song | |||
|author2=Cheol Min Yoo | |||
|author3=An Pio Hong | |||
|author4=Seong Hee Kim | |||
|author5=Hee Jeong Jeong | |||
|author6=Su Young Shin | |||
|author7=Hye Jin Kim | |||
|author8=Dae-Jin Yun | |||
|author9=Chae Oh Lim | |||
|author10=Jeong Dong Bahk | |||
|author11=Sang Yeol Lee | |||
|author12=Ron T. Nagao | |||
|author13=Joe L. Key | |||
|author14=Jong Chan Hong | |||
|title=DNA-Binding Study Identifies C-Box and Hybrid C/G-Box or C/A-Box Motifs as High-Affinity Binding Sites for STF1 and LONG HYPOCOTYL5 Proteins | |||
|journal=Plant Physiology | |||
|date=April 2008 | |||
|volume=146 | |||
|issue=4 | |||
|pages=1862–1877 | |||
|url=http://www.plantphysiol.org/content/plantphysiol/146/4/1862.full.pdf | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1104/pp.107.113217 | |||
|pmid=18287490 | |||
|accessdate=26 March 2019 }}</ref> A at the 12 position | |||
|- | |||
|20. [[C box gene transcriptions|C/T hybrid boxes]] || TGACGTTA || bZIP || N || TGACGTTA.<ref name=Song/> T at the 12 position | |||
|- | |||
|21. [[CCCTC-binding factor gene transcriptions|CCCTC-binding factors]] | |||
(CTCF) | |||
|| NCA-NNA-G(A/G)N-GGC-(A/G)(C/G)(C/T) || ? || N || NCA-NNA-G(G/A)N-GGC-(G/A)(C/G)(T/C).<ref name=Hashimoto>{{ cite journal | |||
|author=Hideharu Hashimoto | |||
|author2=Dongxue Wang | |||
|author3=John R. Horton | |||
|author4=Xing Zhang | |||
|author5=Victor G. Corces | |||
|author6=Xiaodong Cheng | |||
|title=Structural Basis for the Versatile and Methylation-Dependent Binding of CTCF to DNA | |||
|journal=Molecular Cell | |||
|date=1 June 2017 | |||
|volume=66 | |||
|issue=5 | |||
|pages=711-720.e3 | |||
|url=https://www.sciencedirect.com/science/article/pii/S1097276517303179 | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1016/j.molcel.2017.05.004 | |||
|pmid=28529057 | |||
|accessdate=28 August 2020 }}</ref> | |||
|- | |||
|22. [[C-EBP box gene transcriptions|C/EBP boxes]] || TTAGGACAT,<ref name=Misra>{{ cite journal | |||
|author=Ravi P. Misra | |||
|author2=Azad Bonni | |||
|author3=Cindy K. Miranti | |||
|author4=Victor M. Rivera | |||
|author5=Morgan Sheng | |||
|author6=Michael E.Greenberg | |||
|title=L-type Voltage-sensitive Calcium Channel Activation Stimulates Gene Expression by a Serum Response Factor-dependent Pathway | |||
|journal=The Journal of Biological Chemistry | |||
|date=14 October 1994 | |||
|volume=269 | |||
|issue=41 | |||
|pages=25483-25493 | |||
|url=http://www.jbc.org/content/269/41/25483.full.pdf | |||
|arxiv= | |||
|bibcode= | |||
|doi= | |||
|pmid=7929249 | |||
|accessdate=7 December 2019 }}</ref> or TAGCATT.<ref name=Yao>{{ cite journal | |||
| author = Yao EF | |||
|author2=Denison MS | |||
| title = DNA sequence determinants for binding of transformed Ah receptor to a dioxin-responsive enhancer | |||
| journal = Biochemistry | |||
| volume = 31 | |||
| issue = 21 | |||
| pages = 5060–7 | |||
| date = June 1992 | |||
| pmid = 1318077 | |||
| doi = 10.1021/bi00136a019 }}</ref> || bZIP || N || CCAAT-enhancer-binding site (C/EBP) is TAGCATT | |||
|- | |||
|23. [[Cell-cycle box gene transcriptions|Cell-cycle boxes]] | |||
(CCBs) | |||
|| CACGAAAA || ? || N || "cell cycle box" is functional in either orientation, acting as an enhancer | |||
|- | |||
|24. [[Cell cycle regulation gene transcriptions|Cell cycle regulation]] || CCCAACGGT<ref name=Sharma/> || ? || N || tomato genome-wide analysis | |||
|- | |||
|25. [[CENP-B box gene transcriptions|CENP-B boxes]] || TTTCGTTGGAAGCGGGA || ? || N || specifically localized at the centromere | |||
|- | |||
|26. [[Coupling element gene transcriptions|Coupling elements]] | |||
(CE1) | |||
|| TGCCACCGG<ref name=Watanabe/> || ? || N || CE1 (Watanabe) | |||
|- | |||
|27. [[DAF-16-associated element gene transcriptions|DAF-16-associated elements]] | |||
(DAE) | |||
|| TGATAAG || ? || N || DAF-16-associated element (DAE).<ref name=Li>{{ cite journal | |||
|author=Yan-Hui Li | |||
|author2=Gai-Gai Zhang | |||
|title=Towards understanding the lifespan extension by reduced insulin signaling: bioinformatics analysis of DAF-16/FOXO direct targets in ''Caenorhabditis elegans'' | |||
|journal=Oncotarget | |||
|date=12 April 2016 | |||
|volume=7 | |||
|issue=15 | |||
|pages=19185-19192 | |||
|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991374/ | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.18632/oncotarget.8313 | |||
|pmid=2702736 | |||
|accessdate=27 August 2020 }}</ref> | |||
|- | |||
|28. [[D box gene transcriptions|D-boxes]] | |||
(Mracek1) | |||
|| GTTGTATAAC || ? || N || GTTGTATAAC.<ref name=Mracek>{{ cite journal | |||
|author=Philipp Mracek | |||
|author2=Cristina Santoriello | |||
|author3=M. Laura Idda | |||
|author4=Cristina Pagano | |||
|author5=Zohar Ben-Moshe | |||
|author6=Yoav Gothilf | |||
|author7=Daniela Vallone | |||
|author8=Nicholas S. Foulkes | |||
|title=Regulation of ''per'' and ''cry'' Genes Reveals a Central Role for the D-Box Enhancer in Light-Dependent Gene Expression | |||
|journal=PLoS ONE | |||
|date=December 6, 2012 | |||
|volume=7 | |||
|issue=12 | |||
|pages=e51278 | |||
|url=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0051278 | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1371/journal.pone.0051278 | |||
|pmid= | |||
|accessdate=10 February 2019 }}</ref> | |||
|- | |||
|29. [[D box gene transcriptions|D-boxes]] | |||
(Mracek) | |||
|| CTTATGTAAA (Mracek2) || ? || N || CTTATGTAAA.<ref name=Mracek/> | |||
|- | |||
|30. [[D box gene transcriptions|D-boxes]] | |||
(Johnson) | |||
|| TCTCACA || ? || N || TCTCACATT(A/C)AATAAGTCA is a D-box.<ref name=Johnson/> | |||
|- | |||
|31. [[Defense and stress-responsive element gene transcriptions|Defense and stress-responsive elements]] || ATTTTCTTCA || ? || N || ATTTTCTTCA.<ref name=Sharma/> | |||
|- | |||
|32. [[DNA damage response element gene transcriptions|DNA damage response elements]] | |||
(DREs) | |||
(Smith) | |||
|| TTTCAAT<ref name=Smith>{{ cite journal | |||
|author=Joshua J. Smith, Eric S. Cole, Daniel P. Romero | |||
|title=Transcriptional control of RAD51 expression in the ciliate ''Tetrahymena thermophila'' | |||
|journal=Nucleic Acids Research | |||
|date=15 July 2004 | |||
|volume=32 | |||
|issue=14 | |||
|pages=4313-4321 | |||
|url=https://academic.oup.com/nar/article/32/14/4313/1279821 | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1093/nar/gkh771 | |||
|pmid=15304567 | |||
|accessdate=4 September 2020 }}</ref> || ? || N || in the upstream repression sequence (URS) | |||
|- | |||
|33. [[DNA damage response element gene transcriptions|DNA damage response elements]] | |||
(DREs) | |||
(Sumrada) | |||
|| TAGCCGCCG of TAGCCGCCGRRRR.<ref name=Sumrada>{{ cite journal | |||
|author=Roberta A. Sumrada and Terrance G. Cooper | |||
|title=Ubiquitous upstream repression sequences control activation of the inducible arginase gene in yeast | |||
|journal=Proceedings of the National Academy of Sciences USA | |||
|date=June 1987 | |||
|volume=84 | |||
|issue= | |||
|pages=3997-4001 | |||
|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC305008/pdf/pnas00277-0054.pdf | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1073/pnas.84.12.3997 | |||
|pmid=3295874 | |||
|accessdate=6 September 2020 }}</ref> || ? || N || in the upstream repression sequence (URS) | |||
|- | |||
|34. [[DNA replication-related element gene transcriptions|DNA replication-related elements]] | |||
(DREs) | |||
|| TATCGATA || ? || N || DNA replication-related element (DRE).<ref name=Hirose>{{ cite journal | |||
|author=Fumiko Hirose | |||
|author2=Masamitsu Yamaguchi | |||
|author3=Akio Matsukage | |||
|title=Targeted Expression of the DNA Binding Domain of DRE-Binding Factor, a ''Drosophila'' Transcription Factor, Attenuates DNA Replication of the Salivary Gland and Eye Imaginal Disc | |||
|journal=Molecular and Cellular Biology | |||
|date=September 1999 | |||
|volume=19 | |||
|issue=9 | |||
|pages=6020-6028 | |||
|url=https://mcb.asm.org/content/19/9/6020.full | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1128/MCB.19.9.6020 | |||
|pmid=10454549 | |||
|accessdate=4 September 2020 }}</ref> | |||
|- | |||
|35. [[DREB box gene transcriptions|DREB boxes]] || TACCGACAT || ? || N || CRT/DREB box | |||
|- | |||
|36. [[EIF4E basal element gene transcriptions|EIF4E basal elements]] || TTACCCCCCCTT || ? || N || poly(C) motif | |||
|- | |||
|37. [[Endoplasmic reticulum stress response element gene transcriptions|Endoplasmic reticulum stress response elements]] | |||
(ERSE) | |||
|| CCAAT-N9-CCACG || bZIP || N || compare CCAAT-box and ERSE below in the (present) | |||
|- | |||
|38. [[Estrogen response element gene transcriptions|Estrogen response elements]] | |||
(EREs) | |||
|| AGGTTA or GGTCAGGAT || {{chem|Cys|4}} || N || AGGTTATTGCCTCCT or GGTCAGGATGAC | |||
|- | |||
|39. [[I box gene transcriptions|F boxes]] || TGATAAG<ref name=Rose>{{ cite journal | |||
|author=Annkatrin Rose, Iris Meier and Udo Wienand | |||
|title=The tomato I-box binding factor LeMYBI is a member of a novel class of Myb-like proteins | |||
|journal=The Plant Journal | |||
|date=28 October 1999 | |||
|volume=20 | |||
|issue=6 | |||
|pages=641-652 | |||
|url=https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-313X.1999.00638.x | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1046/j.1365-313X.1999.00638.x | |||
|pmid= | |||
|accessdate=8 November 2018 }}</ref> || ? || N || F-box overlaps the I-box | |||
|- | |||
|40. [[Forkhead box gene transcriptions|Forkhead boxes]] || GTAAACAA<ref name=Yoshihara>{{ cite journal | |||
|author=Eiji Yoshihara | |||
|title=TXNIP/TBP-2: A Master Regulator for Glucose Homeostasis | |||
|journal=Antioxidants | |||
|date=18 August 2020 | |||
|volume=9 | |||
|issue=8 | |||
|pages=765-84 | |||
|url=https://www.mdpi.com/2076-3921/9/8/765/pdf | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.3390/antiox9080765 | |||
|pmid=32824669 | |||
|accessdate=5 September 2020 }}</ref> || HTH, Forkhead || N || GTAAACAA FOXO1 | |||
|- | |||
|41. [[Gal4p gene transcriptions|Gal4ps]] || CGGACCGC || ? || N || CGG(A/G)NN(A/G)C(C/T)N(C/T)NCNCCG<ref name=Tang>{{ cite journal | |||
|author=Hongting Tang, Yanling Wu, Jiliang Deng, Nanzhu Chen, Zhaohui Zheng, Yongjun Wei, Xiaozhou Luo, and Jay D. Keasling | |||
|title=Promoter Architecture and Promoter Engineering in ''Saccharomyces cerevisiae'' | |||
|journal=Metabolites | |||
|date=6 August 2020 | |||
|volume=10 | |||
|issue=8 | |||
|pages=320-39 | |||
|url=https://www.mdpi.com/2218-1989/10/8/320/pdf | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.3390/metabo10080320 | |||
|pmid=32781665 | |||
|accessdate=18 September 2020 }}</ref> | |||
|- | |||
|42. [[Γ-interferon activated sequence gene transcriptions|γ-interferon activated sequences]] | |||
(GAS) | |||
|| TTCCTAGAA || ? || N || ALS-GAS1 between nt −633 and nt −625 | |||
|- | |||
|43. [[G box gene transcriptions|G boxes]] || (G/T)CCACGTG(G/T)C || ? || N || no "perfect palindrome" G boxes in either promoter | |||
|- | |||
|44. [[GLM box gene transcriptions#GCN4 motifs|GCN4 motifs]] || TGACTCA, TGAGTCA || bZIP || N || ACGT motif | |||
|- | |||
|45. [[Gcn4p gene transcriptions|Gcn4ps]] || ATGACTCTT<ref name=Tang/> || bZIP || N || [[GLM box gene transcriptions#GCN4 motifs|GCN4 motifs]] | |||
|- | |||
|46. [[GARE gene transcriptions|Gibberellin responsive element-like 2]] | |||
(GARE-like 2) | |||
(Fan) | |||
|| TAACGTA<ref name=Fan>{{ cite journal | |||
|author=Liu-Min Fan, Xiaoyan Feng, Yu Wang and Xing Wang Deng | |||
|title=Gibberellin Signal Transduction in Rice | |||
|journal=Journal of Integrative Plant Biology | |||
|date=2007 | |||
|volume=49 | |||
|issue=6 | |||
|pages=731−741 | |||
|url=https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1744-7909.2007.00511.x | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1111/j.1744-7909.2007.00511.x | |||
|pmid= | |||
|accessdate=16 October 2018 }}</ref> || ? || N || "in the promoters of hydrolase genes".<ref name=Fan/> | |||
|- | |||
|47. [[GLM box gene transcriptions|GLM boxes]] || (G/A)TGA(G/C)TCA(T/C) || ? || N || GCN4-like motif | |||
|- | |||
|48. [[Grainy head transcription factor gene transcriptions|Grainy head transcription factor binding sites]] || AACCGGTT || β-Scaffold factors with minor groove contacts || N || also GACTGGTT | |||
|- | |||
|49. [[TC element gene transcriptions|GT boxes]] | |||
(Motojima) | |||
|| TGGGTGGGGCT || ? || N || (-78 to -69) | |||
|- | |||
|50. [[Middle sporulation element gene transcriptions|Hapless motifs]] || CCAATCA || ? || N || heterotrimeric transcription factor, HAP2/3/4.<ref name=Ozsarac>{{ cite journal | |||
| author = Nesrin Ozsarac, Melissa J. Straffon, Hazel E. Dalton, and Ian W. Dawes | |||
| title = Regulation of Gene Expression during Meiosis in ''Saccharomyces cerevisiae'': ''SPR3'' Is Controlled by both ABFI and a New Sporulation Control Element | |||
| journal = Molecular and Cellular Biology | |||
| volume = 17 | |||
| issue = 3 | |||
| pages = 1152–9 | |||
| date = March 1997 | |||
| pmid = 9032242 | |||
| pmc = 231840 | |||
| doi = 10.1128/MCB.17.3.1152 }}</ref> | |||
|- | |||
|51. [[Heat-responsive element gene transcriptions|Heat-responsive elements]] || AAAAAATTTC || Helix-turn-helix (HTH), Heat shock factors (HSFs) || N || four nGAAn motifs | |||
|- | |||
|52. [[Hsf1p gene transcriptions|Heat shock elements]] | |||
(HSE1) | |||
(Eastmond) | |||
|| nGAAnnTTCnnGAAn || HTH, HSFs || N || HSE1 | |||
|- | |||
|53. [[Hsf1p gene transcriptions|Heat shock elements]] | |||
(HSE2) | |||
(Eastmond) | |||
|| nTTCnnGAAnnTTCn || HTH, HSFs || N || HSE2 is the inverse complement of HSE1 | |||
|- | |||
|54. [[Hsf1p gene transcriptions|Heat shock elements]] | |||
(HSE5) | |||
(Eastmond) | |||
|| nTTCn-(5-bp)-nTTCnnGAAn || HTH, HSFs || N || HSE5 | |||
|- | |||
|55. [[Hsf1p gene transcriptions|Heat shock elements]] | |||
(HSE6) | |||
(Eastmond) | |||
|| nTTCn-nnGAAn-(5-bp)-nGAAn || HTH, HSFs || N || HSE6 | |||
|- | |||
|56. [[Hsf1p gene transcriptions|Heat shock elements]] | |||
(HSE7) | |||
(Eastmond) | |||
|| nGA(A/G)nnTTCnnGAAn || HTH, HSFs || N || HSE7 PFT1 | |||
|- | |||
|57. [[Hsf1p gene transcriptions|Heat shock elements]] | |||
(HSE) | |||
(Eastmond) | |||
|| nGAAnnTTCnnGA(A/G)n || HTH, HSFs || N || HSE7 PFT2 | |||
|- | |||
|58. [[Hsf1p gene transcriptions|Heat shock elements]] | |||
(HSE10) | |||
(Eastmond) | |||
|| nTTCn-(11-bp)-nGAAn-(5 bp)-nGAAn || HTH, HSFs || N || HSE10 | |||
|- | |||
|59. [[Hypoxia-inducible factor gene transcriptions|Hypoxia-inducible factors]] | |||
(HIF-1) | |||
|| GCCCTACGTGCTGTCTCA<ref name=Li2020>{{ cite journal | |||
|author=Qingliang Li, Rezaul M. Karim, Mo Cheng, Mousumi Das, Lihong Chen, Chen Zhang, Harshani R. Lawrence, Gary W. Daughdrill, Ernst Schonbrunn, Haitao Ji and Jiandong Chen | |||
|title=Inhibition of p53 DNA binding by a small molecule protects mice from radiation toxicity | |||
|journal=Oncogene | |||
|date=July 2020 | |||
|volume=39 | |||
|issue=29 | |||
|pages=5187-5200 | |||
|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398576/ | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1038/s41388-020-1344-y | |||
|pmid=32555331 | |||
|accessdate=29 August 2020 }}</ref> || bHLH || N || composed of HIF-1α and HIF-1β | |||
|- | |||
|60. [[I box gene transcriptions|I boxes]] || GATAAG || ? || N || GGATGAGATAAGA | |||
|- | |||
|61. [[Inositol, choline-responsive element gene transcriptions|Inositol/choline-responsive elements]] | |||
(ICRE) | |||
(Case) | |||
|| CANNTGAAAT || ? || N || version of Lopes, see below | |||
|- | |||
|62. [[Inositol, choline-responsive element gene transcriptions|Inositol/choline-responsive elements]] | |||
(ICRE) | |||
(Lopes) | |||
|| ATGTGAAAT || ? || N || using ANNTGAAAT | |||
|- | |||
|63. [[Interferon regulatory factor gene transcriptions|Interferon-stimulated response elements]] | |||
(ISREs) | |||
|| AGTTTCN<sub>2</sub>TTTCN || ? || N || consensus sequence AGTTTCN<sub>2</sub>TTTCN.<ref name=Michalska>{{ cite journal | |||
|author=Agata Michalska, Katarzyna Blaszczyk, Joanna Wesoly and Hans A. R. Bluyssen | |||
|title=A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses | |||
|journal=Frontiers in Immunology | |||
|date=28 May 2018 | |||
|volume=9 | |||
|issue= | |||
|pages=1135 | |||
|url=https://www.frontiersin.org/articles/10.3389/fimmu.2018.01135/full | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.3389/fimmu.2018.01135 | |||
|pmid= | |||
|accessdate=18 March 2021 }}</ref> | |||
|- | |||
|64. [[Kozak sequence gene transcriptions|Kozak sequences]] || GCCGCC(A/G)CCATGG || ? || N || GCCGCC(A/G)CCATGG<ref name=Kozak1987>{{ cite journal | |||
|author=Marilyn Kozak | |||
|date=October 1987 | |||
|title=An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs | |||
|url=http://nar.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=3313277 | |||
|journal=Nucleic Acids Research | |||
|volume=15 | |||
|issue=20 | |||
|pages=8125–8148 | |||
|doi=10.1093/nar/15.20.8125 | |||
|pmid=3313277 }}</ref> | |||
|- | |||
|65. [[Kozak sequence gene transcriptions|Kozak sequences]] | |||
(Matsumoto) | |||
|| GAAAATGG || ? || N || GAAAATGG<ref name=Matsumoto>{{ cite journal | |||
|author=Takuya Matsumoto | |||
|author2=Saemi Kitajima | |||
|author3=Chisato Yamamoto | |||
|author4=Mitsuru Aoyagi | |||
|author5=Yoshiharu Mitoma | |||
|author6=Hiroyuki Harada | |||
|author7=Yuji Nagashima | |||
|title=Cloning and tissue distribution of the ATP-binding cassette subfamily G member 2 gene in the marine pufferfish ''Takifugu rubripes'' | |||
|journal=Fisheries Science | |||
|date=9 August 2020 | |||
|volume=86 | |||
|issue= | |||
|pages=873-887 | |||
|url=https://researchmap.jp/hiroyukiharada/published_papers/29953426/attachment_file.pdf | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1007/s12562-020-01451-z | |||
|pmid= | |||
|accessdate=27 September 2020 }}</ref> | |||
|- | |||
|66. [[L box gene transcriptions|L boxes]] || AAATTAACCAA || ? || N || AAATTAACCAA<ref name=Donald>{{ cite journal | |||
|author=Robert G. K. Donald and Anthony R. Cashmore | |||
|title=Mutation of either G box or I box sequences profoundly affects expression from the ''Arabidopsis rbcS‐1A'' promoter | |||
|journal=The EMBO Journal | |||
|date=1990 | |||
|volume=9 | |||
|issue=6 | |||
|pages=1717-1726 | |||
|url=https://onlinelibrary.wiley.com/doi/pdf/10.1002/j.1460-2075.1990.tb08295.x | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1002/j.1460-2075.1990.tb08295.x | |||
|pmid= | |||
|accessdate=8 November 2018 }}</ref> | |||
|- | |||
|67. [[Maf recognition element gene transcriptions|Maf recognition element]] | |||
(MAREs) | |||
|| TGCTGA(G/C)TCAGCA || ? || N || and TGCTGA(GC/CG)TCAGCA<ref name=Kyo>{{ cite journal | |||
|author=Motoki Kyo, Tae Yamamoto, Hozumi Motohashi, Terue Kamiya, Toshihiro Kuroita, Toshiyuki Tanaka, James Douglas Engel, Bunsei Kawakami, Masayuki Yamamoto | |||
|title=Evaluation of MafG interaction with Maf recognition element arrays by surface plasmon resonance imaging technique | |||
|journal=Genes to Cells | |||
|date=13 February 2004 | |||
|volume=9 | |||
|issue=2 | |||
|pages= | |||
|url=https://onlinelibrary.wiley.com/doi/full/10.1111/j.1356-9597.2004.00711.x | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1111/j.1356-9597.2004.00711.x | |||
|pmid= | |||
|accessdate=8 September 2020 }}</ref> | |||
|- | |||
|68. [[Met31p box gene transcriptions|Met3s]] || TCACGTG || bZIP || N || TCACGTG<ref name=Blaiseau/> | |||
|- | |||
|68. [[M box gene transcriptions|M boxes]] || GTCATGTGCT || ? || N || or AGTCATGTGCT<ref name=Bertolotto>{{ cite journal | |||
|author=Corine Bertolotto, Roser Buscà, Patricia Abbe, Karine Bille, Edith Aberdam, Jean-Paul Ortonne, and Robert Ballotti | |||
|title=Different ''cis''-Acting Elements Are Involved in the Regulation of TRP1 and TRP2 Promoter Activities by Cyclic AMP: Pivotal Role of M Boxes (GTCATGTGCT) and of Microphthalmia | |||
|journal=Molecular and Cellular Biology | |||
|date=February 1998 | |||
|volume=18 | |||
|issue=2 | |||
|pages=694–702 | |||
|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC108780/ | |||
|arxiv= | |||
|bibcode= | |||
|doi= | |||
|pmid=9447965 | |||
|accessdate=8 December 2018 }}</ref> | |||
|- | |||
|69. [[Mcm1 regulatory factor gene transcriptions|Mcm1 regulatory factors]] || TT(A/T)CCNN(A/T)TNGG(A/T)AA || ? || N || Primary consensus sequence apparently: TT(A/T)CCNN(A/T)TNGG(A/T)AA.<ref name=Rossi/> | |||
|- | |||
|70. [[Mcm1 regulatory factor gene transcriptions|Mcm1 regulatory factors]] | |||
(Rossi) | |||
|| TTNCCNNNTNNGGNAA || ? || N || Primary consensus sequence apparently: TT(A/T)CCNN(A/T)TNGG(A/T)AA.<ref name=Rossi/> | |||
|- | |||
|71. [[Motif ten element gene transcriptions|Motif ten elements]] || C(C/G)A(A/G)C(C/G)(C/G)AACG(C/G) || ? || N || Gene ID: 6309 | |||
|- | |||
|72. [[Nuclear factor gene transcriptions|NF‐κB/Rel family of eukaryotic transcription factors]] || CCCCTAAGGGG || β-Scaffold factors with minor groove contacts || N || [[NF-κB]] | |||
|- | |||
|73. [[Nuclear factor gene transcriptions|Nuclear factor 1]] | |||
(NF-1) | |||
|| TTGGCNNNNNGCCAA || NF I || N || palindromic sequence | |||
|- | |||
|74. [[Nuclear factor Y gene transcriptions|Nuclear factor Ys]] || CCAATGG(A/C)(A/G) || ? || N || NF-Y is a trimeric complex | |||
|- | |||
|75. [[P63 DNA-binding site gene transcriptions|p63 DNA binding sites]] || (A/G)(A/G)(A/G)C(A/G)(A/T)G(C/T)(C/T)(C/T)(A/G)(A/G)(A/G)C(A/T)(C/T)G(C/T)(C/T)(C/T) || β-Scaffold factors with minor groove contacts || N || RRRC(A/G)(A/T)GYYYRRRC(A/T)(C/T)GYYY | |||
|- | |||
|76. [[Pdr1,3p gene transcriptions|Pdr1p/Pdr3ps]] || TCCGCGGA || ? || N || Pdr1p/Pdr3p response elements (PDREs) | |||
|- | |||
|77. [[Peroxisome proliferator hormone response element gene transcriptions|Peroxisome proliferator hormone response elements]] | |||
(PPREs) | |||
|| AGGTCANAGGTCA || ? || N || PPARs/RXRs heterodimers bind to PPRE | |||
|- | |||
|78. [[Pollen1 element gene transcriptions|Pollen1 with TCCACCATA]] || AGAAANNNNTCCACCATA || ? || N || adjacent co-dependent regulatory element TCCACCATA | |||
|- | |||
|79. [[Pollen1 element gene transcriptions|TCCACCATA]] || TCCACCATA || ? || N || no regulatory element TCCACCATA was found, nor its ci. | |||
|- | |||
|80. [[Polycomb response element gene transcriptions|Polycomb response elements]] || CGCCAT(A/T)TT || ? || N || CGCCATTT | |||
|- | |||
|81. [[Rap1 regulatory factor gene transcriptions|Rap1 regulatory factors]] || ACCC(A/G)N(A/G)CA || ? || N || "(ACCCRnRCA), less than half of the sites were detectably bound"<ref name=Rossi/> | |||
|- | |||
|82. [[Reb1 general regulatory factor gene transcriptions|Extended Reb1]] || ATTACCCGAA || ? || N || "extended motif VTTACCCGNH (IUPAC nomenclature) (Rhee and Pugh 2011)."<ref name=Rossi/> | |||
|- | |||
|83. [[Rlm1p gene transcriptions|Rlm1ps]] || CTATATATAG || ? || N || CTA(T/A)<sub>4</sub>TAG | |||
|- | |||
|84. [[Rox1p gene transcriptions|Rox1ps]] || RRRTAACAAGAG || ? || N || Heme-dependent repressor of hypoxic genes.<ref name=Tang/> | |||
|- | |||
|85. [[Rpn4p gene transcriptions|Rpn4ps]] || GGTGGCAAA || ? || N || proteasome genes | |||
|- | |||
|86. [[Seed-specific element gene transcriptions|Seed-specific elements]] || CATGCATG || ? || N || SRE consensus: CAGCAGATTGCG is none | |||
|- | |||
|87. [[Shoot specific element gene transcriptions|Shoot specific elements]] || GATAATGATG || ? || N || SRE consensus: CAGCAGATTGCG is none | |||
|- | |||
|88. [[Sip4p gene transcriptions|Sip4ps]] || CC(C/G)T(C/T)C(C/G)TCCG || ? || N || CC(C/G)T(C/T)C(C/G)TCCG<ref name=Tang/> | |||
|- | |||
|89. [[Smp1p gene transcriptions|Smp1ps]] || ACTACTA(A/T)(A/T)(A/T)(A/T)TAG || ? || N || ACTACTA(T/A)<sub>4</sub>TAG<ref name=Tang/> | |||
|- | |||
|90. [[Specificity protein gene transcriptions|SP1]] | |||
(Long) | |||
|| GGGGCGGGCC || ? || N || GGGGCGGGCC<ref name=Long/> | |||
|- | |||
|91. [[Sterol response element gene transcriptions|Sterol response elements]] | |||
(Branco) | |||
|| TCGTATA || ? || N || perhaps plant specific | |||
|- | |||
|92. [[Sterol response element gene transcriptions|Sterol response elements]] | |||
(Yao) | |||
|| AGCAGATTGCG || ? || N || liver specific | |||
|- | |||
|93. [[TATC box gene transcriptions|TATCCAC boxes]] || TATCCAC || ? || N || GA responsive complex component | |||
|- | |||
|94. [[TCCACCATA element gene transcriptions|TCCACCATA elements]] || TCCACCATA || ? || N || adjacent co-dependent regulatory element of POLLEN1 | |||
|- | |||
|95. [[Tetradecanoylphorbol-13-acetate response element gene transcriptions|Tetradecanoylphorbol-13-acetate response elements]] | |||
(TREs) | |||
|| TGA(G/C)TCA || ? || N || ''cis''-regulatory element of the human metallothionein IIa (hMTIIa) promoter and SV40 | |||
|- | |||
|96. [[TC element gene transcriptions|TGF-β control elements]] | |||
(TCEs) | |||
|| GAGTGGGGCG || ? || N || in mouse and rat, GCGTGGGGGA in humans | |||
|- | |||
|97. [[TC element gene transcriptions|TGF-β inhibitory elements]] | |||
(TIEs) | |||
|| GAGTGGTGA || ? || N || in the rat transin/stromelysin promoter | |||
|- | |||
|98. [[Vhr1p gene transcriptions|Vhr1ps]] | |||
(VHR1) | |||
|| AATCA-N<sub>8</sub>-TGA(C/T)T || ? || N || Response to low biotin concentrations | |||
|- | |||
|99. [[Vitamin D response element gene transcriptions|Vitamin D response elements]] | |||
(VDREs) | |||
|| A/GGG/TTCAnnnA/GGG/TTCA || ? || N || (A/G)G(G/T)TCANNN(A/G)G(G/T)TCA | |||
|- | |||
|100. [[X box gene transcriptions|X boxes]] || GTTGGCATGGCAAC<ref name=Zhang>{{ cite journal | |||
|author=XIAN-YANG ZHANG, NABILA JABRANE-FERRAT, CLEMENT K. ASIEDU, SANJA SAMAC, B. MATIJA PETERLIN, AND MELANIE EHRLICH | |||
|title=The Major Histocompatibility Complex Class II Promoter-Binding Protein RFX (NF-X) Is a Methylated DNA-Binding Protein | |||
|journal=MOLECULAR AND CELLULAR BIOLOGY | |||
|date=November 1993 | |||
|volume=13 | |||
|issue=11 | |||
|pages=6810-8 | |||
|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC364743/pdf/molcellb00023-0210.pdf | |||
|arxiv= | |||
|bibcode= | |||
|doi= | |||
|pmid= | |||
|accessdate=2017-04-05 }}</ref> || ? || N || X2 box is AGGTCCA not ⌘F | |||
|- | |||
|101. [[X box gene transcriptions|X-boxes]] || GT(A/C/T)N(C/T)(C/T)AT(A/G)(A/G)NAAC<ref name=Moreno>{{ cite journal | |||
|author=Eduardo Moreno, Maša Lenuzzi, Christian Rödelsperger, Neel Prabh, Hanh Witte, Waltraud Roeseler, Metta Riebesell, Ralf J. Sommer | |||
|title=DAF‐19/RFX controls ciliogenesis and influences oxygen‐induced social behaviors in ''Pristionchus pacificus'' | |||
|journal=Evolution & Development | |||
|date=November 2018 | |||
|volume=20 | |||
|issue=6 | |||
|pages=233-243 | |||
|url=https://onlinelibrary.wiley.com/doi/abs/10.1111/ede.12271 | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1111/ede.12271 | |||
|pmid= | |||
|accessdate=9 March 2021 }}</ref> || ? || N || includes GTTNCCATGGNAAC | |||
|- | |||
|102. [[Xbp1p gene transcriptions|Xbp1ps]] || GcCTCGA(G/A)G(C/A)g(a/g) || ? || N || Transcriptional repressor | |||
|- | |||
|103. [[Xenobiotic response element gene transcriptions|Xenobiotic response elements]] | |||
(XREs) | |||
|| (T/G)NGCGTG(A/C)(G/C)A || ? || N || contains the core sequence GCGTG, see AHRE above | |||
|- | |||
|104. [[Y box gene transcriptions|Y boxes]] || (A/G)CTAACC(A/G)(A/G)(C/T) || ? || N || inverted CAAT box | |||
|- | |||
|105. [[Zap1p gene transcriptions|Zap1ps]] || ACCCTCA || ? || N || ACC(C/T)(C/T)(A/C/G/T)AAGGT | |||
|- | |||
|106. [[Z box gene transcriptions|Z-box (ZboxN) samplings]] | |||
(ZboxNs) | |||
|| ATACGGT || ? || N || No ZboxN occur on either side of A1BG | |||
|- | |||
|107. [[Z box gene transcriptions|Z-box (ZboxSo) samplings]] | |||
(ZboxNs) | |||
|| ATACGTGT || ? || N || No ZboxSo occur on either side of A1BG | |||
|- | |||
|108. [[Zinc responsive element gene transcriptions|Zinc responsive elements]] | |||
(ZREs) | |||
|| MHHAACCBYNMRGGT || ? || N || (A/C)(A/C/T)(A/C/T)AACC(C/G/T)(C/T)N(A/C)(A/G)GGT | |||
|- | |||
|} | |||
==Response element testing (Present)== | |||
{{main|A1BG regulatory elements and regions}} | |||
{| class="wikitable sortable" | |||
|+ Response element | |||
|- | |||
! Name of elements !! Consensus sequences !! Response element class !! Testing !! Activity/Notes | |||
|- | |||
! Abbreviations !! Variations !! Pathways !! Present (Y) !! Random or likely active or activable | |||
|- | |||
! Authors !! !! !! Table (T) !! | |||
|- | |||
|1. [[A box gene transcriptions|A-boxes]] | |||
(A-box) | |||
(Nawkar 2017) | |||
|| TACGTA || Basic leucine zipper (bZIP) | |||
Light signaling and stress response pathways | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|2. [[ABA-response element gene transcriptions|Abscisic acid response elements]] | |||
(ABREs) | |||
(Watanabe 2017) | |||
|| ACGTG(G/T)C|| WD40 repeat family | |||
ABA-signaling pathway,<ref name=Cuming>{{ cite journal | |||
|author=Andrew C. Cuming | |||
|title=Evolution of ABA signaling pathways | |||
|journal=Advances in Botanical Research | |||
|date=5 December 2019 | |||
|volume=92 | |||
|issue= | |||
|pages=281-313 | |||
|url=https://www.sciencedirect.com/science/article/abs/pii/S0065229619300655 | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1016/bs.abr.2019.06.003 | |||
|pmid= | |||
|accessdate=15 May 2023 }}</ref> Ethylene signaling pathway | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|3. [[Abf1 regulatory factor gene transcriptions|Activated B-cell Factor-1s]] | |||
(ABFs, Abfms) | |||
(Rossi 2018) | |||
|| CGTNNNNN(A/G)(C/T)GA(C/T) || General Regulatory Factors | |||
B-cell receptor signal transduction pathway | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|4. [[A box gene transcriptions|boxes A]] | |||
(AP-1 box A) | |||
(Kokoroishi 2015) | |||
|| TGACTCT || bZIP | |||
PKC-dependent pathway | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|5. [[Phosphate starvation-response transcription factor gene transcriptions|Abscisic acid-responsive elements (Pho4s)]], [[G box gene transcriptions|G boxes]] | |||
(G-box) | |||
(Loake 1992) | |||
|| CACGTG || bZIP, bHLH | |||
Purine and histidine biosynthesis pathways, Phenylpropanoid pathway, Light signaling and stress response pathways | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|6. [[ACGT-containing element gene transcriptions|ACGT-containing elements]] || ACGT || bZIP | |||
Purine and histidine biosynthesis pathways, Phenylpropanoid pathway | |||
|| Y | |||
T | |||
|| cores and proximals are likely active or activable, but a few of the UTRs and distal promoters may be random | |||
|- | |||
|7. [[Activating protein gene transcriptions|Activating protein 2 alpha]] | |||
(AP2a) | |||
|| GCCNNNGGC || bHSH | |||
Rapamycin (TOR) regulatory pathways | |||
|| Y | |||
T | |||
|| likely active or activable, positive strand, positive direction AP2a within randoms | |||
|- | |||
|8. [[Activating protein gene transcriptions|Activating protein 2]] | |||
(AP2) | |||
(Cohen) | |||
|| GCCTGGCC || bHSH | |||
Rapamycin (TOR) regulatory pathways | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|9. [[Activating protein gene transcriptions|Activating protein 2]] | |||
(Cohen) | |||
|| TCCCCCGCCC || bHSH | |||
Rapamycin (TOR) regulatory pathways | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|10. [[Activating protein gene transcriptions|Activating protein 2]] | |||
(Murata) | |||
|| (C/G)CCN(3)GG(C/G) || bHSH | |||
Rapamycin (TOR) regulatory pathways | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|11. [[Activating protein gene transcriptions|Activating protein 2]] | |||
(Murata) | |||
|| (C/G)CCN(4)GG(C/G) || bHSH | |||
Rapamycin (TOR) regulatory pathways | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|12. [[Activating protein gene transcriptions|Activating protein 2]] | |||
(Yao) | |||
|| TCTTCCC || bHSH | |||
Rapamycin (TOR) regulatory pathways | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|13. [[Activating protein gene transcriptions|Activating protein 2]] | |||
(Yao) | |||
|| CTCCCA || bHSH | |||
Rapamycin (TOR) regulatory pathways | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|14. [[Activating protein gene transcriptions|Activating proteins]] | |||
(AP-2) | |||
(Yao) | |||
|| GGCCAA || bHSH | |||
Rapamycin (TOR) regulatory pathways | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|15. [[Activating transcription factor gene transcriptions|Activating transcription factors]] | |||
(Burton) | |||
|| (A/C/G)TT(A/G/T)C(A/G)TCA || bZIP | |||
Signal transduction pathways | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|16. [[Activating transcription factor gene transcriptions|Activating transcription factors]] | |||
(Kilberg) | |||
|| (A/G/T)TT(A/G/T)CATCA || bZIP | |||
Signal transduction pathways | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|17. [[Adenylate–uridylate rich element gene transcriptions|Adenylate–uridylate rich elements]] | |||
(AUREs) | |||
(Bakheet) | |||
|| (A/T)(A/T)(A/T)TATTTAT(A/T)(A/T) || stem-loop | |||
ARE-mediated mRNA decay pathways, neddylation pathway, p38 mitogen-activated protein | |||
kinase (MAP kinase) pathway | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|18. [[Adenylate–uridylate rich element gene transcriptions|Adenylate–uridylate rich elements]] | |||
(AREs) | |||
(Chen and Shyu, Class I) | |||
|| ATTTA || stem-loop | |||
ARE-mediated mRNA decay pathways, neddylation pathway, p38 mitogen-activated protein | |||
kinase (MAP kinase) pathway | |||
|| Y | |||
T | |||
|| likely active or activable, UTRs at the lower end of the randoms | |||
|- | |||
|19. [[Adenylate–uridylate rich element gene transcriptions|Adenylate–uridylate rich elements]] | |||
(AREs) | |||
(Chen and Shyu, Class II) | |||
|| TTATTTA(A/T)(A/T) || stem-loop | |||
ARE-mediated mRNA decay pathways, neddylation pathway, p38 mitogen-activated protein | |||
kinase (MAP kinase) pathway | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|20. [[Adenylate–uridylate rich element gene transcriptions|Adenylate–uridylate rich elements]] | |||
(AREs) | |||
(Chen and Shyu, Class III) | |||
|| ATTT || stem-loop | |||
ARE-mediated mRNA decay pathways, neddylation pathway, p38 mitogen-activated protein | |||
kinase (MAP kinase) pathway | |||
|| Y | |||
T | |||
|| likely active or activable, low negative direction proximals overlap randoms | |||
|- | |||
|21. [[Adr1p gene transcriptions|Adr1ps]] || TTGG(A/G)G || {{chem|Cys|2|His|2}} zinc finger binding domain | |||
ARE-mediated mRNA decay pathways, neddylation pathway, p38 mitogen-activated protein | |||
kinase (MAP kinase) pathway | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|22. [[Aft1p gene transcriptions|Aft1s]] || (C/T)(A/G)CACCC(A/G) || bZIP? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|23. [[AGC box gene transcriptions|AGC boxes]] || AGCCGCC || AP-2/EREBP-related factors || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|24. [[Xenobiotic responsive element gene transcriptions|AhR responsive element or Aryl hydrocarbon responsive element II]] | |||
(AHRE-II) | |||
|| CATGN<sub>6</sub>C(A/T)TG || bHLH || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|25. [[Xenobiotic response element gene transcriptions|AhR DNA-binding consensus sequence]] | |||
(AhRY) | |||
(Yao) | |||
|| GCGTGNN(A/T)NNN(C/G) || bHLH || Y | |||
T | |||
|| likely active or activable for ZNF497 | |||
|- | |||
|26. [[Androgen response element gene transcriptions|Androgen response element1s]] | |||
(Kouhpayeh) | |||
|| GGTACA of GGTACAnnnTGTTCT || Zinc finger DNA-binding domain || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|27. [[Androgen response element gene transcriptions|Androgen response element2s]] | |||
(Kouhpayeh) | |||
|| TGTTCT of GGTACAnnnTGTTCT || Zinc finger DNA-binding domain || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|28. [[Androgen response element gene transcriptions|Androgen response elements]] | |||
(Wilson) | |||
|| AGAACANNNTGTTCT || Zinc finger DNA-binding domain || Y | |||
T | |||
|| the two portions AGAACA and TGTTCT occurring separately are likely active or activable | |||
|- | |||
|29. [[AGCE gene transcriptions|Angiotensinogen core promoter elements]] || (A/C)T(C/T)GTG || bZIP? || Y | |||
T | |||
|| likely active or activable, positive direction distal low occurrences overlap randoms | |||
|- | |||
|30. [[Antioxidant-electrophile responsive element gene transcriptions|Antioxidant-electrophile responsive elements]] | |||
(Lacher) | |||
|| GC(A/C/T)(A/G/T)(A/G/T)(C/G/T)T(A/C)A || bHLH || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|31. [[ATA box gene transcriptions|ATA boxes]] || AATAAA || β-Scaffold factor? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|32. [[Adenylate–uridylate rich element gene transcriptions|ATTTA elements]] | |||
(Siegel) | |||
|| (A/T)(A/T)(A/T)(A/T)(A/T)(A/T)(A/T)(A/T)(A/T) || β-Scaffold factor? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|33. [[Auxin response factor gene transcriptions|Auxin response factors]] | |||
(Stigliani) | |||
|| (C/G/T)(A/C/T)(G/T)G(C/T)(C/T)(G/T)(C/G)(A/C/T)(A/G/T) || WD40 repeat family || Y | |||
T | |||
|| likely active or activable, positive direction proximals overlap high randoms, positive direction cores within randoms | |||
|- | |||
|34. [[Auxin response factor gene transcriptions|Auxin response factors]] | |||
(Ulmasov) | |||
|| TGTCTC || WD40 repeat family || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|35. [[Auxin response factor gene transcriptions|Auxin response factors]] | |||
(Boer) | |||
|| TGTCGG || WD40 repeat family || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|36. [[Auxin response factor gene transcriptions|Auxin response factors]] | |||
(ARF5) | |||
|| (C/G/T)N(G/T)GTC(G/T) || WD40 repeat family || Y | |||
T | |||
|| likely active or activable, negative direction proximals ≥ randoms | |||
|- | |||
|37. [[B box gene transcriptions|B-boxes]] | |||
(Johnson) | |||
|| TGGGCA || Zinc finger DNA-binding domains | |||
PKC-dependent pathway | |||
|| Y | |||
T | |||
|| likely active or activable, positive direction distals ≥ randoms | |||
|- | |||
|38. [[B box gene transcriptions|boxes B]] | |||
(Sanchez) | |||
|| TGTCTCA || Zinc finger DNA-binding domains || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|39. [[Factor II B recognition element gene transcriptions|B recognition elements]] | |||
(BRE<sup>u</sup>) | |||
|| (G/C)(G/C)(G/A)CGCC || HTH || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|40. [[Hypoxia response element gene transcriptions|CACA elements]] (Orlando 2019) || CACA || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|40. [[CadC binding domain gene transcriptions|CadC binding domains]] || TTANNNNT || HTH || Y | |||
T | |||
|| likely active or activable, negative direction proximals within randoms | |||
|- | |||
|41. [[Calcineurin-responsive transcription factor gene transcriptions|Calcineurin-responsive transcription factors]] || TG(A/C)GCCNC || ? | |||
calcineurin-dependent signaling pathways | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|42. [[Carbohydrate response element gene transcriptions|Carbohydrate response elements]] || ChoRE1 ACCGG || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|43. [[Carbohydrate response element gene transcriptions|Carbohydrate response elements]] || ChoRE2 CCCAT || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|44. [[Carbohydrate response element gene transcriptions|Carbohydrate response elements]] || Carb E1 ATCTTG || bHLH? || Y | |||
T | |||
|| proximals likely active or activable | |||
|- | |||
|45. [[Carbohydrate response element gene transcriptions|Carbohydrate response elements]] || Carb E2 CACGTG || bHLH || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|46. [[Carbohydrate response element gene transcriptions|Carbohydrate response elements]] || Carb E3 TCCGCC || bHLH? || Y | |||
T | |||
|| likely active or activable, low positive direction distals overlap high randoms | |||
|- | |||
|47. Carbon source-responsive elements [[Carbon source-responsive element gene transcriptions|TCCG elements]] | |||
(TCCGs) | |||
|| TCCG || bHLH? | |||
gluconeogenic pathway | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|48. [[Carbon source-responsive element gene transcriptions|CATTCA elements]] | |||
(CATTs) | |||
|| CATTCA || bHLH? | |||
gluconeogenic pathway | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|49. [[CARE gene transcriptions|CARE (Fan)]] | |||
(CAREs) | |||
(Fan) | |||
|| CAACTC || WD-40 repeat family || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|50. [[CARE gene transcriptions|CARE (Garaeva)]] | |||
(CAREs) | |||
(Garaeva) | |||
|| (A/G/T)TT(A/G/T)CATCA || WD-40 repeat family || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|51. [[CRE box gene transcriptions|cAMP-responsive elements]] | |||
(CREs), Aca1ps, Sko1ps | |||
|| TGACGTCA || bZIP | |||
cAMP-dependent pathway | |||
|| Y | |||
T | |||
|| likely active or activable, same as [[Root specific element gene transcriptions|Root specific elements]] | |||
|- | |||
|52. [[CArG box gene transcriptions|CArG boxes]] || CCAAAAAT(G/A)G || bHLH || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|53. [[Cat8p gene transcriptions|Cat8ps]] || CGG(A/C/G/T)(C/G/T)(A/C/G/T)(A/C/G)(A/C)(A/C/T)GGA || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|54. [[CAT box gene transcriptions|CAT boxes]] || CATTCCT || bHLH || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|55. [[CAT box gene transcriptions|CAT-box-like elements]] || GCCATT || bHLH || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|56. [[C box gene transcriptions|C boxes]] | |||
(Samarsky) | |||
|| AGTAGT || bZIP || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|57. [[C box gene transcriptions|C-boxes]] | |||
(Song) | |||
|| GACGTC || bZIP || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|58. [[C box gene transcriptions|hybrid CG-boxes]] | |||
(Song) | |||
|| TGACGTGT || bZIP || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|59. [[C box gene transcriptions|C boxes]] | |||
(Voronina) | |||
|| GGTGATG || bZIP || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|60. [[CCCTC-binding factor gene transcriptions|CCCTC-binding factors]] | |||
(CTCF) | |||
(Lobanenkov 1990) | |||
|| CCCTC || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|60. [[Cell-cycle box gene transcriptions|Cell-cycle box variants]] | |||
(CCBs) | |||
|| CACGAAA, ACGAAA and C-CGAAA || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|61. [[CGCG box gene transcriptions|CGCG boxes]] || (A/C/G)CGCG(C/G/T) || ? | |||
signal transduction pathways | |||
|| Y | |||
T | |||
|| likely active or activable probably for the respective zinc fingers | |||
|- | |||
|62. [[Circadian control element gene transcriptions|Circadian control elements]] || CAANNNNATC || ? || Y | |||
T | |||
|| likely active or activable but overlaps highest randoms | |||
|- | |||
|63. [[N box gene transcriptions|Class C DNA binding sites]] || CACGNG || bHLH || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|64. [[Cold-responsive element gene transcriptions|Cold-responsive elements]] || CCGAC || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|65. [[Adenylate–uridylate rich element gene transcriptions|Constitutive decay elements]] | |||
(CDEs) | |||
(Siegel) | |||
|| TTC(C/T)(A/G)(C/T)GAA || stem-loop || Y | |||
T | |||
|| likely active or activable possibly for ZNF497 | |||
|- | |||
|66. [[Copper response element gene transcriptions|Copper response elements]] | |||
(CuREs) | |||
(Quinn) | |||
|| TTTGC(T/G)C(A/G) || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|67. [[Copper response element gene transcriptions|Copper response elements]] | |||
(CuREs) | |||
(Park) | |||
|| TGTGCTCA || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|68. [[Coupling element gene transcriptions|Coupling elements]] | |||
(CE3s) | |||
(Watanabe) | |||
|| GCGTGTC || WD-40 repeat family || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|69. [[Coupling element gene transcriptions|Coupling elements]] | |||
(CE3s) | |||
(Ding) | |||
|| CACGCG || WD-40 repeat family || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|70. [[Cytokinin response regulator gene transcriptions|Cytokinin response regulators]] | |||
(ARR1s) | |||
|| AGATT(C/T) || WD40 repeat family || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|71. [[Cytokinin response regulator gene transcriptions|Cytokinin response regulators]] | |||
(ARR10s) | |||
|| (A/G)GATA(A/C)G || WD40 repeat family || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|72. [[Cytokinin response regulator gene transcriptions|Cytokinin response regulators]] | |||
(ARR12s) | |||
|| (A/G)AGATA || WD40 repeat family || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|73. [[Cytokinin response regulator gene transcriptions|Cytokinin response regulators]] | |||
(ARRs) | |||
(Ferreira) | |||
|| (G/A)GGAT(T/C) || WD40 repeat family || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|74. [[Cytokinin response regulator gene transcriptions|Cytokinin response regulators]] | |||
(ARRs) | |||
(Rashotte1) | |||
|| GATCTT || WD40 repeat family || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|75. [[Cytokinin response regulator gene transcriptions|Cytokinin response regulators]] | |||
(ARRs) | |||
(Rashotte2) | |||
|| (G/A)GAT(T/C) || WD40 repeat family || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|76. [[Cytoplasmic polyadenylation element gene transcriptions|Cytoplasmic polyadenylation elements]] | |||
(CPEs) | |||
|| TTTTTAT || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|77. [[DAF-16 binding element gene transcriptions|DAF-16 binding elements]] || (A/G)(C/T)AAA(C/T)A || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|78. [[D box gene transcriptions|D boxes]] | |||
(Samarsky) | |||
|| AGTCTG || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|79. [[D box gene transcriptions|D boxes]] | |||
(Voronina) | |||
|| TCCTG || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|80. [[D box gene transcriptions|D-boxes]] | |||
(Motojima) | |||
|| TGAGTGG || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|115. [[D box gene transcriptions|Destruction boxes]] | |||
(D box) | |||
(Pfleger and Kirschner 2000) | |||
|| CGN(C/T)TNAAN || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|81. [[Xenobiotic response element gene transcriptions|Dioxin-responsive elements]] | |||
(DREs) | |||
|| TNGCGTG || bHLH? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|82. [[Downstream TFIIB recognition element gene transcriptions|Downstream B recognition elements]] || (A/G)T(A/G/T)(G/T)(G/T)(G/T)(G/T) || ? || Y | |||
T | |||
|| likely active or activable, negatives > randoms, positives overlap or outside randoms | |||
|- | |||
|83. [[Downstream core element gene transcriptions|Downstream core elements]] | |||
(DCESIs) | |||
|| CTTC of CTTC...CTGT...AGC || ? || Y | |||
T | |||
|| likely active or activable, depending on overlaps | |||
|- | |||
|84. [[Downstream core element gene transcriptions|Downstream core elements]] | |||
(DCESIIs) | |||
|| CTGT of CTTC...CTGT...AGC || ? || Y | |||
T | |||
|| likely active or activable, depending on overlaps | |||
|- | |||
|85. [[Downstream core element gene transcriptions|Downstream core elements]] | |||
(DCESIIIs) | |||
|| AGC of CTTC...CTGT...AGC || ? || Y | |||
T | |||
|| likely active or activable, depending on overlaps | |||
|- | |||
|86. [[Downstream promoter element gene transcriptions|Downstream promoter elements]] | |||
(DPEs) | |||
(Juven-Gershon) | |||
|| (A/G)G(A/T)(C/T)(A/C/G)T || ? || Y | |||
T | |||
|| most or all of the real DPE (Juven-Gershon)s are likely active or activable | |||
|- | |||
|87. [[Downstream promoter element gene transcriptions|Downstream promoter elements]] | |||
(DPEs) | |||
(Kadonaga) | |||
|| (A/G)G(A/T)CGTG || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|88. [[Downstream promoter element gene transcriptions|Downstream promoter elements]] | |||
(DPEs) | |||
(Matsumoto) | |||
|| AGTCTC || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|89. [[E2 box gene transcriptions|E2 boxes]] || (G/A)CAG(A/C/G/T)TG(A/C/G/T) || bHLH || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|90. [[EIN3 binding site gene transcriptions|EIN3 binding sites]] || A(C/T)G(A/T)A(C/T)CT || ? | |||
Ethylene signaling pathway | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|91. [[Endoplasmic reticulum stress response element gene transcriptions|Endoplasmic reticulum stress response elements]] || CCAAT-N9-CCACG, part 1 see Hap motif no.114 below, ESRE2, CCACG || bZIP || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|92. [[Endosperm expression gene transcriptions|Endosperm expressions]] || TGTGTCA || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|93. [[Enhancer box gene transcriptions|Enhancer boxes]] || CA(A/C/G/T)(A/C/G/T)TG || bHLH | |||
metabolic pathways | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|94. [[Estrogen response element gene transcriptions|Estrogen response elements]] | |||
(ERE1s) | |||
(Driscoll) | |||
|| GGTCA || {{chem|Cys|4}} | |||
estrogen response element-dependent signaling pathway | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|95. [[Estrogen response element gene transcriptions|Estrogen response elements]] | |||
(ERE2s) | |||
(Driscoll) | |||
|| TGACC || {{chem|Cys|4}} | |||
estrogen response element-dependent signaling pathway | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|96. [[Ethylene responsive element gene transcriptions|Ethylene responsive elements]] || ATTTCAAA || WD40 repeat family | |||
Ethylene signaling pathway | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|97. [[Forkhead box gene transcriptions|Forkhead boxes]] || (A/G)(C/T)AAA(C/T)A || HTH, Forkhead || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|98. [[GAAC element gene transcriptions|GAAC elements]] || GAACT || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|99. [[Γ-interferon activated sequence gene transcriptions|Γ-interferon activated sequences]] | |||
(GAS), see STAT5 | |||
|| TTNCNNNAA || β-Scaffold factors with minor groove contacts || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|100. [[GATA gene transcriptions|GATA boxes]] || GATA || Zinc finger DNA-binding domains, bHLH | |||
STAT5 pathway | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|101. [[GATA gene transcriptions|GATA (GATAAG, GATAAH, GATTA) motifs]] | |||
(Staschke) | |||
|| GAT(A/T)A || Zinc finger DNA-binding domains, bHLH | |||
Rapamycin (TOR) Regulatory Pathways | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|102. [[ABA-response element gene transcriptions|GATC repeats]] | |||
(ABREN) | |||
(Watanabe ''et al''. 2017) | |||
|| GATC || ? | |||
ABA-signaling pathway, Ethylene signaling pathway | |||
|| Y | |||
T | |||
|| GATC UTRs, proximals and positive strand, negative direction distals greater than randoms, negative strand, negative direction distals, positive direction distals likely randoms. GATCs are likely active or activable | |||
|- | |||
|103. [[GC box gene transcriptions|GC boxes]] | |||
(Briggs) | |||
|| (G/T)(G/A)GGCG(G/T)(G/A)(G/A)(C/T) || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|103. [[GC box gene transcriptions|GC boxes]] | |||
(Ye) | |||
|| GGGCGG || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|104. [[AGC box gene transcriptions|GCC boxes]] || GCCGCC || ? | |||
Ethylene signaling pathway | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|105. [[Gcn4p gene transcriptions|General control nonderepressible 4 protein binding site]] | |||
(GCRE, GCN4) | |||
|| TGA(C/G/T)T(A/C/G)(A/T) || bZIP | |||
Rapamycin (TOR) Regulatory Pathways | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|106. [[GGC triplet gene transcriptions|GGCGGC triplet]] || GGCGGC || Zn(II)<sub>2</sub>Cys<sub>6</sub> || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|107. [[GGC triplet gene transcriptions|GGC triplets]] || GGC || Zn(II)<sub>2</sub>Cys<sub>6</sub> || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|108. [[GARE gene transcriptions|Gibberellic acid responsive elements]] | |||
(GAREs) | |||
|| TAACAAA || WD40 repeat family || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|109. [[GARE gene transcriptions|Gibberellic acid responsive elements-like 1]] | |||
(GAREL1s) | |||
|| TAACA(A/G)A || WD40 repeat family || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|110. [[Gibberellin responsive element gene transcriptions|Gibberellin responsive elements]] | |||
(GREs) | |||
(Sharma) | |||
|| AAACAGA<ref name=Sharma>{{ cite journal | |||
|author=Bhaskar Sharma | |||
|author2=Joemar Taganna | |||
|title=Genome-wide analysis of the U-box E3 ubiquitin ligase enzyme gene family in tomato | |||
|journal=Scientific Reports | |||
|date=12 June 2020 | |||
|volume=10 | |||
|issue=9581 | |||
|pages= | |||
|url=https://www.nature.com/articles/s41598-020-66553-1 | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1038/s41598-020-66553-1 | |||
|pmid=32533036 | |||
|accessdate=27 August 2020 }}</ref> || WD40 repeat family | |||
Gibberellin (GA) growth regulator pathway, GA-biosynthesis pathway | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|111. [[Gcr1p gene transcriptions|G-protein-coupled receptors]] | |||
(GCR1s), CT boxes | |||
|| CTTCC || ? | |||
cAMP signal pathway, phosphatidylinositol signal pathway | |||
|| Y | |||
T | |||
|| likely active or activable. | |||
|- | |||
|112. [[Glucocorticoid response element gene transcriptions|Glucocorticoid response elements]] || AGAACA || bHLH | |||
gluconeogenesis pathway | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|113. [[TC element gene transcriptions|GT boxes]] | |||
(Sato) | |||
|| GGGG(T/A)GGGG || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|114. [[Hac1p gene transcriptions|Hac1]] ''KAR2'' || CAGCGTG || ? | |||
unfolded protein response (UPR) pathway | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|115. [[H and ACA box gene transcriptions|H and ACA boxes]] || AGAGGA || Hairpin-hinge-hairpin-tail || Y | |||
T | |||
|| likely active or activable, negative distals likely random | |||
|- | |||
|116. [[CAAT box gene transcriptions|Hap motif]] and [[Endoplasmic reticulum stress response element gene transcriptions#CCAAT samplings|ESRE CCAAT]] | |||
(Hap4p) | |||
|| CCAAT || bZIP || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|117. [[H box gene transcriptions|H-boxes]] | |||
(Grandbastien) | |||
|| CC(A/T)ACCNNNNNNN(A/C)T || hairpin-hinge-hairpin-tail | |||
phenylpropanoid pathway | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|118. [[H box gene transcriptions|H-boxes]] | |||
(Lindsay) | |||
|| CCTACC || hairpin-hinge-hairpin-tail || Y | |||
T | |||
|| likely active or activable, equal to or greater than the randoms for the negative direction distals | |||
|- | |||
|119. [[H box gene transcriptions|H box]] | |||
(Mitchell) | |||
|| ANANNA || hairpin-hinge-hairpin-tail || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|120. [[H box gene transcriptions|H box]] | |||
(Rozhdestvensky) | |||
|| ACACCA || hairpin-hinge-hairpin-tail || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|121. [[Hsf1p gene transcriptions|Heat shock elements]] | |||
(HSE3s) | |||
(Eastmond) | |||
|| nGAAn-(5-bp)-nGAAnnTTCn || HTH, HSFs || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|122. [[Hsf1p gene transcriptions|Heat shock elements]] | |||
(HSEs) | |||
(Eastmond) | |||
|| nGA(A/G)n-(5-bp)-nGAAnnTTCn (GAP1) || HTH, HSFs || Y | |||
T | |||
|| same result as HSE3, likely active or activable | |||
|- | |||
|123. [[Hsf1p gene transcriptions|Heat shock elements]] | |||
(HSEs) | |||
(Eastmond) | |||
|| nGAAn-(5-bp)-nGA(A/G)nnTTCn (GAP2) || HTH, HSFs || Y | |||
T | |||
|| same result as HSE3, likely active or activable | |||
|- | |||
|124. [[Hsf1p gene transcriptions|Heat shock elements]] | |||
(HSE4s) | |||
(Eastmond) | |||
|| nGAAn-(5-bp)-nGAAn-(5-bp)-nGAAn || HTH, HSFs || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|125. [[Hsf1p gene transcriptions|Heat shock factors]] | |||
(Hsfs) | |||
(Tang) | |||
|| NGAAN || HTH, HSFs || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|85. [[HMG box gene transcriptions|Helper site]] | |||
(Atcha et al. 2007), (Cadigan and Waterman 2012) | |||
|| (C/G)C(C/G)G(C/G) || ? | |||
Wnt/beta-catenin signaling pathway | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|126. [[Hex sequence gene transcriptions|Hex sequences]] || TGACGTGGC || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|127. [[HMG box gene transcriptions|High Mobility Group boxes]] | |||
(HMG boxes) | |||
|| (A/T)(A/T)CAAAG || β-Scaffold factors with minor groove contacts || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|128. [[HNF gene transcriptions|HNF6s]] || (A/G/T)(A/T)(A/G)T(C/T)(A/C/G)AT(A/C/G/T)(A/G/T) || {{chem|Cys|4}} | |||
GH/HNF-6 pathway, HNF6/HNF1β pathway, HNF6 pathway, KLF4/HNF-6 pathway | |||
|| Y | |||
T | |||
|| likely active or activable, although the negative direction distals are at or less than randoms | |||
|- | |||
|129. [[Homeobox gene transcriptions|Homeoboxes]] || CAAG || HTH | |||
lignin pathway, Wnt dorsalisation pathway, lefty-signaling pathway | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|130. [[Homeobox gene transcriptions|Homeodomains]] || TAAT || HTH || Y | |||
T | |||
|| likely active or activable, low occurrence UTRs and negative direction distals overlap high randoms | |||
|- | |||
|131. [[HY box gene transcriptions|HY boxes]] || TG(A/T)GGG || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|132. [[Hypoxia-inducible factor gene transcriptions|Hypoxia-inducible factors]] || ACGTG || bHLH || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|133. [[Hypoxia response element gene transcriptions|Hypoxia response elements]] || CACGC || WD40 repeat family || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|134. [[Hypoxia response element gene transcriptions|CACA elements]] || CACA || WD40 repeat family || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|135. [[Initiator element gene transcriptions|Initiator elements]] | |||
(Inrs) | |||
|| YYRNWYY || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|136. [[Initiator element gene transcriptions|Initiator elements]] | |||
(Inrs) | |||
|| BBCABW || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|137. [[Initiator element gene transcriptions|Initiator-like elements]] | |||
(Ins-Like) | |||
|| TTCTCT || ? || Y | |||
T | |||
|| likely active or activable, where real Inr-like negative direction distals are within the range of the randoms | |||
|- | |||
|138. [[Initiator element gene transcriptions|Initiator-like elements]] | |||
(TCT) | |||
|| (C/T)CT(C/T)T(C/T)(C/T) || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|139. [[Inositol, choline-responsive element gene transcriptions|Inositol/choline-responsive elements]] | |||
(ICRE) | |||
(Case, Lopes) | |||
|| CATGTGAAAT includes the canonical basic helix-loop-helix (bHLH) binding site CANNTG (Lopes et al. 1991) || bHLH || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|140. [[Inositol, choline-responsive element gene transcriptions|Inositol/choline-responsive elements]] | |||
(ICREs) | |||
(Schwank) | |||
|| TYTTCACATGY contains the core sequence CANNTG || bHLH || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|141. [[Interferon regulatory factor gene transcriptions|Interferon regulatory factor]] | |||
(IRF3) | |||
|| GCTTTCC || HTH || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|142. [[Interferon regulatory factor gene transcriptions|IFN-stimulated response elements]] | |||
(ISREs) | |||
(Lu) | |||
|| GAAANNGAAA || HTH || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|143. [[Interferon regulatory factor gene transcriptions|IRS consensus]] | |||
(Fujii) | |||
|| AANNGAAA || HTH || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|144. [[Interferon regulatory factor gene transcriptions|Tryptophan residues]] | |||
(Lu) | |||
|| GAAA || HTH || Y | |||
T | |||
|| likely active or activable, the tryptophan residues occur in the IRS, IFN, ICRE, Cell-cycle box variants, V-box, Pollen1, and β-Scaffold response elements | |||
|- | |||
|145. [[Jasmonic acid-responsive element gene transcriptions|Jasmonic acid-responsive elements]] | |||
(JAREs) | |||
|| TGACG || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|146. [[Krüppel-like factor gene transcriptions|Krüppel-like factors]] || GGGNN(G/T)(G/T)(G/T) || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|147. [[Leu3 gene transcriptions|Leu3 transcription factors]] || (C/G)C(G/T)NNNN(A/C)G(C/G) || Zn(II)<sub>2</sub>Cys<sub>6</sub> || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|148. [[M35 box gene transcriptions|-35 sequence]] || TTGACA || ? || Y | |||
T | |||
|| likely active or activable, the UTR does overlap the randoms at the random's upper end | |||
|- | |||
|149. [[Met31p box gene transcriptions|Met31ps]] || AAACTGTG<ref name=Blaiseau>{{ cite journal | |||
|author=Pierre‐Louis Blaiseau and Dominique Thomas | |||
|title=Multiple transcriptional activation complexes tether the yeast activator Met4 to DNA | |||
|journal=The EMBO Journal | |||
|date=2 November 1998 | |||
|volume=17 | |||
|issue= | |||
|pages=6327-6336 | |||
|url=https://www.embopress.org/doi/full/10.1093/emboj/17.21.6327 | |||
|arxiv= | |||
|bibcode= | |||
|doi=10.1093/emboj/17.21.6327 | |||
|pmid= | |||
|accessdate=4 February 2021 }}</ref> || bZIP || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|150. [[Metal responsive element gene transcriptions|Metal responsive elements]] | |||
(MRE) | |||
|| TGC(A/G)C(A/C/G/T)C || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|151. [[Middle sporulation element gene transcriptions|Middle sporulation element]] | |||
(MSE) | |||
(Branco) | |||
|| ACACAAA || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|152. [[Middle sporulation element gene transcriptions|Midsporulation element]] | |||
(MSE) | |||
(Ozsarac) | |||
|| C(A/G)CAAA(A/T) || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|153. [[Mig1p gene transcriptions|Multicopy inhibitor of the ''GAL1'' promoter]] | |||
(''MIG1'') | |||
|| (C/G)(C/T)GGGG || bZIP || Y | |||
T | |||
|| likely active or activable, UTRs may be random | |||
|- | |||
|154. [[Mig1p gene transcriptions|MITF E-box (CAYRTG)]] | |||
(''MITF'') | |||
|| CA(C/T)(A/G)TG || ? || Y | |||
T | |||
|| likely active or activable, negative distals overlap randoms at low end | |||
|- | |||
|155. [[Musashi binding element gene transcriptions|Musashi binding elements]] | |||
(MBE1s) | |||
|| (G/A)U<sub>1</sub>AGU || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|156. [[Musashi binding element gene transcriptions|Musashi binding elements]] | |||
(MBE2s) | |||
|| (G/A)U<sub>2</sub>AGU || ? || Y | |||
T | |||
|| likely active or activable, negative direction distals may be random | |||
|- | |||
|157. [[Musashi binding element gene transcriptions|Musashi binding elements]] | |||
(MBE3s) | |||
|| (G/A)U<sub>3</sub>AGU || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|158. [[MYB recognition element gene transcriptions|MYB ACGT-containing elements]] | |||
(ACEs) | |||
|| CACGT || ? || Y | |||
T | |||
|| likely active or activable, positive strand UTR is likely random, negative strand, positive direction distals are likely random | |||
|- | |||
|159. [[MYB recognition element gene transcriptions|Myeloblastosis recognition element]] | |||
(MRE) | |||
|| A(A/C)C(A/T)A(A/C)C || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|160. [[Myocyte enhancer factor gene transcriptions|Myocyte enhancer factors]] | |||
(MEFs) | |||
|| (C/T)TA(A/T)(A/T)(A/T)(A/T)TA(A/G) || β-Scaffold factors with minor groove contacts || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|161. [[UTR promoter gene transcriptions|Nanos/Pumilio response elements]] | |||
(PREs) | |||
|| TGTAAAT || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|162. [[N box gene transcriptions|N-boxes]] | |||
(Lee) | |||
|| CCGGAA || bHLH || Y | |||
T | |||
||likely active or activable | |||
|- | |||
|163. [[N box gene transcriptions|N-boxes]] | |||
(Bai) | |||
|| CACGAG || bHLH || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|164. [[N box gene transcriptions|N-boxes]] | |||
(Gao) | |||
|| CACGGC or CACGAC, CACG(A/G)C || bHLH || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|165. [[N box gene transcriptions|N-boxes]] | |||
(Leal) | |||
|| CACNAG || bHLH || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|166. [[Ndt80p gene transcriptions|Non-DiTyrosine 80 transcription factor DNA binding domain]] | |||
(Ndt80) | |||
|| (A/G/T)NC(A/G)CAAA(A/T) || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|167. [[Nuclear factor of activated T cell gene transcriptions (NFAT)|Nuclear factor of activated T cells]] | |||
(NFATs) | |||
complement and inverse of the [[Pyrimidine box gene transcriptions|Pyrimidine boxes]] | |||
|| GGAAAA || β-Scaffold factors with minor groove contacts || Y | |||
T | |||
|| likely active or activable, negative direction distals likely random | |||
|- | |||
|168. [[Nuclear factor gene transcriptions|NF𝜿B (Sato)]] | |||
(NF𝜿BSs) | |||
|| GAATTC || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|169. [[Nutrient-sensing response element gene transcriptions|Nutrient-sensing response element 1]] | |||
(NSRE) | |||
|| GTTTCATCA || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|170. [[Oaf1p gene transcriptions|Oaf1 transcription factor]] || CGGN<sub>3</sub>TNAN<sub>9-12</sub>CCG || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|171. [[ORE1 binding site gene transcriptions|ORESARA1]] | |||
(ORE1) | |||
(Matallana) | |||
|| (A/C/G)(A/C)GT(A/G)N<sub>5,6</sub>(C/T)AC(A/G) || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|172. [[ORE1 binding site gene transcriptions|ORESARA1]] | |||
(ORE1) | |||
(Olsen) | |||
|| T(A/G/T)(A/G)CGT(A/G)(A/C/T)(A/G/T) || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|173. [[P53 response element gene transcriptions|p53 response elements]] || (A/G)(A/G)(A/G)C(A/T)(A/T)G(C/T)(C/T)(C/T) || β-Scaffold factors with minor groove contacts || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|174. [[P53 response element gene transcriptions|p53 response elements]] | |||
(Long1) | |||
|| CAGGCCC || β-Scaffold factors with minor groove contacts || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|175. [[P53 response element gene transcriptions|p53 response elements]] | |||
(Long2) | |||
|| GGGCGTG || β-Scaffold factors with minor groove contacts || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|176. [[P box gene transcriptions|P-box (Mena)]] || (A/T)AAAG || ? || Y | |||
T | |||
|| likely active or activable, the positive direction proximals overlap the randoms | |||
|- | |||
|177. [[P box gene transcriptions|P-box]] | |||
(Motojima) | |||
|| TGAGTTCA || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|178. [[P box gene transcriptions|P-box]] | |||
(Yu) | |||
|| GTAA(T/C) || ? || Y | |||
T | |||
|| likely active or activable with some overlapping the randoms | |||
|- | |||
|179. [[Peroxisome proliferator hormone response element gene transcriptions|Peroxisome proliferator-activated receptor alpha]] || CGACCCC || ? || Y | |||
T | |||
|| likely active or activable, positive direction distal overlaps upper end of randoms | |||
|- | |||
|180. [[Phosphate starvation-response transcription factor gene transcriptions|Phosphate starvation-response transcription factor]] | |||
(Pho4) | |||
(Tang 2020) | |||
|| CAC(A/G)T(T/G) || bHLH | |||
purine and histidine biosynthesis pathways | |||
|| Y | |||
T | |||
|| likely active or activable, positive strands of the UTRs and negative direction distals are in the random range | |||
|- | |||
|181. [[Pollen1 element gene transcriptions|Pollen1 elements]] || AGAAA || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|182. [[Polycomb response element gene transcriptions|Polycomb response elements]] | |||
(PRE) | |||
|| GCCAT || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|183. [[Pribnow box gene transcriptions|Pribnow boxes]] || TATAAT || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|184. [[Prolamin box gene transcriptions|Prolamin boxes]] || TG(A/T)AAAG || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|185. [[Q element gene transcriptions|Q elements]] | |||
See [[Retinoic acid response element gene transcriptions|Retinoic acid response element]] | |||
|| AGGTCA || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|186. [[Xenobiotic response element gene transcriptions|Quinone reductase response element]] | |||
(QRDRE) | |||
(Yao) | |||
|| TCCCCT of TCCCCTTGCGTG || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|187. [[Rap1 regulatory factor gene transcriptions|Rap1 reduced consensus]] || (A/G)(A/C)ACCC(A/G)N(A/G)C(A/C)(C/T)(A/C) || WD40 repeat family || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|188. [[Reb1 general regulatory factor gene transcriptions|Reb1 bound and exact occurrences]] || TTACCC(G/T) || WD40 repeat family || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|189. [[Retinoic acid response element gene transcriptions|Retinoic acid response element]] | |||
(RARE) | |||
|| AG(A/G)TCA || ? || Y | |||
T | |||
|| likely active or activable, positive direction distals appear random | |||
|- | |||
|190. [[Rgt1p gene transcriptions|Glucose transporter gene repressor]] | |||
(Rgt1) | |||
|| CGG(A/G)(A/T)N(A/T)(A/T) || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|191. [[ROR-response element gene transcriptions|classic RORE motif]] | |||
(RORE) | |||
|| A(A/T)NTAGGTCA || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|192. [[ROR-response element gene transcriptions|variant RORE motif]] || C(T/A)(G/A)GGNCA || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|193. [[MYB recognition element gene transcriptions|R response elements]] | |||
(RRE) | |||
|| CATCTG || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|194. [[Serum response element gene transcriptions|Serum response elements]] | |||
(SRE) | |||
see [[CArG box gene transcriptions|CArG boxes]] | |||
|| ACAGGATGT || bHLH-ZIP || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|195. [[Servenius sequence gene transcriptions|Servenius sequences]] || GGACCCT || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|196. [[Specificity protein gene transcriptions|SP1]] | |||
(Zhang) | |||
|| (G/T)GGGCGG(G/A)(G/A)(C/T) || ? | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|197. [[Specificity protein gene transcriptions|SP1-box 1]] | |||
(Motojima) | |||
|| GGGGCT || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|198. [[Specificity protein gene transcriptions|SP1-box 2]] | |||
(Motojima) | |||
|| CTGCCC || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|199. [[Specificity protein gene transcriptions|SP-1]] | |||
(Sato) | |||
|| CCGCCCC || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|200. [[Specificity protein gene transcriptions|SP1]] | |||
(Yao) | |||
|| GCGGC || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|201. [[STAT5 gene transcription laboratory|STAT5]] || TTCNNNGAA || β-Scaffold factors with minor groove contacts || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|202. [[Msn2,4p gene transcriptions|Stress-response elements]] | |||
(STREs) | |||
|| CCCCT || ? || Y | |||
T | |||
|| likely active or activable, positive cores overlap randoms | |||
Positive strand, negative direction: CCCCT at 3059 | |||
|- | |||
|203. [[Sucrose box gene transcriptions|Sucrose boxes]] || NNAATCA || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|204. [[TACTAAC box gene transcriptions|TACTAAC boxes]] || TACTAA(C/T) || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|205. [[TAGteam gene transcriptions|TAGteams]] || CAGGTAG || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|206. [[Tapetum box gene transcriptions|Tapetum boxes]] || TCGTGT || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|207. [[TATA box gene transcriptions|metazoan TATA boxes]] || TATA(A/T)AA(A/G) || β-Scaffold factors with minor groove contacts || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|208. [[TATA box gene transcriptions|TATA boxes]] || TATA(A/T)A(A/T)(A/G) || β-Scaffold factors with minor groove contacts || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|209. [[TAT box gene transcriptions|TAT Boxes]] | |||
(Yang) | |||
|| TATAAAA || WD40 repeat family || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|210. [[TAT box gene transcriptions|TAT Boxes]] | |||
(Fan) | |||
|| TATCCAT || WD40 repeat family || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|211. [[Tbf1 regulatory factor gene transcriptions|Tbf1 regulatory factors]] || A(A/G)CCCTAA || General Regulatory Factors || Y | |||
T | |||
|| ''Saccharomyces cerevisiae'', likely active or activable | |||
|- | |||
|212. [[T box gene transcriptions|T boxes]] | |||
(Conlon) | |||
|| TCACACCT || bZIP || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|213. [[T box gene transcriptions|T boxes]] | |||
(Zhang) | |||
|| AACGTT || bZIP || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|214. [[TEA consensus sequence gene transcriptions|TEA consensus sequences]] || CATTCY || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|215. [[Tec1p gene transcriptions|Tec1ps]] || GAATGT || ? || Y | |||
T | |||
|| likely random, Ste12p cofactor | |||
|- | |||
|216. [[Telomeric repeat DNA-binding factor gene transcriptions|Telomeric repeat DNA-binding factors]] | |||
(TRFs) | |||
|| TTAGGG || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|217. [[Thyroid hormone response element gene transcriptions|Thyroid hormone response elements]] | |||
(TREs)(THRs) | |||
|| AGGTCA || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|218. [[Transcription factor 3 gene transcriptions|Transcription factor 3]] | |||
(TCF3) | |||
|| GTCTGGT || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|219. [[Translational control sequence gene transcriptions|Translational control sequences]] | |||
(TCSs) | |||
|| (A/T)TT(A/G)TCT || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|220. [[Hac1p gene transcriptions|Unfolded protein response element]] | |||
(URE) (UPRE-1) | |||
|| CANCNTG || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|221. [[Unfolded protein response element gene transcriptions|Unfolded protein response elements]] | |||
(UPREs) | |||
|| TGACGTG(G/A) || bZIP || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|222. [[DNA damage response element gene transcriptions|Upstream repressor site 1]] | |||
(URS1, core) | |||
(Sumrada) | |||
|| CCGCC || ? || Y | |||
T | |||
|| likely active or activable, negative direction proximals are within randoms | |||
|- | |||
|223. [[Upstream stimulatory factor gene transcriptions|Upstream stimulating factors]] | |||
(USFs) | |||
|| GCC(A/T)NN(C/G/T)(A/G) || bHLH-ZIP || Y | |||
T | |||
|| likely active or activable, cores overlap lower randoms | |||
|- | |||
|224. [[Adenylate–uridylate rich element gene transcriptions|UUA rich elements]] | |||
(Chen) | |||
|| TTATTTA(A/T)(A/T) || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|225. [[V box gene transcriptions|V boxes]] || (A/G)TT(A/T)(C/T) || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|226. [[Vitamin D response element gene transcriptions|Vitamin D response elements]] | |||
(VDREs) | |||
|| (A/G)G(G/T)(G/T)CA || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|227. [[W box gene transcriptions|W boxes]] || (C/T)TGAC(C/T) || WRKY || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|228. [[X core promoter element gene transcriptions|X core promoter elements]] || (A/G/T)(C/G)G(C/T)GG(A/G)A(C/G)(A/C) || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|229. [[Xenobiotic response element gene transcriptions|Xenobiotic response elements]] | |||
(XREs) | |||
|| GCGTG || bHLH | |||
aryl hydrocarbon receptor pathways | |||
|| Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|230. [[Yap1p,2p gene transcriptions|Yap recognition sequences]] || TTACTAA || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|231. [[YY1 gene transcriptions|YY1 binding sites]] || CCATCTT || {{chem|Cys|2|His|2}} || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|232. [[Z box gene transcriptions|Z boxes]] | |||
NSoSp form | |||
|| A(C/T)A(C/G)G(G/T)(A/G/T)T || ? || Y | |||
T | |||
|| likely active or activable, negative direction distals within randoms | |||
|- | |||
|233. [[Z box gene transcriptions|Z boxes]] | |||
ZboxG | |||
|| A(C/T)A(C/G)GT(A/G)T || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|234. [[Z box gene transcriptions|Z boxes]] | |||
ZboxSp | |||
|| CAGGT(A/G) || ? || Y | |||
T | |||
|| likely active or activable | |||
|- | |||
|} | |||
==Totals== | |||
( | Of 376 response elements, there are 121 Ns for not present (absent) in either A1BG promoter and 255 Ys for (present) or transcription factors that occur in the promoters on either side A1BG. There are 255 likely active or activable (67.82 %). With 4560 nts considered between ZSCAN22 and A1BG, halfway would be at 2280. Less than 2280 suggests the nearest other gene. In the positive direction, 4445 nts considered between ZNF497 and A1BG, halfway would be 2222 for another nearest gene. Less than 2222 suggests the nearest other gene. | ||
==Number of non-degenerate nucleotides per response element== | |||
see [[Non-degenerate nucleotides per response element]] | |||
==Acknowledgements== | ==Acknowledgements== | ||
Line 1,646: | Line 3,777: | ||
* [[A1BG gene transcriptions]] | * [[A1BG gene transcriptions]] | ||
* [[A1BG regulatory elements and regions]] | * [[A1BG regulatory elements and regions]] | ||
* [[A1BG response element negative results]] | |||
* [[A1BG response element positive results]] | * [[A1BG response element positive results]] | ||
* [[Complex locus A1BG and ZNF497]] | * [[Complex locus A1BG and ZNF497]] | ||
Line 1,663: | Line 3,795: | ||
<!-- footer categories --> | <!-- footer categories --> | ||
Latest revision as of 04:35, 30 January 2025
Associate Editor(s)-in-Chief: Henry A. Hoff
Def. nucleotide "sequences, usually upstream, which are recognized by specific regulatory transcription factors, thereby causing gene response to various regulatory agents", [that] "may be found in both promoter and enhancer regions"[1] are called response elements.
Hypotheses
- A1BG has no response elements in either promoter.
- A1BG is not transcribed by a response element.
- Each response element does not participate in the transcription of A1BG.
Response element testing
Name of elements, Abbreviations, Authors | Consensus sequences, Variations | Testing | Order | Resource | nucleotides for one occurrence or likelihood found |
---|---|---|---|---|---|
1. ABA-response element-like, (ABRE-like) | ACGTGTCC | Absent | 27 | ABA-response elements 13:07, 8 October 2020 | 48 |
2. ABA-response elements, novel, (ABREN, novel ABRE) | GATCGATC, CGATCGAT, GATCGAT | Absent | 28 | ABA-response elements 13:07, 8 October 2020 | 47-48 |
3. ABA responsive elements (ABREs) | ACGTG(G/T)C | Present | 29 | ABA-response elements 05:53, 9 October 2020 | likely active or activable |
4. Abf1 regulatory factors | CGTNNNNNACGAT | Absent | 31 | Abf1 regulatory factors 18:32, 10 October 2020 | 413 |
5. A-boxes | TACGTA | Present | 26 | A-boxes 21:24, 7 October 2020 | likely active or activable |
6. Abscisic acid-responsive elements (Pho4s), G boxes | CACGTG | Present | 126 | Abscisic acid-responsive elements (Pho4s), G boxes 06:38, 10 May 2022 | likely active or activable |
7. ACGT-containing elements | ACGT | Present | 182 | ACGT-containing elements 03:02, 25 September 2022 | cores, proximals likely active or activable, few UTRs, distals may be random |
8. Activated B-cell Factor-1s (ABFs, Abfms) | CGTNNNNN(A/G)(C/T)GA(C/T) | Present | 30 | Abf1 regulatory factors 17:47, 10 October 2020 | likely active or activable |
9. Activating proteins (APs), (Murata) | GCCCACGGG | Absent | 275 | Activating proteins 05:32, 15 December 2022 | 49 |
10. Activating protein 2 alpha (AP2a) | GCCNNNGGC | Present | 184 | Activating protein 2 alpha 00:57, 29 September 2022 | likely active or activable, positive strand, positive direction within randoms |
11. Activating protein 2 (AP2), (Cohen1) | GCCTGGCC | Present | 187 | Activating protein 2 06:54, 30 September 2022 | likely active or activable |
12. Activating protein 2, (Cohen2) | TCCCCCGCCC | Present | 188 | Activating protein 2 07:41, 30 September 2022 | likely active or activable |
13. Activating protein 2, (Murata) | (C/G)CCN(3)GG(C/G) | Present | 183 | Activating protein 2 23:47, 28 September 2022 | likely active or activable |
14. Activating protein 2, (Murata) | (C/G)CCN(4)GG(C/G) | Present | 186 | Activating protein 2 19:10, 29 September 2022 | likely active or activable |
15. Activating protein 2, (Yao1) | TCTTCCC | Present | 189 | Activating protein 2 08:11, 30 September 2022 | likely active or activable |
16. Activating protein 2, (Yao2) | CTCCCA | Present | 190 | Activating protein 2 19:00, 30 September 2022 | likely active or activable |
17. Activating protein 2, (AP-2), (Yao3) | GGCCAA | Present | 191 | Activating proteins 22:23, 30 September 2022 | likely active or activable |
18. Activating protein 2, (AP-2), (Roesler) | CCCCACC(A/C) | Present | 353 | AP-2 (Roesler) samplings 19:31, 21 April 2023 | likely active or activable |
19. Activating transcription factors, (ATF), (Burton) | (A/C/G)TT(A/G/T)C(A/G)TCA | Present | 192 | Activating transcription factors 01:48, 1 October 2022 | likely active or activable |
20. Activating transcription factors, (ATF), (Kilberg) | (A/G/T)TT(A/G/T)CATCA | Present | 193 | Activating transcription factors 02:21, 1 October 2022 | likely active or activable |
21. Adenylate–uridylate rich elements, (AUREs), (Bakheet) | (A/T)(A/T)(A/T)TATTTAT(A/T)(A/T) | Present | 116 | Adenylate–uridylate rich elements 02:16, 3 October 2021 | likely active or activable |
22. Adenylate–uridylate rich elements, (AREs), (Chen and Shyu, Class I) | ATTTA | Present | 273 | Adenylate–uridylate rich elements 04:44, 15 December 2022 | likely active or activable, UTRs at the lower end of the randoms |
23. Adenylate–uridylate rich elements, (AREs), (Chen and Shyu, Class II) | TTATTTA(A/T)(A/T) | Present | 272 | Adenylate–uridylate rich elements 04:31, 15 December 2022 | likely active or activable |
24. Adenylate–uridylate rich elements, (AREs), (Chen and Shyu, Class III) | ATTT | Present | 271 | Adenylate–uridylate rich elements 04:06, 15 December 2022 | likely active or activable, low negative direction proximals overlap randoms |
25. Adr1ps, (ADR), (Tang 2020) | TTGG(A/G)G | Present | 268 | Adr1ps 01:36, 15 December 2022 | likely active or activable |
26. Aft1s, (AFT) | (C/T)(A/G)CACCC(A/G) | Present | 194 | Aft1s 15:48, 3 October 2022 | likely active or activable |
27. AGC boxes | AGCCGCC (Leubner-Metzger 1998) | Present | 8 | AGC boxes 14:40, 2 May 2014 | likely active or activable |
28. AhR DNA-binding consensus sequence, (AhRY), (Yao) | GCGTGNN(A/T)NNN(C/G) | Present | 234 | AhR DNA-binding consensus sequence 05:37, 5 November 2022 | likely active or activable for ZNF497 |
29. AhR-responsive elements (AHRE) (Yao 1992) | (G/T)NGCGTG(A/C)(C/G)A | Absent | 84 | AhR/ARNT complex 20:45, 17 February 2021 | 23*46 |
30. Alpha-amylase conserved elements (Sharma 2020) | TATCCATCCATCC | Absent | 36 | Alpha-amylase conserved elements 04:22, 13 October 2019 | 413 |
31. Alpha-amylase conserved elements portion | TATCCA | Present | 347 | Alpha-amylase conserved elements portion 05:39, 11 April 2023 | likely active or activable |
32. Amino acid response elements, (AARE1), (Maruyama) | ATTGCATCA | Absent | 110 | Amino acid response elements 01:32, 22 May 2021 | 49 |
33. Amino acid response elements, (AARE), (Broer) | TTTGCATCA[2][3] | Absent | 38 | Amino acid response elements 01:59, 1 November 2020 | 49 |
34. Amino acid response element-like, (AARE-like), (AARE3), (Maruyama) | TGGTGAAAG | Absent | 39 | Amino acid response element-like 02:27, 2 November 2020 | 49 |
35. Androgen response elements, (AREs), (Kouhpayeh) | GGTACANNNTGTTCT | Absent | 40 | Androgen response elements 17:01, 2 November 2020 | 412 |
36. Androgen response element1s, (Kouhpayeh) | GGTACA of GGTACAnnnTGTTCT | Present | 196 | Androgen response element1s 17:22, 4 October 2022 | likely active or activable |
37. Androgen response element2s, (Kouhpayeh) | TGTTCT of GGTACAnnnTGTTCT | Present | 197 | Androgen response element2s 17:01, 5 October 2022 | likely active or activable |
38. Androgen response elements, (AREs), (Wilson) | AGAACANNNTGTTCT | Absent | 117 | Androgen response elements 16:21, 11 November 2021 | 412 |
39. Androgen response elements, (Wilson) | AGAACANNNTGTTCT | Present | 198 | Androgen response elements 18:53, 5 October 2022 | the two portions AGAACA and TGTTCT occurring separately are likely active or activable |
40. Angiotensinogen core promoter elements (AGCE) | (A/C)T(C/T)GTG | Present | 256 | Angiotensinogen core promoter elements 20:01, 5 December 2022 | likely active or activable, positive direction distal low occurrences overlap randoms |
41. Antioxidant-electrophile responsive elements, (ARE), (Otsuki) | GTGAGGTCGC[4] or GCTGAGT, GCAGGCT of GC(A/C/T)(A/G/T)(A/G/T)(C/G/T)T(A/C)A[5] | Absent | 41 | Antioxidant-electrophile responsive elements 06:06, 4 November 2020 | (4/3)*2*45-410 |
42. Antioxidant-electrophile responsive elements, (Lacher) | GC(A/C/T)(A/G/T)(A/G/T)(C/G/T)T(A/C)A | Present | 199 | Antioxidant-electrophile responsive elements 23:22, 5 October 2022 | likely active or activable |
43. Aryl hydrocarbon responsive element II, (AHRE-II) | CATGN6C(A/T)TG | Present | 257 | AhR responsive element or Aryl hydrocarbon responsive element II 18:04, 6 December 2022 | likely active or activable |
44. ATA boxes | AATAAA | Present | 267 | ATA boxes 19:59, 14 December 2022 | likely active or activable |
45. ATTTA elements, (Siegel) | (A/T)(A/T)(A/T)(A/T)(A/T)(A/T)(A/T)(A/T)(A/T) | Present | 270 | ATTTA elements 04:04, 15 December 2022 | likely active or activable |
46. Auxin response factors, (ARF), (Stigliani) | (C/G/T)(A/C/T)(G/T)G(C/T)(C/T)(G/T)(C/G)(A/C/T)(A/G/T) | Present | 235 | Auxin response factors 05:55, 5 November 2022 | likely active or activable, positive direction proximals overlap high randoms, positive direction cores within randoms |
47. Auxin response factors, (ARF), (Ulmasov) | TGTCTC | Present | 236 | Auxin response factors 06:02, 5 November 2022 | likely active or activable |
48. Auxin response factors, (ARF), (Boer) | TGTCGG | Present | 200 | Auxin response factors 17:03, 7 October 2022 | likely active or activable |
49. Auxin response factors, (ARF5) | (C/G/T)N(G/T)GTC(G/T) | Present | 201 | Auxin response factors 04:15, 10 October 2022 | likely active or activable, negative direction proximals ≥ randoms |
50. B-boxes, (Johnson) | TGGGCA | Present | 203 | B-boxes 18:05, 10 October 2022 | likely active or activable, positive direction distals ≥ randoms |
51. boxes A | TGACTCT | Present | 125 | Box A 06:50, 9 May 2022 | likely active or activable |
52. boxes B, (Sanchez) | TGTCTCA | Present | 202 | Box B 15:26, 10 October 2022 | likely active or activable |
53. B recognition elements, (BREu) | (G/C)(G/C)(G/A)CGCC | Present | 255 | B recognition elements 20:39, 4 December 2022 | likely active or activable |
54. CAACTC regulatory elements, (CAREs), (Fan) | CAACTC | Present | 122 | CARE (Fan) 17:45, 7 May 2022 | likely active or activable |
55. CAAT boxes | (C/T)(A/G)(A/G)CCAATC(A/G) | Absent | 14 | CAAT boxes 02:41, 22 March 2019 | 48, consensus sequence for the CCAAT-enhancer-binding site (C/EBP) is TAGCATT. |
56. CACA elements (Orlando 2019) | CACA | Present | 108 | CACA elements 05:04, 7 May 2021 | likely active or activable |
57. CadC binding domains | TTANNNNT | Present | 204 | CadC binding domains 22:14, 12 October 2022 | likely active or activable, negative direction proximals within randoms |
58. Calcineurin-responsive transcription factors | TG(A/C)GCCNC | Present | 265 | Calcineurin-responsive transcription factors 19:14, 12 December 2022 | likely active or activable |
59. Calcium-response elements, (CaRE1s), (Tao 2002) | CTATTTCGAG | Absent | 42 | Calcium-response elements 19:43, 7 November 2020 | 410 |
60. Carbohydrate response elements, (ChREs), (ChoRE1, ChoRE2), (Long 2020) | CACGTGACCGGATCTTG, TCCGCCCCCATCACGTG | Absent | 43 | Carbohydrate response elements 20:50, 10 November 2020 | 417 |
61. Carbohydrate response elements, (ChoRE1), (Carb) | ACCGG | Present | 143 | Carbohydrate response elements 18:56, 18 June 2022 | likely active or activable |
62. Carbohydrate response elements, (ChoRE2), (Carb1) | CCCAT | Present | 205 | Carbohydrate response elements 06:01, 13 October 2022 | likely active or activable |
63. Carbohydrate response elements, (Carb E1) | ATCTTG | Present | 206 | Carbohydrate response elements 18:45, 13 October 2022 | proximals likely active or activable |
64. Carbohydrate response elements, (Carb E2) | CACGTG | Present | 207 | Carbohydrate response elements 21:30, 13 October 2022 | likely active or activable |
65. Carbohydrate response elements, (Carb E3) | TCCGCC | Present | 208 | Carbohydrate response elements 01:21, 14 October 2022 | likely active or activable, low positive direction distals overlap high randoms |
66. Carbon source-responsive elements, (CSREs) | CATTCATCCG | Absent | 105 | Carbon source-responsive elements 17:08, 19 March 2021 | 410, confers carbon source-dependent regulation |
67. Carbon source-responsive elements, (TCCGs) | TCCG | Present | 209 | TCCG elements 02:41, 16 October 2022 | likely active or activable |
68. Carbon source-responsive elements, (CATTs) | CATTCA | Present | 210 | CATTCA elements 17:05, 18 October 2022 | likely active or activable |
69. CArG boxes, (Kamada 1992), (McDonald 2006) | CC(A/T)6GG | Absent | 211 | CArG boxes 19:08, 18 October 2022 | 26*44 |
70. CArG boxes, (Deng 2011) | CCAAAAAT(G/A)G | Absent | 212 | CArG boxes 19:08, 18 October 2022 | 2*49 |
71. CArG boxes, (suggested more general motif), (Deng 2011) | C(C/A/T)(A/T)6(A/G)G from two different CArG-box motifs at 502 bp (CTAAATATGG) and 287 bp (CAATAATTGG) upstream | Present | 213 | CArG boxes 19:08, 18 October 2022 | likely active or activable, positive strand, negative direction: CATTAAAAGG at 3441 and CAAAAAAAAG at 1399 |
72. Cat8ps, (Tang 2020) | CGG(A/C/G/T)(C/G/T)(A/C/G/T)(A/C/G)(A/C)(A/C/T)GGA | Present | 214 | Cat8ps 22:21, 18 October 2022 | likely active or activable |
73. CAT boxes, (Saitoh 1993) | CATTCCT | Present | 215 | CAT boxes 23:56, 18 October 2022 | likely active or activable |
74. CAT-box-like elements, (Berberich 1993) | GCCATT | Present | 216 | CAT-box-like elements 19:38, 20 October 2022 | likely active or activable |
75. Cbf1 regulatory factors | TCACGTGA | Absent | 112 | Cbf1 regulatory factors 15:57, 11 June 2021 | 48 |
76. C-boxes, (Johnson) | GAGGCCATCT | Absent | 33 | C-boxes 02:51, 22 October 2020 | 410 |
77. C boxes, (Samarsky) | AGTAGT | Present | 217 | C boxes 02:22, 21 October 2022 | likely active or activable |
78. C-boxes, (Song) | GACGTC | Present | 218 | C-boxes 06:22, 21 October 2022 | likely active or activable |
79. C/A hybrid boxes, (Song) | TGACGTAT | Absent | 32 | C/A hybrid boxes 16:18, 20 October 2020 | 48 |
80. C/G hybrid boxes, (Song) | TGACGTGT | Present | 244 | CG hybrid boxes 18:35, 15 November 2022 | likely active or activable |
81. C/T hybrid boxes, (Song) | TGACGTTA | Absent | 34 | C/T hybrid boxes 01:51, 24 October 2020 | 48 |
82. C boxes, (Voronina) | GGTGATG | Present | 243 | C boxes 18:28, 15 November 2022 | likely active or activable |
83. CCAAT-enhancer-binding site (C/EBP) activating transcription factor (ATF), or C/EBP-ATF responsive elements, (CAREs), (Garaeva) | (A/G/T)TT(A/G/T)CATCA | Present | 123 | CARE (Garaeva) 01:10, 8 May 2022 | likely active or activable |
84. CCAAT-enhancer-binding site (C/EBP), C/EBP boxes | TTAGGACAT,[6] or TAGCATT.[7] | Absent | 44 | C/EBP boxes 23:21, 18 November 2020 | 47-49 |
85. CCCTC-binding factors, (CTCF), (Hashimoto 2017) | NCA-NNA-G(A/G)N-GGC-(A/G)(C/G)(C/T) | Absent | 35 | CCCTC-binding factors 23:02, 24 October 2020 | 49 |
86. CCCTC-binding factors, (CTCF), (Lobanenkov 1990) | CCCTC | Present | 370 | CCCTC-binding factors 23:44, 12 May 2023 | likely active or activable |
87. C clamp, (HMG DBD), (Cadigan 2012) | (C/G)CTTTGAT(C/G) | Absent | 367 | C clamp 06:03, 10 May 2023 | 48 |
88. Cell-cycle boxes, (CCBs) | CACGAAAA | Absent | 107 | Cell-cycle boxes 22:13, 19 April 2021 | 48, "cell cycle box" is functional in either orientation, acting as an enhancer |
89. Cell-cycle box variants, (CCBs) | CACGAAA, ACGAAA and C-CGAAA | Present | 219 | Cell-cycle box variants 05:54, 23 October 2022 | likely active or activable |
90. Cell cycle regulation, (Sharma 2020) | CCCAACGGT | Absent | 45 | Cell cycle regulation 20:53, 25 November 2020 | 49 |
91. CENP-B boxes | TTTCGTTGGAAGCGGGA | Absent | 16 | CENP-B boxes 15:05, 16 October 2019 | 417, specifically localized at the centromere |
92. CGCG boxes, (Yang 2002) | (A/C/G)CGCG(C/G/T) | Present | 264 | CGCG boxes 07:14, 12 December 2022 | likely active or activable, probably for zinc fingers |
93. Circadian control elements | CAANNNNATC | Present | 263 | Circadian control elements 00:33, 12 December 2022 | likely active or activable but overlaps highest randoms |
94. Class C DNA binding sites, (Leal) | CACGNG | Present | 164 | Class C DNA binding sites 06:16, 5 August 2022 | likely active or activable, distals may be random |
95. Cold-responsive elements | CCGAC | Present | 220 | Cold-responsive elements 05:34, 24 October 2022 | likely active or activable |
96. Constitutive decay elements, (CDEs), (Siegel) | TTC(C/T)(A/G)(C/T)GAA | Present | 269 | Constitutive decay elements 03:50, 15 December 2022 | likely active or activable possibly for ZNF497 |
97. Copper response elements, (CuREs), (Quinn) | TTTGC(T/G)C(A/G) | Present | 221 | Copper response elements 07:57, 24 October 2022 | likely active or activable |
98. Copper response elements, (CuREs), (Park) | TGTGCTCA | Present | 222 | Copper response elements 05:45, 25 October 2022 | likely active or activable |
99. Coupling elements, (CE1), (Watanabe) | TGCCACCGG | Absent | 46 | Coupling elements 01:51, 1 December 2020 | 49 |
100. Coupling elements, (CE3s), (Watanabe) | GCGTGTC | Present | 118 | Coupling elements 15:47, 12 February 2022 | likely active or activable |
101. Coupling elements, (CE3s), (Ding) | CACGCG | Present | 119 | Coupling elements 02:59, 15 February 2022 | likely active or activable |
102. cyclic-AMP-responsive elements, (CREs), Aca1ps, Sko1ps, (Montminy 1986) | TGACGTCA | Present | 274 | cAMP-responsive elements 05:05, 15 December 2022 | likely active or activable, same as Root specific elements |
103. Cytokinin response regulators, (ARR1s) | AGATT(C/T) | Present | 227 | Cytokinin response regulators 16:21, 31 October 2022 | likely active or activable |
104. Cytokinin response regulators, (ARR10s) | (A/G)GATA(A/C)G | Present | 223 | Cytokinin response regulators 17:47, 27 October 2022 | likely active or activable or may be random |
105. Cytokinin response regulators, (ARR12s) | (A/G)AGATA | Present | 224 | Cytokinin response regulators 06:09, 28 October 2022 | likely active or activable |
106. Cytokinin response regulators, (ARRs), (Ferreira) | (G/A)GGAT(T/C) | Present | 225 | Cytokinin response regulators 03:25, 31 October 2022 | likely active or activable |
107. Cytokinin response regulators, (ARRs), (Rashotte1) | GATCTT | Present | 226 | Cytokinin response regulators 16:21, 31 October 2022 | likely active or activable |
108. Cytokinin response regulators, (ARRs), (Rashotte2) | (G/A)GAT(T/C) | Present | 228 | Cytokinin response regulators 20:24, 1 November 2022 | likely active or activable |
109. Cytoplasmic polyadenylation elements, (CPEs) | TTTTTAT | Present | 160 | Cytoplasmic polyadenylation elements 06:10, 25 July 2022 | likely active or activable |
110. DAF-16-associated elements, (DAE), (Li) | TGATAAG | Absent | 47 | DAF-16-associated elements 22:51, 3 December 2020 | 47 |
111. DAF-16 binding elements | (A/G)(C/T)AAA(C/T)A | Present | 229 | DAF-16 binding elements 19:54, 2 November 2022 | likely active or activable |
112. D-boxes, (Mracek1) | GTTGTATAAC | Absent | 49 | D-boxes 02:46, 10 December 2020 | 410 |
113. D-boxes, (Mracek2) | CTTATGTAAA | Absent | 50 | D-boxes 02:20, 12 December 2020 | 410 |
114. D-boxes, (Johnson) | TCTCACATT(A/C)AATAAGTCA | Absent | 48 | D-boxes 04:12, 8 December 2020 | 2*418 |
115. D boxes, (Samarsky) | AGTCTG | Present | 262 | D boxes 00:16, 12 December 2022 | likely active or activable |
116. D boxes, (Voronina) | TCCTG | Present | 230 | D boxes 02:28, 4 November 2022 | likely active or activable |
117. D-boxes, (Motojima) | TGAGTGG | Present | 261 | D-boxes 00:11, 12 December 2022 | likely active or activable |
118. Defense and stress-responsive elements, (Sharma) | ATTTTCTTCA | Absent | 51 | Defense and stress-responsive elements 21:02, 13 December 2020 | 410 |
119. Destruction box, (D box), (Pfleger and Kirschner 2000) | CGN(C/T)TNAAN | Present | 371 | Destruction boxes 17:39, 15 May 2023 | likely active or activable |
120. Dioxin-responsive elements, (DREs) | TNGCGTG | Present | 231 | Dioxin-responsive elements 20:43, 4 November 2022 | likely active or activable |
121. DNA damage response elements, (DREs), (Smith) | TTTCAAT | Absent | 52 | DNA damage response elements 12:25, 17 December 2020 | 47 |
122. DNA damage response elements, (DREs), (Sumrada) | TAGCCGCCG of TAGCCGCCGRRRR | Absent | 276 | DNA damage response elements 06:31, 17 December 2022 | 49-24*49 |
123. DNA replication-related elements, (DREs), (Hirose) | TATCGATA | Absent | 53 | DNA replication-related elements 02:56, 20 December 2020 | 48 |
124. Downstream B recognition elements | (A/G)T(A/G/T)(G/T)(G/T)(G/T)(G/T) | Present | 278 | Downstream B recognition elements 22:45, 20 December 2022 | likely active or activable, negatives > randoms, positives overlap or outside randoms |
125. Downstream core elements, (DCESIs) | CTTC of CTTC...CTGT...AGC | Present | 279 | Downstream core elements 21:36, 22 December 2022 | likely active or activable, depending on overlaps |
126. Downstream core elements, (DCESIIs) | CTGT of CTTC...CTGT...AGC | Present | 280 | Downstream core elements 06:59, 26 December 2022 | likely active or activable, depending on overlaps |
127. Downstream core elements, (DCESIIIs) | AGC of CTTC...CTGT...AGC | Present | 281 | Downstream core elements 02:54, 28 December 2022 | likely active or activable, depending on overlaps |
128. Downstream promoter elements, (DPEs), (Juven-Gershon 2010) | RGWYVT, (A/G)G(A/T)(C/T)(A/C/G)T | Present | 157 | Downstream promoter elements 05:18, 17 July 2022 | most or all of the real DPE (Juven-Gershon)s are likely active or activable |
129. Downstream promoter elements, (DPEs), (Butler 2002) | RGWYV or (A/G)G(A/T)(C/T)(A/C/G) | Present | 3 | Downstream promoter elements 00:22, 13 October 2019 | likely active or activable |
130. Downstream promoter elements, (DPEs) (Butler 2002) | RGWYV or (A/G)G(A/T)(C/T)(A/C/G) | Present | 376 | Downstream promoter elements 19:59, 15 June 2023 | likely active or activable |
131. Downstream promoter elements, (DPEs), (Kadonaga) | (A/G)G(A/T)CGTG | Present | 155 | Downstream promoter elements 20:16, 16 July 2022 | likely active or activable |
132. Downstream promoter elements, (DPEs), (Matsumoto) | AGTCTC | Present | 156 | Downstream promoter elements 21:32, 16 July 2022 | likely active or activable |
133. Downstream TFIIB recognition elements (BREd, dBRE) (Deng 2005) | (A/G)T(A/G/T)(G/T)(G/T)(G/T)(G/T) | Present | 6 | Downstream TFIIB recognition elements 23:26, 26 December 2019 | likely active or activable |
134. DREB boxes (CRT/DREB box) | TACCGACAT | Absent | 21 | DREB boxes 17:03, 28 December 2019 | 49 |
135. E2 boxes | (A/G)CAGNTGN | Present | 195 | E2 boxes 17:04, 3 October 2022 | likely active or activable |
136. EIF4E basal elements (poly(C) motif) | TTACCCCCCCTT | Absent | 15 | EIF4E basal elements 05:11, 13 October 2019 | 412 |
137. EIN3 binding sites | A(C/T)G(A/T)A(C/T)CT | Present | 282 | EIN3 binding sites 01:44, 29 December 2022 | likely active or activable |
138. Endoplasmic reticulum stress response elements, (ERSE) | CCAAT-N9-CCACG | Absent | 284 | Endoplasmic reticulum stress response elements 01:58, 31 December 2022 | 410 |
139. Endoplasmic reticulum stress response elements, (ESRE2) | CCACG, for part 1 (CCAAT) see Hap motif | Present | 283 | Endoplasmic reticulum stress response elements 01:57, 31 December 2022 | likely active or activable |
140. Endosperm expressions | TGTGTCA | Present | 285 | Endosperm expressions 03:16, 31 December 2022 | likely active or activable |
141. Enhancer boxes (E-box), (Massari 2000) | CANNTG | Present | 7 | Enhancer boxes 00:09, 13 October 2019 | likely active or activable |
142. Estrogen response elements, (EREs), (Matsumoto) | AGGTTA or GGTCAGGAT of AGGTTATTGCCTCCT or GGTCAGGATGAC | Absent | 335 | Estrogen response elements 05:34, 9 March 2023 | 46-412 |
143. Estrogen response elements, (EREs), (Yasar) | GGTCAGGATGAC | Absent | 336 | Estrogen response elements 05:37, 9 March 2023 | 412 |
144. Estrogen response elements, (ERE1s), (Driscoll) | GGTCA | Present | 338 | Estrogen response elements 03:27, 14 March 2023 | likely active or activable |
145. Estrogen response elements, (ERE2s), (Driscoll) | TGACC | Present | 339 | Estrogen response elements 03:37, 14 March 2023 | likely active or activable |
146. Ethylene responsive elements, (EtREs) | ATTTCAAA | Present | 237 | Ethylene responsive elements 18:06, 5 November 2022 | likely active or activable |
147. F boxes, (Rose) | TGATAAG | Absent | 67 | F boxes 05:52, 28 January 2021 | 47, F-box overlaps the I-box |
148. Forkhead boxes, (FOXO1), (Yoshihara) | GTAAACAA | Absent | 351 | Forkhead boxes 04:33, 20 April 2023 | 48 |
149. Forkhead boxes, (FOXA2), (Li 2017) | (A/G)(C/T)AAA(C/T)A | Present | 286 | Forkhead boxes 03:54, 1 January 2023 | likely active or activable |
150. GAAC elements | GAACT | Present | 287 | GAAC elements 22:49, 1 January 2023 | likely active or activable |
151. Galactose-inducible transcription activator 4s, (Gal4s), (Tang) | CGG(A/G)NN(A/G)C(C/T)N(C/T)NCNCCG | Absent | 54 | Gal4ps 22:28, 31 December 2020 | 410 |
152. γ-interferon activated sequences, (GAS) | TTCCTAGAA | Absent | 352 | γ-interferon activated sequences 18:24, 20 April 2023 | 49 |
153. Γ-interferon activated sequences, (GAS) | TTNCNNNAA | Present | 288 | Γ-interferon activated sequences 01:56, 3 January 2023, see STAT5 | likely active or activable |
154. GATA boxes | GATA | Present | 258 | GATA boxes 06:29, 8 December 2022 | likely active or activable, may be random in proximals |
155. GATA (GATAAG, GATAAH, GATTA) motifs, (Staschke) | GAT(A/T)A | Present | 259 | GATA (GATAAG, GATAAH, GATTA) motifs 20:11, 9 December 2022 | likely active or activable |
156. GATC repeats, (ABREN), (Watanabe et al. 2017) | GATC | Present | 369 | GATC samplings 20:08, 11 May 2023 | GATC UTRs, proximals and positive strand, negative direction distals greater than randoms, negative strand, negative direction distals, positive direction distals likely randoms. GATCs are likely active or activable |
157. G boxes, (Song) | (G/T)CCACGTG(G/T)C | Absent | 115 | G boxes 03:20, 25 July 2021 | 49 |
158. G-box motif, (Oeda) | GCCACGTGGC | Absent | 114 | G boxes 04:25, 20 July 2021 | 410, no "perfect palindrome" G boxes in either promoter |
159. GC boxes, (Briggs 1986), (Rroji 2021) | (G/T)(G/A)GGCG(G/T)(G/A)(G/A)(C/T) | Present | 289 | GC boxes 16:57, 3 January 2023 | likely active or activable |
160. GC boxes, (Ye 2019) | GGGCGG | Present | 290 | GC boxes 08:28, 4 January 2023 | likely active or activable |
161. GCC boxes, (Sato 1996) | GCCGCC | Present | 291 | GCC boxes 06:52, 5 January 2023 | likely active or activable |
162. GCN4 motifs, (Zhang 2014) | TGA(C/G)TCA | Absent | 185 | GCN4 motifs 05:52, 30 September 2022 | 47 |
163. General control nonderepressible 4 protein binding sites, (Staschke 2010), (GCRE, GCN4) | TGA(C/G/T)T(A/C/G)(A/T) | Present | 292 | General control nonderepressible 4 protein binding site 07:05, 5 January 2023 | likely active or activable |
164. Gcn4ps, (Tang) | ATGACTCTT | Absent | 245 | Gcn4ps 22:17, 15 November 2022 | 49 |
165. GGCGGC triplet | GGCGGC | Present | 293 | GGCGGC triplet 00:32, 7 January 2023 | likely active or activable |
166. GGC triplets | GGC | Present | 295 | GGC triplets 19:40, 7 January 2023 | likely active or activable |
167. Gibberellic acid responsive elements-like 1, (GAREL1s) | TAACA(A/G)A | Present | 238 | Gibberellic acid responsive elements-like 1 19:12, 5 November 2022 | likely active or activable |
168. Gibberellin responsive element-like 2, (GARE-like 2), (Fan) | TAACGTA | Absent | 55 | Gibberellin responsive element-like 2 06:39, 2 January 2021 | 47 |
169. Gibberellin responsive elements, (GREs), (Sharma) | AAACAGA | Present | 296 | Gibberellin responsive elements 01:19, 8 January 2023 | likely active or activable |
170. GLM boxes, (GCN4-like motif) | (G/A)TGA(G/C)TCA(T/C) | Absent | 20 | GLM boxes 04:17, 13 October 2019 | 23*46 |
171. Glucocorticoid response elements, (GlRE), (Parsonnet 2019) | AGAACA | Present | 260 | Glucocorticoid response elements 05:34, 10 December 2022 | likely active or activable |
172. Glucose transporter gene repressor, (Rgt1), (Kim 2019) | CGG(A/G)(A/T)N(A/T)(A/T) | Present | 311 | Glucose transporter gene repressor 20:06, 21 January 2023 | likely active or activable |
173. G-protein-coupled receptors,(GCR1s), CT boxes | CTTCC | Present | 297 | G-protein-coupled receptors 03:36, 8 January 2023 | likely active or activable |
174. Grainy head transcription factor binding sites | AACCGGTT | Absent | 56 | Grainy head transcription factor binding sites 23:33, 6 January 2021 | 48 |
175. Grainy head transcription factor binding sites | GACTGGTT | Absent | 354 | Grainy head transcription factor binding sites 07:13, 22 April 2023 | 48 |
176. GT boxes, (Motojima) | TGGGTGGGGCT | Absent | 57 | GT boxes 00:39, 11 January 2021 | (-78 to -69) 411 |
177. GT boxes, (Sato) | GGGG(T/A)GGGG | Present | 298 | GT boxes 04:33, 8 January 2023 | likely active or activable |
178. Hac1, KAR2 | CAGCGTG | Present | 299 | Hac1 05:27, 8 January 2023 | likely active or activable |
179. H and ACA boxes | AGAGGA | Present | 301 | H and ACA boxes 04:33, 9 January 2023 | likely active or activable, negative distals likely random |
180. Hapless motifs (Ozsarac 1997) | CCAATCA | Absent | 150 | Hapless motifs 02:33, 30 June 2022 | heterotrimeric transcription factor, HAP2/3/4 47 |
181. Hap motif (Hap4p) | CCAAT | Present | 302 | Hap motif 20:38, 9 January 2023 and ESRE CCAAT | likely active or activable |
182. H-boxes, (Grandbastien) | CC(A/T)ACCNNNNNNN(A/C)T | Present | 121 | H-boxes 16:34, 7 May 2022 | likely active or activable |
183. H-boxes, (Lindsay) | CCTACC | Present | 124 | H-boxes 14:39, 8 May 2022 | likely active or activable, equal to or greater than the randoms for the negative direction distals |
184. H box, (Mitchell) | ANANNA | Present | 266 | H box 20:03, 12 December 2022 | likely active or activable |
185. H box, (Rozhdestvensky) | ACACCA | Present | 120 | H box 05:46, 5 May 2022 | likely active or activable |
186. Heat-responsive elements | AAAAAATTTC | Absent | 58 | Heat-responsive elements 02:10, 14 January 2021 | four nGAAn motifs 410 |
187. Heat shock elements, (HSE1), (Eastmond) | nGAAnnTTCnnGAAn | Absent | 59 | Heat shock elements 04:13, 20 January 2021 | HSE1 49 |
188. Heat shock elements, (HSE2), (Eastmond) | nTTCnnGAAnnTTCn | Absent | 127 | Heat shock elements 16:30, 10 May 2022 | HSE2 is the inverse complement of HSE1 49 |
189. Heat shock elements, (HSE3s), (Eastmond) | nGAAn-(5-bp)-nGAAnnTTCn | Present | 130 | Heat shock elements 17:47, 13 May 2022 | likely active or activable |
190. Heat shock elements, (HSEs), (Eastmond) | nGA(A/G)n-(5-bp)-nGAAnnTTCn (GAP1) | Present | 132 | Heat shock elements 16:28, 16 May 2022 | same result as HSE3, likely active or activable |
191. Heat shock elements, (HSEs), (Eastmond) | nGAAn-(5-bp)-nGA(A/G)nnTTCn (GAP2) | Present | 133 | Heat shock elements 06:36, 17 May 2022 | same result as HSE3, likely active or activable |
192. Heat shock elements, (HSE4s), (Eastmond) | nGAAn-(5-bp)-nGAAn-(5-bp)-nGAAn | Present | 131 | Heat shock elements 05:14, 14 May 2022 | likely active or activable |
193. Heat shock elements, (HSE5), (Eastmond) | nTTCn-(5-bp)-nTTCnnGAAn | Absent | 60 | Heat shock elements 02:49, 23 January 2021 | HSE5 49 |
194. Heat shock elements, (HSE6), (Eastmond) | nTTCn-nnGAAn-(5-bp)-nGAAn | Absent | 61 | Heat shock elements 18:05, 23 January 2021 | HSE6 49 |
195. Heat shock elements, (HSE7), (Eastmond) | nGA(A/G)nnTTCnnGAAn | Absent | 62 | Heat shock elements 22:36, 23 January 2021 | HSE7 PFT1 2*48 |
196. Heat shock elements, (HSE), (Eastmond) | nGAAnnTTCnnGA(A/G)n | Absent | 63 | Heat shock elements 05:45, 24 January 2021 | HSE7 PFT2 2*48 |
197. Heat shock elements, (HSE10), (Eastmond) | nTTCn-(11-bp)-nGAAn-(5 bp)-nGAAn | Absent | 64 | Heat shock elements 22:33, 26 January 2021 | HSE10 49 |
198. Heat shock factors, (Hsfs), (Tang) | NGAAN | Present | 128 | Heat shock factors 06:01, 11 May 2022 | likely active or activable |
199. Helper site, (Atcha et al. 2007), (Cadigan and Waterman 2012) | (C/G)C(C/G)G(C/G) | Present | 368 | Helper site 10:54, 10 May 2023 | likely active or activable |
200. Hepatic nuclear factors (HNFs) | (A/G/T)(A/T)(A/G)T(C/T)(A/C/G)AT(A/C/G/T)(A/G/T) | Present | 135 | HNF6s 17:53, 20 May 2022 | likely active or activable, although the negative direction distals are at or less than randoms |
201. Hex sequences | TGACGTGGC | Present | 134 | Hex sequences 19:57, 17 May 2022 | likely active or activable |
202. High Mobility Group boxes, (HMG boxes) | (A/T)(A/T)CAAAG | Present | 358 | High Mobility Group boxes 22:01, 30 April 2023 | likely active or activable |
203. Homeoboxes | CAAG | Present | 253 | Homeoboxes 04:28, 4 December 2022 | likely active or activable, occurs in Rox1ps |
204. Homeodomains | TAAT | Present | 254 | Homeodomains 19:46, 4 December 2022 | likely active or activable, low occurrence UTRs and negative direction distals overlap high randoms, occurs in CArG boxes and Pribnow boxes |
205. HY boxes | TG(A/T)GGG | Present | 136 | HY boxes 12:43, 25 May 2022 | likely active or activable |
206. Hypoxia-inducible factors, (HIF-1), (Li 2020) | GCCCTACGTGCTGTCTCA | Absent | 65 | Hypoxia-inducible factors 16:43, 27 January 2021 | composed of HIF-1α and HIF-1β 418 |
207. Hypoxia-inducible factors (HIF) (Orlando 2019), ABA-response element (ABRE) (Asad 2019) | ACGTG | Present | 37 | Hypoxia-inducible factors 06:03, 7 May 2021, ABA-response element (ABRE) 03:06, 8 October 2020 | likely active or activable |
208. Hypoxia response elements (HRE) (Orlando 2019) | CACGC | Present | 109 | Hypoxia response elements 05:04, 7 May 2021 | likely active or activable |
209. I boxes | GATAAG of GGATGAGATAAGA | Absent | 66 | I boxes 05:49, 28 January 2021 | 413 |
210. Initiator element (Inr) (Liston 1999) | YYA+1NWYY | Present | 2 | Initiator elements 04:01, 13 October 2019 | likely active or activable |
211. Initiator element (Inr) (Juven-Gershon 2008) | YYR+1NWYY | Present | 24 | Initiator elements 17:44, 27 September 2020 | likely active or activable |
212. Initiator element (Inr) (Ngoc 2017) | BBCA+1BW | Present | 13 | Initiator elements 14:57, 5 June 2022 | likely active or activable |
213. Initiator element (Inr), Drosophila melanogaster (Butler 2002) | TCA+1(G/T)T(C/T) | Present | 375 | Initiator elements 06:40, 21 June 2023 | likely active or activable, UTRs are likely random |
214. Initiator element-like (Inr-like) (Matsumoto 2020) | TTCTCT | Present | 25 | Initiator-like elements 01:25, 29 September 2020 | likely active or activable |
215. Initiator element-like (TCT) (Parry 2010) | (C/T)CT(C/T)T(C/T)(C/T) | Present | 346 | Initiator-like elements 22:06, 10 April 2023 | likely active or activable |
216. Inositol/choline-responsive elements, (ICRE), (Case) | CANNTGAAAT | Absent | 68 | Inositol/choline-responsive elements 21:43, 29 January 2021 | version of Lopes, see below 48 |
217. Inositol/choline-responsive elements, (ICRE), (Case, Lopes) | CATGTGAAAT includes the canonical basic helix-loop-helix (bHLH) binding site CANNTG | Present | 139 | Inositol/choline-responsive elements 23:14, 9 June 2022 | likely active or activable |
218. Inositol/choline-responsive elements, (ICRE), (Lopes) | ATGTGAAAT | Absent | 137 | Inositol/choline-responsive elements 23:01, 7 June 2022 | 49, using ANNTGAAAT, likely active or activable |
219. Inositol/choline-responsive elements, (ICREs), (Schwank) | TYTTCACATGY contains the core sequence CANNTG | Present | 138 | Inositol/choline-responsive elements 05:39, 9 June 2022 | likely active or activable |
220. Interferon regulatory factor, (IRF3) | GCTTTCC | Present | 359 | Interferon regulatory factor 03:07, 2 May 2023 | likely active or activable |
221. Interferon-stimulated response elements, (ISREs), (Michalska) | AGTTTCN2TTTCN | Absent | 106 | Interferon-stimulated response elements 15:43, 28 March 2021 | 410 |
222. Interferon-stimulated response elements, (ISREs), (Lu) | GAAANNGAAA | Present | 140 | IFN-stimulated response elements 06:41, 12 June 2022 | likely active or activable |
223. IRS consensus, (Fujii) | AANNGAAA | Present | 141 | IRS consensus 03:16, 14 June 2022 | likely active or activable |
224. Jasmonic acid-responsive elements, (JAREs) | TGACG | Present | 144 | Jasmonic acid-responsive elements 23:12, 20 June 2022 | likely active or activable |
225. K-boxes, (Saito 2020) | GTTCGG-NNAN-CCNNAC | Absent | 104 | K-boxes 22:22, 17 March 2021 | 411 |
226. K-box1s, (Saito 2020) | GTTCGG | Present | 366 | K-boxes 20:59, 4 May 2023 | likely active or activable |
227. KEN box, (Pfleger and Kirschner 2000) | AA(A/G)GA(A/G)AA(C/T) | Present | 372 | KEN boxes 20:13, 15 May 2023 | likely active or activable |
228. Kozak sequences, (Kozak 1987) | GCCGCC(A/G)CCATGG | Absent | 103 | Kozak sequences 18:12, 17 March 2021 | 2*412 |
229. Kozak sequences, (Matsumoto) | GAAAATGG | Absent | 69 | Kozak sequences 01:16, 2 February 2021 | 48 |
230. Krüppel-like factors | GGGNN(G/T)(G/T)(G/T) | Present | 145 | Krüppel-like factors 18:25, 23 June 2022 | likely active or activable |
231. L boxes (Donald) | AAATTAACCAA | Absent | 70 | L boxes 04:21, 2 February 2021 | 411 |
232. Leu3 transcription factors, (Leu3), (Reddy 2020) | (C/G)C(G/T)NNNN(A/C)G(C/G) | Present | 294 | Leu3 transcription factors 04:52, 7 January 2023 | likely active or activable |
233. M3 motif | (C/G)CGGAAG(C/T) or SCGGAAGY | Present | 373 | M3 motif 05:47, 6 June 2023 | likely active or activable |
234. M22 | TGCGCAN(G/T) or TGCGCANK | Present | 374 | M22 samplings 00:52, 11 June 2023 | likely active or activable |
235. M35 or -35 sequence | TTGACA | Present | 146 | -35 sequence 16:16, 25 June 2022 | likely active or activable, the UTR does overlap the randoms at the random's upper end |
236. Maf recognition element, (MAREs), (Kyo) | TGCTGA(G/C)TCAGCA | Absent | 71 | Maf recognition element 03:29, 3 February 2021 | 2*412 |
237. M boxes, (Bertolotto) | GTCATGTGCT or AGTCATGTGCT | Absent | 72 | M boxes 16:05, 3 February 2021 | 410-411 |
238. M-CAT boxes, (Berberich 1993) | GCGGCCTC | Absent | 349 | M-CAT boxes 18:06, 18 April 2023 | 48 |
239. Mcm1 regulatory factors, (Rossi) | TT(A/T)CCNN(A/T)TNGG(A/T)AA | Absent | 73 | Mcm1 regulatory factors 03:17, 4 February 2021 | 23*49 |
240. Mcm1 regulatory factors, (Rossi) | TTNCCNNNTNNGGNAA | Absent | 111 | Mcm1 regulatory factors 04:32, 9 June 2021 | 49 |
241. Met3s, (Blaiseau) | TCACGTG | Absent | 148 | Met3s 08:09, 27 June 2022 | 47 |
242. Met31ps, (Blaiseau) | AAACTGTG | Present | 147 | Met31ps 07:26, 27 June 2022 | likely active or activable |
243. Metal responsive elements, (MRE) | TGC(A/G)C(A/C/G/T)C | Present | 149 | Metal responsive elements 02:25, 30 June 2022 | likely active or activable |
244. Middle sporulation element, (MSE), (Branco) | ACACAAA | Present | 151 | Middle sporulation element 05:04, 2 July 2022 | likely active or activable |
245. Midsporulation element, (MSE), (Ozsarac) | C(A/G)CAAA(A/T) | Present | 169 | Midsporulation element 15:07, 14 August 2022 | likely active or activable |
246. MITF E-box, (MITF) | CA(C/T)(A/G)TG, (CAYRTG) | Present | 360 | MITF E-box (CAYRTG) 16:09, 2 May 2023 | likely active or activable, negative distals overlap randoms at low end |
247. Motif ten elements (MTE) (Lim 2004) | C(C/G)A(A/G)C(C/G)(C/G)AACG(C/G), CSARCSSAACGS | Absent | 5 | Motif ten elements 06:49, 13 October 2019 | 25*47 |
248. Multicopy inhibitor of the GAL1 promoter, (MIG1), (Gancedo 1998) | (C/G)(C/T)GGGG | Present | 361 | Multicopy inhibitor of the GAL1 promoter 16:09, 2 May 2023 | likely active or activable, UTRs may be random |
249. Musashi binding elements, (MBE1s) | (G/A)U1AGU | Present | 152 | Musashi binding elements 15:31, 10 July 2022 | likely active or activable |
250. Musashi binding elements, (MBE2s) | (G/A)U2AGU | Present | 153 | Musashi binding elements 06:37, 14 July 2022 | likely active or activable, negative direction distals may be random |
251. Musashi binding elements, (MBE3s) | (G/A)U3AGU | Present | 154 | Musashi binding elements 19:37, 16 July 2022 | likely active or activable |
252. Myeloblastosis (MYB) ACGT-containing elements, (ACEs) | CACGT | Present | 159 | MYB ACGT-containing elements 17:07, 22 July 2022 | likely active or activable, positive strand UTR is likely random, negative strand, positive direction distals are likely random |
253. Myeloblastosis recognition element, (MRE) | A(A/C)C(A/T)A(A/C)C | Present | 161 | Myeloblastosis recognition element 15:36, 25 July 2022 | likely active or activable |
254. Myocyte enhancer factors, (MEFs) | (C/T)TA(A/T)(A/T)(A/T)(A/T)TA(A/G) | Present | 162 | Myocyte enhancer factors 05:44, 28 July 2022 | likely active or activable |
255. Nanos/Pumilio response elements, (PREs) | TGTAAAT | Present | 163 | Nanos/Pumilio response elements 15:29, 31 July 2022 | likely active or activable |
256. N-boxes, (Lee) | CCGGAA | Present | 168 | N-boxes 05:07, 14 August 2022 | likely active or activable |
257. N-boxes, (Bai) | CACGAG | Present | 167 | N-boxes 17:10, 10 August 2022 | likely active or activable |
258. N-boxes, (Gao) | CACGGC or CACGAC, CACG(A/G)C | Present | 166 | N-boxes 05:54, 7 August 2022 | likely active or activable |
259. N-boxes, (Leal) | CACNAG | Present | 165 | N-boxes 06:16, 5 August 2022 | likely active or activable |
260. Non-DiTyrosine 80 transcription factor DNA binding domain, (Ndt80) | (A/G/T)NC(A/G)CAAA(A/T) | Present | 170 | Non-DiTyrosine 80 transcription factor DNA binding domain 20:36, 17 August 2022 | likely active or activable |
261. Nuclear factor of activated T cells, (NFATs) | GGAAAA | Present | 171 | Nuclear factor of activated T cells 22:08, 19 August 2022 | likely active or activable, negative direction distals likely random, complement and inverse of the Pyrimidine boxes |
262. NF‐κB/Rel family of eukaryotic transcription factors, (NF-κB) | CCCCTAAGGGG | Absent | 74 | NF‐κB/Rel family of eukaryotic transcription factors 02:53, 9 February 2021 | 411 |
263. NF𝜿B (Sato)(NF𝜿BSs) | GAATTC | Present | 323 | NF𝜿B (Sato) 07:30, 8 February 2023 | likely active or activable |
264. Nuclear factor 1, (NF-1) | TTGGCNNNNNGCCAA | Absent | 75 | Nuclear factor 1 03:51, 9 February 2021 | palindromic sequence 410 |
265. Nuclear factor Ys | CCAATGG(A/C)(A/G) | Absent | 76 | Nuclear factor Ys 04:48, 9 February 2021 | NF-Y is a trimeric complex 48 |
266. Nutrient-sensing response element 1, (NSRE) | GTTTCATCA | Present | 172 | Nutrient-sensing response element 1 04:29, 21 August 2022 | likely active or activable |
267. Oaf1 transcription factor | CGGN3TNAN9-12CCG | Present | 173 | Oaf1 transcription factor 05:57, 31 August 2022 | likely active or activable |
268. Oresara1, (ORE1), (Matallana) | (A/C/G)(A/C)GT(A/G)N5,6(C/T)AC(A/G) | Present | 174 | ORESARA1 05:42, 4 September 2022 | likely active or activable |
269. Oresara1, (ORE1), (Olsen) | T(A/G/T)(A/G)CGT(A/G)(A/C/T)(A/G/T) | Present | 175 | ORESARA1 23:53, 7 September 2022 | likely active or activable |
270. p53 response elements | (A/G)(A/G)(A/G)C(A/T)(A/T)G(C/T)(C/T)(C/T) | Present | 176 | p53 response elements 18:30, 8 September 2022 | likely active or activable |
271. p53 response elements, (Long1) | CAGGCCC | Present | 177 | p53 response elements 03:26, 11 September 2022 | likely active or activable |
272. p53 response elements, (Long2) | GGGCGTG | Present | 178 | p53 response elements 20:10, 13 September 2022 | likely active or activable |
273. p63 DNA binding sites, (Perez 2007) | (A/G)(A/G)(A/G)C(A/G)(A/T)G(C/T)(C/T)(C/T)(A/G)(A/G)(A/G)C(A/T)(C/T)G(C/T)(C/T)(C/T), RRRC(A/G)(A/T)GYYYRRRC(A/T)(C/T)GYYY | Absent | 78 | p63 DNA binding sites 04:14, 14 February 2021 | 412 |
274. P-box (Mena) | (A/T)AAAG | Present | 180 | P-box (Mena) 22:30, 21 September 2022 | likely active or activable, the positive direction proximals overlap the randoms |
275. P-box, (Motojima) | TGAGTTCA | Present | 181 | P-box 18:27, 24 September 2022 | likely active or activable |
276. P-box, (Yu) | GTAA(T/C) | Present | 179 | P-box 02:46, 18 September 2022 | likely active or activable with some overlapping the randoms |
277. Pleiotropic drug resistance 1p (Pdr1p), (Tang 2020) | TCCGCGGA | Absent | 79 | Pdr1p/Pdr3ps 04:07, 15 February 2021 | Pdr1p/Pdr3p response elements (PDREs) 48 |
278. Pleiotropic drug resistance 1p (Pdr1p), (Salin 2008) | TCCG(C/T)GG(A/G) | Present | 363 | Pdr1p/Pdr3ps 03:11, 4 May 2023 | likely active or activable |
279. Peroxisome proliferator-activated receptor alpha | CGACCCC | Present | 80 | Peroxisome proliferator-activated receptor alpha 18:37, 15 February 2021 | likely active or activable, positive direction distal overlaps upper end of randoms |
280. Peroxisome proliferator hormone response elements, (PPREs) | AGGTCANAGGTCA | Absent | 81 | Peroxisome proliferator hormone response elements 18:37, 15 February 2021 | PPARs/RXRs heterodimers bind to PPRE 412 |
281. Phosphate starvation-response transcription factor (Pho4) | CAC(A/G)T(T/G) | Present | 129 | Pho4ps 16:20, 12 May 2022 | likely active or activable, positive strand of the UTRs is in the random range but the negative direction distals are outside the randoms |
282. Pollen1 element with TCCACCATA | AGAAANNNNTCCACCATA | Absent | 303 | Pollen1 with TCCACCATA 23:24, 9 January 2023 | adjacent co-dependent regulatory element TCCACCATA 49-414 |
283. Pollen1 elements | AGAAA | Present | 304 | Pollen1 elements 21:40, 10 January 2023 | likely active or activable |
284. Pollen1 element | TCCACCATA | Absent | 305 | TCCACCATA 08:30, 11 January 2023 | no regulatory element TCCACCATA was found, nor its ci. 49 |
285. Polycomb response elements | CGCCAT(A/T)TT | Absent | 82 | Polycomb response elements 06:52, 16 February 2021 | 2*48-49 |
286. Polycomb response elements, (PRE) | GCCAT | Present | 306 | Polycomb response elements 22:28, 13 January 2023 | likely active or activable |
287. Pribnow boxes | TATAAT | Present | 307 | Pribnow boxes 03:43, 15 January 2023 | likely active or activable |
288. Prolamin boxes | TG(A/T)AAAG, TGTAAAG | Present | 308 | Prolamin boxes 06:14, 18 January 2023 | likely active or activable |
289. Q elements | AGGTCA | Present | 309 | Q elements 20:23, 18 January 2023 See Retinoic acid response element | likely active or activable |
290. Quinone reductase response element, (QRDRE), (Yao) | TCCCCT of TCCCCTTGCGTG | Present | 232 | Quinone reductase response element 05:08, 5 November 2022 | likely active or activable |
291. Rap1 regulatory factors | ACCC(A/G)N(A/G)CA | Absent | 85 | Rap1 regulatory factors 05:04, 20 February 2021 | "(ACCCRnRCA), less than half of the sites were detectably bound"[8] 47 |
292. Rap1 reduced consensus | (A/G)(A/C)ACCC(A/G)N(A/G)C(A/C)(C/T)(A/C) | Present | 240 | Rap1 reduced consensus 03:47, 15 November 2022 | likely active or activable |
293. Reb1 extended, (Rossi) | ATTACCCGAA | Absent | 113 | Extended Reb1 00:07, 20 June 2021 | 410 |
294. Reb1 bound and exact occurrences | TTACCC(G/T) | Present | 241 | Reb1 bound and exact occurrences 16:38, 15 November 2022 | likely active or activable |
295. Retinoic acid response element | AG(A/G)TCA | Present | 310 | Retinoic acid response element 19:56, 19 January 2023 | likely active or activable, positive direction distals appear random |
296. Ribophorin (RPN) (Rpn4), PACE (proteasome associated control element) | GGTGGCAAA | Absent | 88 | Rpn4ps 03:15, 23 February 2021 | 49 |
297. Rlm1ps | CTA(A/T)(A/T)(A/T)(A/T)TAG | Absent | 86 | Rlm1ps 05:55, 22 February 2021 | 4TAG 24*46 |
298. RORE motif, (RORE) | A(A/T)NTAGGTCA | Present | 312 | classic RORE motif 05:51, 22 January 2023 | likely active or activable |
299. RORE motif, variant | C(T/A)(G/A)GGNCA | Present | 313 | variant RORE motif 03:04, 24 January 2023 | likely active or activable |
300. Rox1ps (Tang 2020) | RRRTAACAAGAG | Absent | 87 | Rox1ps Heme-dependent repressor of hypoxic genes 21:50, 22 February 2021 | 23*49 |
301. R response elements (RRE) | CATCTG | Present | 158 | R response elements 16:04, 19 July 2022 | likely active or activable |
302. Seed-specific elements (SRE) | CATGCATG | Absent | 89 | Seed-specific elements 20:18, 23 February 2021 | 48-412 |
303. Serum response elements, (SRE) | ACAGGATGT | Present | 314 | Serum response elements 16:38, 25 January 2023 | likely active or activable |
304. Servenius sequences | GGACCCT | Present | 315 | Servenius sequences 03:07, 28 January 2023 | likely active or activable |
305. Shoot specific elements, (SREs) | GATAATGATG | Absent | 90 | Shoot specific elements 15:13, 24 February 2021 | 410 |
306. Shue box element, (Crowder 1988) | CCCTG(C/G) | Present | 348 | Shue box elements 05:24, 18 April 2023 | likely active or activable |
307. Sip4ps (Tang) | CC(C/G)T(C/T)C(C/G)TCCG | Absent | 91 | Sip4ps 02:55, 25 February 2021 | 23*48 |
308. Smp1ps (Tang) | ACTACTA(T/A)4TAG | Absent | 92 | Smp1ps 23:43, 25 February 2021 | 2*410 |
309. SP1, (Long) | GGGGCGGGCC | Absent | 355 | SP1 19:43, 25 April 2023 | 410 |
310. Sp1 element, (Berberich 1993) | GGGGCGGGT | Absent | 350 | Sp1 elements 21:03, 18 April 2023 | 49 |
311. SP1, (Zhang) | (G/T)GGGCGG(G/A)(G/A)(C/T) | Present | 319 | SP1 05:57, 2 February 2023 | likely active or activable |
312. SP-1, (Sato) | CCGCCCC | Present | 318 | SP-1 05:54, 2 February 2023 | likely active or activable |
313. SP1, (Yao) | GCGGC | Present | 320 | SP1 05:57, 4 February 2023 | likely active or activable |
314. SP1-box 1, (Motojima) | GGGGCT | Present | 316 | SP1-box 1 05:46, 29 January 2023 | likely active or activable |
315. SP1-box 2, (Motojima) | CTGCCC | Present | 317 | SP1-box 2 19:30, 30 January 2023 | likely active or activable |
316. STAT5 | TTCNNNGAA | Present | 321 | STAT5 03:41, 5 February 2023 | likely active or activable, positive distal likely random |
317. Sterile12, (STE12), (Tang 2020) | TGAAAC | Present | 356 | Sterile12 encodes a transcription factor (Ste12) 05:53, 27 April 2023 | likely active or activable |
318. Sterol response elements, (Branco) | TCGTATA | Absent | 93 | Sterol response elements 19:00, 28 February 2021 | perhaps plant specific 47 |
319. Sterol response elements, (Yao) | AGCAGATTGCG | Absent | 94 | Sterol response elements 03:22, 1 March 2021 | liver specific 411 |
320. Stress-response elements, (STREs) | CCCCT | Present | 322 | Stress-response elements 07:49, 7 February 2023 | likely active or activable, positive cores overlap randoms |
321. Sucrose boxes | NNAATCA | Present | 324 | Sucrose boxes 08:03, 10 February 2023 | likely active or activable |
322. TACTAAC boxes | TACTAA(C/T) | Present | 325 | TACTAAC boxes 06:05, 12 February 2023 | likely active or activable |
323. TAGteams | CAGGTAG | Present | 326 | TAGteams 04:15, 14 February 2023 | likely active or activable |
324. Tapetum boxes | TCGTGT | Present | 327 | Tapetum boxes 08:10, 16 February 2023 | likely active or activable |
325. TATA boxes | TATAAAA (Carninci 2006) TAT box (Yang 2006) | Present | 1 | TATAAAA boxes 03:53, 2 April 2023 | likely active or activable |
326. TATA boxes | TATAAA (Butler 2002) | Present | 4 | TATA boxes (Butler 2002) 07:05, 3 April 2023 | likely active or activable |
327. TATA boxes (Watson 2014) | TATA(A/T)A(A/T) (Watson 2014) | Present | 10 | TATA boxes (Watson 2014) 04:32, 4 December 2017 | likely active or activable |
328. TATA boxes (Yang 2007) | TATA(A/T)AA(A/G) (Juven-Gershon 2010) | Present | 17 | metazoan TATA box 01:05, 13 October 2019 | likely active or activable |
329. TATA boxes (Yang 2007) | TATA(A/T)A(A/T)(A/G) (Basehoar 2004) | Present | 9 | TATA boxes 04:16, 13 June 2024 | likely active or activable |
330. TAT boxes (Fan 2007) | TATCCAT | Present | 239 | TAT box (Fan) samplings 06:17, 13 November 2022 | likely active or activable |
331. TATCCAC boxes | TATCCAC | Absent | 18 | TATCCAC boxes 03:59, 13 October 2019 | GA responsive complex component 47 |
332. TATCCAC boxes (Yang 2007) | TATCCAC | Absent | 19 | TATC box gene transcriptions 03:59, 13 October 2019 | 47 |
333. Tbf1 regulatory factors | A(A/G)CCCTAA | Present | 242 | Tbf1 regulatory factors 17:38, 15 November 2022 | Saccharomyces cerevisiae, likely active or activable |
334. T boxes, (Conlon) | TCACACCT | Present | 246 | T boxes 23:28, 18 November 2022 | likely active or activable |
335. T boxes, (Zhang) | AACGTT | Present | 247 | T boxes 17:21, 20 November 2022 | likely active or activable |
336. TCCACCATA elements | TCCACCATA | Absent | 77 | TCCACCATA elements 05:10, 13 February 2021 | adjacent co-dependent regulatory element of POLLEN1 49 |
337. TEA consensus sequences | CATTCY | Present | 328 | TEA consensus sequences 06:35, 24 February 2023 | likely active or activable |
338. Telomeric repeat DNA-binding factors, (TRFs) | TTAGGG | Present | 330 | Telomeric repeat DNA-binding factors 06:35, 2 March 2023 | likely active or activable |
339. Tetradecanoylphorbol-13-acetate response elements, (TREs) | TGA(G/C)TCA | Absent | 23 | Tetradecanoylphorbol-13-acetate response elements 15:07, 24 August 2020 | cis-regulatory element of the human metallothionein IIa (hMTIIa) promoter and SV40 2*46 |
340. TGF-β control elements, (TCEs) | GCGTGGGGGA | Absent | 95 | TGF-β control elements 17:38, 5 March 2021 | GCGTGGGGGA in humans 410 |
341. TGF-β inhibitory elements, (TIEs) | GAGTGGTGA | Absent | 22 | TGF-β inhibitory elements 01:57, 23 August 2020 | in the rat transin/stromelysin promoter 49 |
342. Thyroid hormone response elements, (TREs)(THRs) | AGGTCA | Present | 331 | Thyroid hormone response elements 23:06, 3 March 2023 | likely active or activable |
343. Transcription factor 3, (TCF3) | GTCTGGT | Present | 332 | Transcription factor 3 19:21, 5 March 2023 | likely active or activable |
344. Translational control sequences, (TCSs) | (A/T)TT(A/G)TCT | Present | 333 | Translational control sequences 20:33, 7 March 2023 | likely active or activable |
345. Transposon enhancement control (TEC) or Tec1 | GAATGT | Present | 329 | Tec1ps 22:49, 26 February 2023 | likely random, Ste12p cofactor |
346. Tryptophan residues, (Lu) | GAAA | Present | 142 | Tryptophan residues 03:55, 18 June 2022 | likely active or activable, the tryptophan residues occur in the IRS, IFN, ICRE, Cell-cycle box variants, V-box, Pollen1, and β-Scaffold response elements |
347. Unfolded protein response element, (URE), (UPRE-1) | CANCNTG | Present | 300 | Unfolded protein response element 18:24, 8 January 2023 | likely active or activable |
348. Unfolded protein response elements, (UPREs) | TGACGTG(G/A) | Present | 334 | Unfolded protein response elements 21:02, 7 March 2023 | likely active or activable |
349. Upstream repressor site 1, (URS1, core), (Sumrada) | CCGCC | Present | 277 | Upstream repressor site 1 06:31, 17 December 2022 | likely active or activable |
350. Upstream stimulating factors, (USFs) | GCC(A/T)NN(C/G/T)(A/G) | Present | 337 | Upstream stimulating factors 05:51, 11 March 2023 | likely active or activable |
351. V boxes | (A/G)TT(A/T)(C/T) | Present | 340 | V boxes 20:50, 16 March 2023 | likely active or activable |
352. Vhr1ps, (VHR1), (Weider 2016), (Tang 2020) | AATCA-N8-TGA(C/T)T | Absent | 96 | Vhr1ps 01:26, 9 March 2021 | Response to low biotin concentrations 2*49 |
353. Vitamin D response elements, (VDRE2s) | A/GGG/TTCAnnnA/GGG/TTCA | Absent | 97 | Vitamin D response elements 03:48, 10 March 2021 | 410 |
354. Vitamin D response elements (VDRE) (Kakhki 2018) | (A/G)G(G/T)TCA, RGKTCA | Present | 341 | Vitamin D response elements 04:37, 19 March 2023 | likely active or activable |
355. W boxes (W-boxes) (WRKY) | (C/T)TGAC(C/T) | Present | 342 | W boxes 20:46, 20 March 2023 | likely active or activable |
356. X1a boxes (Ferstl 2004) | TCTGCC | Present | 364 | X-boxes 04:29, 4 May 2023 | likely active or activable |
357. X1b boxes (Ferstl 2004) | AGAGACAGAT | Absent | 357 | X-boxes 17:57, 30 April 2023 | 410 |
358. X2 boxes (Ferstl 2004) | AGGTCCA | Present | 362 | X-boxes 01:41, 4 May 2023 | likely active or activable |
359. X boxes (Zhang 1993) | GTTGGCATGGCAAC | Absent | 12 | X boxes 16:03, 27 April 2023 | X2 box is AGGTCCA 414 |
360. X-boxes (Moreno) | GT(A/C/T)N(C/T)(C/T)AT(A/G)(A/G)NAAC | Absent | 98 | X-boxes 16:43, 10 March 2021 | includes GTTNCCATGGNAAC (4/3)*24*47-412 |
361. X core promoter elements (XCPE1) | (A/G/T)(C/G)G(C/T)GG(A/G)A(C/G)(A/C) | Present | 343 | X core promoter elements 19:37, 22 March 2023 | likely active or activable |
362. Xenobiotic response elements, (XREs) | (T/G)NGCGTG(A/C)(G/C)A | Absent | 83 | Xenobiotic response elements 20:45, 17 February 2021 | contains the core sequence GCGTG, see AHRE above 2*47 |
363. Xenobiotic response elements (XREs) (Shen 1992) | GCGTG | Present | 233 | Xenobiotic response elements 05:22, 5 November 2022 | likely active or activable |
364. XhoI site-binding protein 1 protein (Xbp1p), (Mai 1997), (Tang 2020) | GcCTCGA(G/A)G(C/A)g(a/g) | Absent | 99 | Xbp1ps 14:40, 11 March 2021 | Transcriptional repressor 2*410 |
365. Yap response elements (Salin 2008) | T(G/T)ACT(A/C)A | Present | 365 | Yap response elements 05:18, 4 May 2023 | likely active or activable |
366. Yap recognition sequences (Tang 2020) | TTACTAA | Present | 344 | Yap recognition sequences 19:57, 24 March 2023 | likely active or activable |
367. Y boxes, (Koike 1997) | (A/G)CTAACC(A/G)(A/G)(C/T) | Absent | 11 | Y boxes 00:44, 13 October 2019 | inverted CAAT box, 48 |
368. YY1 binding sites | CCATTTA | Absent | 100 | YY1 binding sites 06:23, 12 March 2021 | 47 |
369. YY1 binding sites | CCATCTT | Present | 345 | YY1 binding sites 22:07, 25 March 2023 | likely active or activable |
370. Z-box (ZboxN) samplings, (ZboxNs) | ATACGGT | Absent | 251 | Z-box (ZboxN) samplings 19:47, 2 December 2022 | 47 |
371. Z-box (ZboxSo) samplings, (ZboxNs) | ATACGTGT | Absent | 252 | Z-box (ZboxSo) samplings 20:21, 3 December 2022 | 48 |
372. Z boxes, NSoSp form | A(C/T)A(C/G)G(G/T)(A/G/T)T | Present | 249 | Z boxes 17:23, 28 November 2022 | likely active or activable, negative direction distals within randoms |
373. Z boxes, ZboxG | A(C/T)A(C/G)GT(A/G)T | Present | 250 | Z boxes 03:00, 1 December 2022 | likely active or activable |
374. Z boxes, ZboxSp | CAGGT(A/G) | Present | 248 | Z boxes 05:10, 24 November 2022 | likely active or activable |
375. Zinc-responsive elements, (Zhao 1998), (Tang 2020) (ZREs) | ACCYYNAAGGT or ACC(C/T)(C/T)NAAGGT | Absent | 101 | Zap1ps 15:52, 15 March 2021 | 49 |
376. Zinc responsive elements, (ZREs), (Nicola 2007) | MHHAACCBYNMRGGT or (A/C)(A/C/T)(A/C/T)AACC(C/G/T)(C/T)N(A/C)(A/G)GGT | Absent | 102 | Zinc responsive elements 19:02, 15 March 2021 | (4/3)3*49 |
Response element testing (Absent)
Name of elements | Consensus sequences | Response element class | Testing | Activity |
---|---|---|---|---|
Abbreviations | Variations | Absent (N) | Notes | |
Authors | ||||
1. novel ABA-response elements
(ABREN, novel ABRE) |
GATCGATC, CGATCGAT, GATCGAT | WD40 repeat family | N | ABREN, CGATCGAT motif, and core of ABREN and CGATCGAT motif.[9] |
2. ABA-response element-like
(ABRE-like) |
ACGTGTCC | WD40 repeat family | N | third highest scoring motif.[9] |
3. Abf1 regulatory factors | CGTCCTCTACGAT | General Regulatory Factors | N | CGTNNNNNACGAT.[8] |
4. Activating proteins
(Murata) |
GCCCACGGG | bHSH | N | Activating protein 2.[10] |
5. AhR-responsive elements
(AHRE) (Yao) |
(G/T)NGCGTG(A/C)(C/G)A | bHLH | N | in the promoter region of AhR responsive genes |
6. Alpha-amylase conserved elements | TATCCA | ? | N | TATCCATCCATCC.[11] |
7. Amino acid response elements
(AARE) (Maruyama) |
ATTGCATCA | ? | N | AARE1 (ATTGCATCA)[12] |
8. Amino acid response elements
(AARE) (Broer) |
TTTGCATCA | ? | N | TTTGCATCA.[2][3] |
9. Amino acid response element-like
(AARE-like) |
TGGTGAAAG | ? | N | AARE-like sequence (TGGTGAAAG, named AARE3).[12] |
10. Androgen response elements
(AREs) (Kouhpayeh) |
GGTACANNNTGTTCT | Zinc finger DNA-binding domain | N | GGTACACGGTGTTCT.[13] |
11. Androgen response elements
(AREs) (Wilson) |
TGATTCGTGAG | Zinc finger DNA-binding domain | N | AGAACANNNTGTTCT.[14] |
12. Antioxidant-electrophile responsive elements
(Otsuki) |
GTGAGGTCGC | bHLH | N | GTGAGGTCGC.[4] or GCTGAGT, GCAGGCT of GC(A/C/T)(A/G/T)(A/G/T)(C/G/T)T(A/C)A[5], an antioxidant response element (ARE) |
13. CAAT boxes | (C/T)(A/G)(A/G)CCAATC(A/G) | bZIP | N | consensus sequence for the CCAAT-enhancer-binding site (C/EBP) is TAGCATT. |
14. Calcium-response elements | CTATTTCGAG | ? | N | CaRE1 CTATTTCGAG.[15] |
15. Carbohydrate response elements
(ChREs) |
CACGTGACCGGATCTTG, TCCGCCCCCATCACGTG | ? | N | ChoRE1, ChoRE2.[16] |
16. Carbon source-responsive elements
(CSREs) |
CATTCATCCG | ? | N | confers carbon source-dependent regulation |
17. Cbf1 regulatory factors | TCACGTGA | ? | N | strongly bound Cbf1 motifs enriched at both ends with a "T" on the 5′ and "A" on the 3′ end. |
18. C-boxes
(Johnson) |
GAGGCCATCT | bZIP | N | GAGGCCATCT.[17] |
19. C/A hybrid boxes | TGACGTAT | bZIP | N | TGACGTAT.[18] A at the 12 position |
20. C/T hybrid boxes | TGACGTTA | bZIP | N | TGACGTTA.[18] T at the 12 position |
21. CCCTC-binding factors
(CTCF) |
NCA-NNA-G(A/G)N-GGC-(A/G)(C/G)(C/T) | ? | N | NCA-NNA-G(G/A)N-GGC-(G/A)(C/G)(T/C).[19] |
22. C/EBP boxes | TTAGGACAT,[6] or TAGCATT.[7] | bZIP | N | CCAAT-enhancer-binding site (C/EBP) is TAGCATT |
23. Cell-cycle boxes
(CCBs) |
CACGAAAA | ? | N | "cell cycle box" is functional in either orientation, acting as an enhancer |
24. Cell cycle regulation | CCCAACGGT[11] | ? | N | tomato genome-wide analysis |
25. CENP-B boxes | TTTCGTTGGAAGCGGGA | ? | N | specifically localized at the centromere |
26. Coupling elements
(CE1) |
TGCCACCGG[9] | ? | N | CE1 (Watanabe) |
27. DAF-16-associated elements
(DAE) |
TGATAAG | ? | N | DAF-16-associated element (DAE).[20] |
28. D-boxes
(Mracek1) |
GTTGTATAAC | ? | N | GTTGTATAAC.[21] |
29. D-boxes
(Mracek) |
CTTATGTAAA (Mracek2) | ? | N | CTTATGTAAA.[21] |
30. D-boxes
(Johnson) |
TCTCACA | ? | N | TCTCACATT(A/C)AATAAGTCA is a D-box.[17] |
31. Defense and stress-responsive elements | ATTTTCTTCA | ? | N | ATTTTCTTCA.[11] |
32. DNA damage response elements
(DREs) (Smith) |
TTTCAAT[22] | ? | N | in the upstream repression sequence (URS) |
33. DNA damage response elements
(DREs) (Sumrada) |
TAGCCGCCG of TAGCCGCCGRRRR.[23] | ? | N | in the upstream repression sequence (URS) |
34. DNA replication-related elements
(DREs) |
TATCGATA | ? | N | DNA replication-related element (DRE).[24] |
35. DREB boxes | TACCGACAT | ? | N | CRT/DREB box |
36. EIF4E basal elements | TTACCCCCCCTT | ? | N | poly(C) motif |
37. Endoplasmic reticulum stress response elements
(ERSE) |
CCAAT-N9-CCACG | bZIP | N | compare CCAAT-box and ERSE below in the (present) |
38. Estrogen response elements
(EREs) |
AGGTTA or GGTCAGGAT | Cys 4 |
N | AGGTTATTGCCTCCT or GGTCAGGATGAC |
39. F boxes | TGATAAG[25] | ? | N | F-box overlaps the I-box |
40. Forkhead boxes | GTAAACAA[26] | HTH, Forkhead | N | GTAAACAA FOXO1 |
41. Gal4ps | CGGACCGC | ? | N | CGG(A/G)NN(A/G)C(C/T)N(C/T)NCNCCG[27] |
42. γ-interferon activated sequences
(GAS) |
TTCCTAGAA | ? | N | ALS-GAS1 between nt −633 and nt −625 |
43. G boxes | (G/T)CCACGTG(G/T)C | ? | N | no "perfect palindrome" G boxes in either promoter |
44. GCN4 motifs | TGACTCA, TGAGTCA | bZIP | N | ACGT motif |
45. Gcn4ps | ATGACTCTT[27] | bZIP | N | GCN4 motifs |
46. Gibberellin responsive element-like 2
(GARE-like 2) (Fan) |
TAACGTA[28] | ? | N | "in the promoters of hydrolase genes".[28] |
47. GLM boxes | (G/A)TGA(G/C)TCA(T/C) | ? | N | GCN4-like motif |
48. Grainy head transcription factor binding sites | AACCGGTT | β-Scaffold factors with minor groove contacts | N | also GACTGGTT |
49. GT boxes
(Motojima) |
TGGGTGGGGCT | ? | N | (-78 to -69) |
50. Hapless motifs | CCAATCA | ? | N | heterotrimeric transcription factor, HAP2/3/4.[29] |
51. Heat-responsive elements | AAAAAATTTC | Helix-turn-helix (HTH), Heat shock factors (HSFs) | N | four nGAAn motifs |
52. Heat shock elements
(HSE1) (Eastmond) |
nGAAnnTTCnnGAAn | HTH, HSFs | N | HSE1 |
53. Heat shock elements
(HSE2) (Eastmond) |
nTTCnnGAAnnTTCn | HTH, HSFs | N | HSE2 is the inverse complement of HSE1 |
54. Heat shock elements
(HSE5) (Eastmond) |
nTTCn-(5-bp)-nTTCnnGAAn | HTH, HSFs | N | HSE5 |
55. Heat shock elements
(HSE6) (Eastmond) |
nTTCn-nnGAAn-(5-bp)-nGAAn | HTH, HSFs | N | HSE6 |
56. Heat shock elements
(HSE7) (Eastmond) |
nGA(A/G)nnTTCnnGAAn | HTH, HSFs | N | HSE7 PFT1 |
57. Heat shock elements
(HSE) (Eastmond) |
nGAAnnTTCnnGA(A/G)n | HTH, HSFs | N | HSE7 PFT2 |
58. Heat shock elements
(HSE10) (Eastmond) |
nTTCn-(11-bp)-nGAAn-(5 bp)-nGAAn | HTH, HSFs | N | HSE10 |
59. Hypoxia-inducible factors
(HIF-1) |
GCCCTACGTGCTGTCTCA[30] | bHLH | N | composed of HIF-1α and HIF-1β |
60. I boxes | GATAAG | ? | N | GGATGAGATAAGA |
61. Inositol/choline-responsive elements
(ICRE) (Case) |
CANNTGAAAT | ? | N | version of Lopes, see below |
62. Inositol/choline-responsive elements
(ICRE) (Lopes) |
ATGTGAAAT | ? | N | using ANNTGAAAT |
63. Interferon-stimulated response elements
(ISREs) |
AGTTTCN2TTTCN | ? | N | consensus sequence AGTTTCN2TTTCN.[31] |
64. Kozak sequences | GCCGCC(A/G)CCATGG | ? | N | GCCGCC(A/G)CCATGG[32] |
65. Kozak sequences
(Matsumoto) |
GAAAATGG | ? | N | GAAAATGG[33] |
66. L boxes | AAATTAACCAA | ? | N | AAATTAACCAA[34] |
67. Maf recognition element
(MAREs) |
TGCTGA(G/C)TCAGCA | ? | N | and TGCTGA(GC/CG)TCAGCA[35] |
68. Met3s | TCACGTG | bZIP | N | TCACGTG[36] |
68. M boxes | GTCATGTGCT | ? | N | or AGTCATGTGCT[37] |
69. Mcm1 regulatory factors | TT(A/T)CCNN(A/T)TNGG(A/T)AA | ? | N | Primary consensus sequence apparently: TT(A/T)CCNN(A/T)TNGG(A/T)AA.[8] |
70. Mcm1 regulatory factors
|
TTNCCNNNTNNGGNAA | ? | N | Primary consensus sequence apparently: TT(A/T)CCNN(A/T)TNGG(A/T)AA.[8] |
71. Motif ten elements | C(C/G)A(A/G)C(C/G)(C/G)AACG(C/G) | ? | N | Gene ID: 6309 |
72. NF‐κB/Rel family of eukaryotic transcription factors | CCCCTAAGGGG | β-Scaffold factors with minor groove contacts | N | NF-κB |
73. Nuclear factor 1
(NF-1) |
TTGGCNNNNNGCCAA | NF I | N | palindromic sequence |
74. Nuclear factor Ys | CCAATGG(A/C)(A/G) | ? | N | NF-Y is a trimeric complex |
75. p63 DNA binding sites | (A/G)(A/G)(A/G)C(A/G)(A/T)G(C/T)(C/T)(C/T)(A/G)(A/G)(A/G)C(A/T)(C/T)G(C/T)(C/T)(C/T) | β-Scaffold factors with minor groove contacts | N | RRRC(A/G)(A/T)GYYYRRRC(A/T)(C/T)GYYY |
76. Pdr1p/Pdr3ps | TCCGCGGA | ? | N | Pdr1p/Pdr3p response elements (PDREs) |
77. Peroxisome proliferator hormone response elements
(PPREs) |
AGGTCANAGGTCA | ? | N | PPARs/RXRs heterodimers bind to PPRE |
78. Pollen1 with TCCACCATA | AGAAANNNNTCCACCATA | ? | N | adjacent co-dependent regulatory element TCCACCATA |
79. TCCACCATA | TCCACCATA | ? | N | no regulatory element TCCACCATA was found, nor its ci. |
80. Polycomb response elements | CGCCAT(A/T)TT | ? | N | CGCCATTT |
81. Rap1 regulatory factors | ACCC(A/G)N(A/G)CA | ? | N | "(ACCCRnRCA), less than half of the sites were detectably bound"[8] |
82. Extended Reb1 | ATTACCCGAA | ? | N | "extended motif VTTACCCGNH (IUPAC nomenclature) (Rhee and Pugh 2011)."[8] |
83. Rlm1ps | CTATATATAG | ? | N | CTA(T/A)4TAG |
84. Rox1ps | RRRTAACAAGAG | ? | N | Heme-dependent repressor of hypoxic genes.[27] |
85. Rpn4ps | GGTGGCAAA | ? | N | proteasome genes |
86. Seed-specific elements | CATGCATG | ? | N | SRE consensus: CAGCAGATTGCG is none |
87. Shoot specific elements | GATAATGATG | ? | N | SRE consensus: CAGCAGATTGCG is none |
88. Sip4ps | CC(C/G)T(C/T)C(C/G)TCCG | ? | N | CC(C/G)T(C/T)C(C/G)TCCG[27] |
89. Smp1ps | ACTACTA(A/T)(A/T)(A/T)(A/T)TAG | ? | N | ACTACTA(T/A)4TAG[27] |
90. SP1
(Long) |
GGGGCGGGCC | ? | N | GGGGCGGGCC[16] |
91. Sterol response elements
(Branco) |
TCGTATA | ? | N | perhaps plant specific |
92. Sterol response elements
(Yao) |
AGCAGATTGCG | ? | N | liver specific |
93. TATCCAC boxes | TATCCAC | ? | N | GA responsive complex component |
94. TCCACCATA elements | TCCACCATA | ? | N | adjacent co-dependent regulatory element of POLLEN1 |
95. Tetradecanoylphorbol-13-acetate response elements
(TREs) |
TGA(G/C)TCA | ? | N | cis-regulatory element of the human metallothionein IIa (hMTIIa) promoter and SV40 |
96. TGF-β control elements
(TCEs) |
GAGTGGGGCG | ? | N | in mouse and rat, GCGTGGGGGA in humans |
97. TGF-β inhibitory elements
(TIEs) |
GAGTGGTGA | ? | N | in the rat transin/stromelysin promoter |
98. Vhr1ps
(VHR1) |
AATCA-N8-TGA(C/T)T | ? | N | Response to low biotin concentrations |
99. Vitamin D response elements
(VDREs) |
A/GGG/TTCAnnnA/GGG/TTCA | ? | N | (A/G)G(G/T)TCANNN(A/G)G(G/T)TCA |
100. X boxes | GTTGGCATGGCAAC[38] | ? | N | X2 box is AGGTCCA not ⌘F |
101. X-boxes | GT(A/C/T)N(C/T)(C/T)AT(A/G)(A/G)NAAC[39] | ? | N | includes GTTNCCATGGNAAC |
102. Xbp1ps | GcCTCGA(G/A)G(C/A)g(a/g) | ? | N | Transcriptional repressor |
103. Xenobiotic response elements
(XREs) |
(T/G)NGCGTG(A/C)(G/C)A | ? | N | contains the core sequence GCGTG, see AHRE above |
104. Y boxes | (A/G)CTAACC(A/G)(A/G)(C/T) | ? | N | inverted CAAT box |
105. Zap1ps | ACCCTCA | ? | N | ACC(C/T)(C/T)(A/C/G/T)AAGGT |
106. Z-box (ZboxN) samplings
(ZboxNs) |
ATACGGT | ? | N | No ZboxN occur on either side of A1BG |
107. Z-box (ZboxSo) samplings
(ZboxNs) |
ATACGTGT | ? | N | No ZboxSo occur on either side of A1BG |
108. Zinc responsive elements
(ZREs) |
MHHAACCBYNMRGGT | ? | N | (A/C)(A/C/T)(A/C/T)AACC(C/G/T)(C/T)N(A/C)(A/G)GGT |
Response element testing (Present)
Name of elements | Consensus sequences | Response element class | Testing | Activity/Notes |
---|---|---|---|---|
Abbreviations | Variations | Pathways | Present (Y) | Random or likely active or activable |
Authors | Table (T) | |||
1. A-boxes
(A-box) (Nawkar 2017) |
TACGTA | Basic leucine zipper (bZIP)
Light signaling and stress response pathways |
Y
T |
likely active or activable |
2. Abscisic acid response elements
(ABREs) (Watanabe 2017) |
ACGTG(G/T)C | WD40 repeat family
ABA-signaling pathway,[40] Ethylene signaling pathway |
Y
T |
likely active or activable |
3. Activated B-cell Factor-1s
(ABFs, Abfms) (Rossi 2018) |
CGTNNNNN(A/G)(C/T)GA(C/T) | General Regulatory Factors
B-cell receptor signal transduction pathway |
Y
T |
likely active or activable |
4. boxes A
(AP-1 box A) (Kokoroishi 2015) |
TGACTCT | bZIP
PKC-dependent pathway |
Y
T |
likely active or activable |
5. Abscisic acid-responsive elements (Pho4s), G boxes
(G-box) (Loake 1992) |
CACGTG | bZIP, bHLH
Purine and histidine biosynthesis pathways, Phenylpropanoid pathway, Light signaling and stress response pathways |
Y
T |
likely active or activable |
6. ACGT-containing elements | ACGT | bZIP
Purine and histidine biosynthesis pathways, Phenylpropanoid pathway |
Y
T |
cores and proximals are likely active or activable, but a few of the UTRs and distal promoters may be random |
7. Activating protein 2 alpha
(AP2a) |
GCCNNNGGC | bHSH
Rapamycin (TOR) regulatory pathways |
Y
T |
likely active or activable, positive strand, positive direction AP2a within randoms |
8. Activating protein 2
(AP2) (Cohen) |
GCCTGGCC | bHSH
Rapamycin (TOR) regulatory pathways |
Y
T |
likely active or activable |
9. Activating protein 2
(Cohen) |
TCCCCCGCCC | bHSH
Rapamycin (TOR) regulatory pathways |
Y
T |
likely active or activable |
10. Activating protein 2
(Murata) |
(C/G)CCN(3)GG(C/G) | bHSH
Rapamycin (TOR) regulatory pathways |
Y
T |
likely active or activable |
11. Activating protein 2
(Murata) |
(C/G)CCN(4)GG(C/G) | bHSH
Rapamycin (TOR) regulatory pathways |
Y
T |
likely active or activable |
12. Activating protein 2
(Yao) |
TCTTCCC | bHSH
Rapamycin (TOR) regulatory pathways |
Y
T |
likely active or activable |
13. Activating protein 2
(Yao) |
CTCCCA | bHSH
Rapamycin (TOR) regulatory pathways |
Y
T |
likely active or activable |
14. Activating proteins
(AP-2) (Yao) |
GGCCAA | bHSH
Rapamycin (TOR) regulatory pathways |
Y
T |
likely active or activable |
15. Activating transcription factors
(Burton) |
(A/C/G)TT(A/G/T)C(A/G)TCA | bZIP
Signal transduction pathways |
Y
T |
likely active or activable |
16. Activating transcription factors
(Kilberg) |
(A/G/T)TT(A/G/T)CATCA | bZIP
Signal transduction pathways |
Y
T |
likely active or activable |
17. Adenylate–uridylate rich elements
(AUREs) (Bakheet) |
(A/T)(A/T)(A/T)TATTTAT(A/T)(A/T) | stem-loop
ARE-mediated mRNA decay pathways, neddylation pathway, p38 mitogen-activated protein kinase (MAP kinase) pathway |
Y
T |
likely active or activable |
18. Adenylate–uridylate rich elements
(AREs) (Chen and Shyu, Class I) |
ATTTA | stem-loop
ARE-mediated mRNA decay pathways, neddylation pathway, p38 mitogen-activated protein kinase (MAP kinase) pathway |
Y
T |
likely active or activable, UTRs at the lower end of the randoms |
19. Adenylate–uridylate rich elements
(AREs) (Chen and Shyu, Class II) |
TTATTTA(A/T)(A/T) | stem-loop
ARE-mediated mRNA decay pathways, neddylation pathway, p38 mitogen-activated protein kinase (MAP kinase) pathway |
Y
T |
likely active or activable |
20. Adenylate–uridylate rich elements
(AREs) (Chen and Shyu, Class III) |
ATTT | stem-loop
ARE-mediated mRNA decay pathways, neddylation pathway, p38 mitogen-activated protein kinase (MAP kinase) pathway |
Y
T |
likely active or activable, low negative direction proximals overlap randoms |
21. Adr1ps | TTGG(A/G)G | Cys 2His 2 zinc finger binding domain ARE-mediated mRNA decay pathways, neddylation pathway, p38 mitogen-activated protein kinase (MAP kinase) pathway |
Y
T |
likely active or activable |
22. Aft1s | (C/T)(A/G)CACCC(A/G) | bZIP? | Y
T |
likely active or activable |
23. AGC boxes | AGCCGCC | AP-2/EREBP-related factors | Y
T |
likely active or activable |
24. AhR responsive element or Aryl hydrocarbon responsive element II
(AHRE-II) |
CATGN6C(A/T)TG | bHLH | Y
T |
likely active or activable |
25. AhR DNA-binding consensus sequence
(AhRY) (Yao) |
GCGTGNN(A/T)NNN(C/G) | bHLH | Y
T |
likely active or activable for ZNF497 |
26. Androgen response element1s
(Kouhpayeh) |
GGTACA of GGTACAnnnTGTTCT | Zinc finger DNA-binding domain | Y
T |
likely active or activable |
27. Androgen response element2s
(Kouhpayeh) |
TGTTCT of GGTACAnnnTGTTCT | Zinc finger DNA-binding domain | Y
T |
likely active or activable |
28. Androgen response elements
(Wilson) |
AGAACANNNTGTTCT | Zinc finger DNA-binding domain | Y
T |
the two portions AGAACA and TGTTCT occurring separately are likely active or activable |
29. Angiotensinogen core promoter elements | (A/C)T(C/T)GTG | bZIP? | Y
T |
likely active or activable, positive direction distal low occurrences overlap randoms |
30. Antioxidant-electrophile responsive elements
(Lacher) |
GC(A/C/T)(A/G/T)(A/G/T)(C/G/T)T(A/C)A | bHLH | Y
T |
likely active or activable |
31. ATA boxes | AATAAA | β-Scaffold factor? | Y
T |
likely active or activable |
32. ATTTA elements
(Siegel) |
(A/T)(A/T)(A/T)(A/T)(A/T)(A/T)(A/T)(A/T)(A/T) | β-Scaffold factor? | Y
T |
likely active or activable |
33. Auxin response factors
(Stigliani) |
(C/G/T)(A/C/T)(G/T)G(C/T)(C/T)(G/T)(C/G)(A/C/T)(A/G/T) | WD40 repeat family | Y
T |
likely active or activable, positive direction proximals overlap high randoms, positive direction cores within randoms |
34. Auxin response factors
(Ulmasov) |
TGTCTC | WD40 repeat family | Y
T |
likely active or activable |
35. Auxin response factors
(Boer) |
TGTCGG | WD40 repeat family | Y
T |
likely active or activable |
36. Auxin response factors
(ARF5) |
(C/G/T)N(G/T)GTC(G/T) | WD40 repeat family | Y
T |
likely active or activable, negative direction proximals ≥ randoms |
37. B-boxes
(Johnson) |
TGGGCA | Zinc finger DNA-binding domains
PKC-dependent pathway |
Y
T |
likely active or activable, positive direction distals ≥ randoms |
38. boxes B
(Sanchez) |
TGTCTCA | Zinc finger DNA-binding domains | Y
T |
likely active or activable |
39. B recognition elements
(BREu) |
(G/C)(G/C)(G/A)CGCC | HTH | Y
T |
likely active or activable |
40. CACA elements (Orlando 2019) | CACA | ? | Y
T |
likely active or activable |
40. CadC binding domains | TTANNNNT | HTH | Y
T |
likely active or activable, negative direction proximals within randoms |
41. Calcineurin-responsive transcription factors | TG(A/C)GCCNC | ?
calcineurin-dependent signaling pathways |
Y
T |
likely active or activable |
42. Carbohydrate response elements | ChoRE1 ACCGG | ? | Y
T |
likely active or activable |
43. Carbohydrate response elements | ChoRE2 CCCAT | ? | Y
T |
likely active or activable |
44. Carbohydrate response elements | Carb E1 ATCTTG | bHLH? | Y
T |
proximals likely active or activable |
45. Carbohydrate response elements | Carb E2 CACGTG | bHLH | Y
T |
likely active or activable |
46. Carbohydrate response elements | Carb E3 TCCGCC | bHLH? | Y
T |
likely active or activable, low positive direction distals overlap high randoms |
47. Carbon source-responsive elements TCCG elements
(TCCGs) |
TCCG | bHLH?
gluconeogenic pathway |
Y
T |
likely active or activable |
48. CATTCA elements
(CATTs) |
CATTCA | bHLH?
gluconeogenic pathway |
Y
T |
likely active or activable |
49. CARE (Fan)
(CAREs) (Fan) |
CAACTC | WD-40 repeat family | Y
T |
likely active or activable |
50. CARE (Garaeva)
(CAREs) (Garaeva) |
(A/G/T)TT(A/G/T)CATCA | WD-40 repeat family | Y
T |
likely active or activable |
51. cAMP-responsive elements
(CREs), Aca1ps, Sko1ps |
TGACGTCA | bZIP
cAMP-dependent pathway |
Y
T |
likely active or activable, same as Root specific elements |
52. CArG boxes | CCAAAAAT(G/A)G | bHLH | Y
T |
likely active or activable |
53. Cat8ps | CGG(A/C/G/T)(C/G/T)(A/C/G/T)(A/C/G)(A/C)(A/C/T)GGA | ? | Y
T |
likely active or activable |
54. CAT boxes | CATTCCT | bHLH | Y
T |
likely active or activable |
55. CAT-box-like elements | GCCATT | bHLH | Y
T |
likely active or activable |
56. C boxes
(Samarsky) |
AGTAGT | bZIP | Y
T |
likely active or activable |
57. C-boxes
(Song) |
GACGTC | bZIP | Y
T |
likely active or activable |
58. hybrid CG-boxes
(Song) |
TGACGTGT | bZIP | Y
T |
likely active or activable |
59. C boxes
(Voronina) |
GGTGATG | bZIP | Y
T |
likely active or activable |
60. CCCTC-binding factors
(CTCF) (Lobanenkov 1990) |
CCCTC | ? | Y
T |
likely active or activable |
60. Cell-cycle box variants
(CCBs) |
CACGAAA, ACGAAA and C-CGAAA | ? | Y
T |
likely active or activable |
61. CGCG boxes | (A/C/G)CGCG(C/G/T) | ?
signal transduction pathways |
Y
T |
likely active or activable probably for the respective zinc fingers |
62. Circadian control elements | CAANNNNATC | ? | Y
T |
likely active or activable but overlaps highest randoms |
63. Class C DNA binding sites | CACGNG | bHLH | Y
T |
likely active or activable |
64. Cold-responsive elements | CCGAC | ? | Y
T |
likely active or activable |
65. Constitutive decay elements
(CDEs) (Siegel) |
TTC(C/T)(A/G)(C/T)GAA | stem-loop | Y
T |
likely active or activable possibly for ZNF497 |
66. Copper response elements
(CuREs) (Quinn) |
TTTGC(T/G)C(A/G) | ? | Y
T |
likely active or activable |
67. Copper response elements
(CuREs) (Park) |
TGTGCTCA | ? | Y
T |
likely active or activable |
68. Coupling elements
(CE3s) (Watanabe) |
GCGTGTC | WD-40 repeat family | Y
T |
likely active or activable |
69. Coupling elements
(CE3s) (Ding) |
CACGCG | WD-40 repeat family | Y
T |
likely active or activable |
70. Cytokinin response regulators
(ARR1s) |
AGATT(C/T) | WD40 repeat family | Y
T |
likely active or activable |
71. Cytokinin response regulators
(ARR10s) |
(A/G)GATA(A/C)G | WD40 repeat family | Y
T |
likely active or activable |
72. Cytokinin response regulators
(ARR12s) |
(A/G)AGATA | WD40 repeat family | Y
T |
likely active or activable |
73. Cytokinin response regulators
(ARRs) (Ferreira) |
(G/A)GGAT(T/C) | WD40 repeat family | Y
T |
likely active or activable |
74. Cytokinin response regulators
(ARRs) (Rashotte1) |
GATCTT | WD40 repeat family | Y
T |
likely active or activable |
75. Cytokinin response regulators
(ARRs) (Rashotte2) |
(G/A)GAT(T/C) | WD40 repeat family | Y
T |
likely active or activable |
76. Cytoplasmic polyadenylation elements
(CPEs) |
TTTTTAT | ? | Y
T |
likely active or activable |
77. DAF-16 binding elements | (A/G)(C/T)AAA(C/T)A | ? | Y
T |
likely active or activable |
78. D boxes
(Samarsky) |
AGTCTG | ? | Y
T |
likely active or activable |
79. D boxes
(Voronina) |
TCCTG | ? | Y
T |
likely active or activable |
80. D-boxes
(Motojima) |
TGAGTGG | ? | Y
T |
likely active or activable |
115. Destruction boxes
(D box) (Pfleger and Kirschner 2000) |
CGN(C/T)TNAAN | ? | Y
T |
likely active or activable |
81. Dioxin-responsive elements
(DREs) |
TNGCGTG | bHLH? | Y
T |
likely active or activable |
82. Downstream B recognition elements | (A/G)T(A/G/T)(G/T)(G/T)(G/T)(G/T) | ? | Y
T |
likely active or activable, negatives > randoms, positives overlap or outside randoms |
83. Downstream core elements
(DCESIs) |
CTTC of CTTC...CTGT...AGC | ? | Y
T |
likely active or activable, depending on overlaps |
84. Downstream core elements
(DCESIIs) |
CTGT of CTTC...CTGT...AGC | ? | Y
T |
likely active or activable, depending on overlaps |
85. Downstream core elements
(DCESIIIs) |
AGC of CTTC...CTGT...AGC | ? | Y
T |
likely active or activable, depending on overlaps |
86. Downstream promoter elements
(DPEs) (Juven-Gershon) |
(A/G)G(A/T)(C/T)(A/C/G)T | ? | Y
T |
most or all of the real DPE (Juven-Gershon)s are likely active or activable |
87. Downstream promoter elements
(DPEs) (Kadonaga) |
(A/G)G(A/T)CGTG | ? | Y
T |
likely active or activable |
88. Downstream promoter elements
(DPEs) (Matsumoto) |
AGTCTC | ? | Y
T |
likely active or activable |
89. E2 boxes | (G/A)CAG(A/C/G/T)TG(A/C/G/T) | bHLH | Y
T |
likely active or activable |
90. EIN3 binding sites | A(C/T)G(A/T)A(C/T)CT | ?
Ethylene signaling pathway |
Y
T |
likely active or activable |
91. Endoplasmic reticulum stress response elements | CCAAT-N9-CCACG, part 1 see Hap motif no.114 below, ESRE2, CCACG | bZIP | Y
T |
likely active or activable |
92. Endosperm expressions | TGTGTCA | ? | Y
T |
likely active or activable |
93. Enhancer boxes | CA(A/C/G/T)(A/C/G/T)TG | bHLH
metabolic pathways |
Y
T |
likely active or activable |
94. Estrogen response elements
(ERE1s) (Driscoll) |
GGTCA | Cys 4 estrogen response element-dependent signaling pathway |
Y
T |
likely active or activable |
95. Estrogen response elements
(ERE2s) (Driscoll) |
TGACC | Cys 4 estrogen response element-dependent signaling pathway |
Y
T |
likely active or activable |
96. Ethylene responsive elements | ATTTCAAA | WD40 repeat family
Ethylene signaling pathway |
Y
T |
likely active or activable |
97. Forkhead boxes | (A/G)(C/T)AAA(C/T)A | HTH, Forkhead | Y
T |
likely active or activable |
98. GAAC elements | GAACT | ? | Y
T |
likely active or activable |
99. Γ-interferon activated sequences
(GAS), see STAT5 |
TTNCNNNAA | β-Scaffold factors with minor groove contacts | Y
T |
likely active or activable |
100. GATA boxes | GATA | Zinc finger DNA-binding domains, bHLH
STAT5 pathway |
Y
T |
likely active or activable |
101. GATA (GATAAG, GATAAH, GATTA) motifs
(Staschke) |
GAT(A/T)A | Zinc finger DNA-binding domains, bHLH
Rapamycin (TOR) Regulatory Pathways |
Y
T |
likely active or activable |
102. GATC repeats
(ABREN) (Watanabe et al. 2017) |
GATC | ?
ABA-signaling pathway, Ethylene signaling pathway |
Y
T |
GATC UTRs, proximals and positive strand, negative direction distals greater than randoms, negative strand, negative direction distals, positive direction distals likely randoms. GATCs are likely active or activable |
103. GC boxes
(Briggs) |
(G/T)(G/A)GGCG(G/T)(G/A)(G/A)(C/T) | ? | Y
T |
likely active or activable |
103. GC boxes
(Ye) |
GGGCGG | ? | Y
T |
likely active or activable |
104. GCC boxes | GCCGCC | ?
Ethylene signaling pathway |
Y
T |
likely active or activable |
105. General control nonderepressible 4 protein binding site
(GCRE, GCN4) |
TGA(C/G/T)T(A/C/G)(A/T) | bZIP
Rapamycin (TOR) Regulatory Pathways |
Y
T |
likely active or activable |
106. GGCGGC triplet | GGCGGC | Zn(II)2Cys6 | Y
T |
likely active or activable |
107. GGC triplets | GGC | Zn(II)2Cys6 | Y
T |
likely active or activable |
108. Gibberellic acid responsive elements
(GAREs) |
TAACAAA | WD40 repeat family | Y
T |
likely active or activable |
109. Gibberellic acid responsive elements-like 1
(GAREL1s) |
TAACA(A/G)A | WD40 repeat family | Y
T |
likely active or activable |
110. Gibberellin responsive elements
(GREs) (Sharma) |
AAACAGA[11] | WD40 repeat family
Gibberellin (GA) growth regulator pathway, GA-biosynthesis pathway |
Y
T |
likely active or activable |
111. G-protein-coupled receptors
(GCR1s), CT boxes |
CTTCC | ?
cAMP signal pathway, phosphatidylinositol signal pathway |
Y
T |
likely active or activable. |
112. Glucocorticoid response elements | AGAACA | bHLH
gluconeogenesis pathway |
Y
T |
likely active or activable |
113. GT boxes
(Sato) |
GGGG(T/A)GGGG | ? | Y
T |
likely active or activable |
114. Hac1 KAR2 | CAGCGTG | ?
unfolded protein response (UPR) pathway |
Y
T |
likely active or activable |
115. H and ACA boxes | AGAGGA | Hairpin-hinge-hairpin-tail | Y
T |
likely active or activable, negative distals likely random |
116. Hap motif and ESRE CCAAT
(Hap4p) |
CCAAT | bZIP | Y
T |
likely active or activable |
117. H-boxes
(Grandbastien) |
CC(A/T)ACCNNNNNNN(A/C)T | hairpin-hinge-hairpin-tail
phenylpropanoid pathway |
Y
T |
likely active or activable |
118. H-boxes
(Lindsay) |
CCTACC | hairpin-hinge-hairpin-tail | Y
T |
likely active or activable, equal to or greater than the randoms for the negative direction distals |
119. H box
(Mitchell) |
ANANNA | hairpin-hinge-hairpin-tail | Y
T |
likely active or activable |
120. H box
(Rozhdestvensky) |
ACACCA | hairpin-hinge-hairpin-tail | Y
T |
likely active or activable |
121. Heat shock elements
(HSE3s) (Eastmond) |
nGAAn-(5-bp)-nGAAnnTTCn | HTH, HSFs | Y
T |
likely active or activable |
122. Heat shock elements
(HSEs) (Eastmond) |
nGA(A/G)n-(5-bp)-nGAAnnTTCn (GAP1) | HTH, HSFs | Y
T |
same result as HSE3, likely active or activable |
123. Heat shock elements
(HSEs) (Eastmond) |
nGAAn-(5-bp)-nGA(A/G)nnTTCn (GAP2) | HTH, HSFs | Y
T |
same result as HSE3, likely active or activable |
124. Heat shock elements
(HSE4s) (Eastmond) |
nGAAn-(5-bp)-nGAAn-(5-bp)-nGAAn | HTH, HSFs | Y
T |
likely active or activable |
125. Heat shock factors
(Hsfs) (Tang) |
NGAAN | HTH, HSFs | Y
T |
likely active or activable |
85. Helper site
(Atcha et al. 2007), (Cadigan and Waterman 2012) |
(C/G)C(C/G)G(C/G) | ?
Wnt/beta-catenin signaling pathway |
Y
T |
likely active or activable |
126. Hex sequences | TGACGTGGC | ? | Y
T |
likely active or activable |
127. High Mobility Group boxes
(HMG boxes) |
(A/T)(A/T)CAAAG | β-Scaffold factors with minor groove contacts | Y
T |
likely active or activable |
128. HNF6s | (A/G/T)(A/T)(A/G)T(C/T)(A/C/G)AT(A/C/G/T)(A/G/T) | Cys 4 GH/HNF-6 pathway, HNF6/HNF1β pathway, HNF6 pathway, KLF4/HNF-6 pathway |
Y
T |
likely active or activable, although the negative direction distals are at or less than randoms |
129. Homeoboxes | CAAG | HTH
lignin pathway, Wnt dorsalisation pathway, lefty-signaling pathway |
Y
T |
likely active or activable |
130. Homeodomains | TAAT | HTH | Y
T |
likely active or activable, low occurrence UTRs and negative direction distals overlap high randoms |
131. HY boxes | TG(A/T)GGG | ? | Y
T |
likely active or activable |
132. Hypoxia-inducible factors | ACGTG | bHLH | Y
T |
likely active or activable |
133. Hypoxia response elements | CACGC | WD40 repeat family | Y
T |
likely active or activable |
134. CACA elements | CACA | WD40 repeat family | Y
T |
likely active or activable |
135. Initiator elements
(Inrs) |
YYRNWYY | ? | Y
T |
likely active or activable |
136. Initiator elements
(Inrs) |
BBCABW | ? | Y
T |
likely active or activable |
137. Initiator-like elements
(Ins-Like) |
TTCTCT | ? | Y
T |
likely active or activable, where real Inr-like negative direction distals are within the range of the randoms |
138. Initiator-like elements
(TCT) |
(C/T)CT(C/T)T(C/T)(C/T) | ? | Y
T |
likely active or activable |
139. Inositol/choline-responsive elements
(ICRE) (Case, Lopes) |
CATGTGAAAT includes the canonical basic helix-loop-helix (bHLH) binding site CANNTG (Lopes et al. 1991) | bHLH | Y
T |
likely active or activable |
140. Inositol/choline-responsive elements
(ICREs) (Schwank) |
TYTTCACATGY contains the core sequence CANNTG | bHLH | Y
T |
likely active or activable |
141. Interferon regulatory factor
(IRF3) |
GCTTTCC | HTH | Y
T |
likely active or activable |
142. IFN-stimulated response elements
(ISREs) (Lu) |
GAAANNGAAA | HTH | Y
T |
likely active or activable |
143. IRS consensus
(Fujii) |
AANNGAAA | HTH | Y
T |
likely active or activable |
144. Tryptophan residues
(Lu) |
GAAA | HTH | Y
T |
likely active or activable, the tryptophan residues occur in the IRS, IFN, ICRE, Cell-cycle box variants, V-box, Pollen1, and β-Scaffold response elements |
145. Jasmonic acid-responsive elements
(JAREs) |
TGACG | ? | Y
T |
likely active or activable |
146. Krüppel-like factors | GGGNN(G/T)(G/T)(G/T) | ? | Y
T |
likely active or activable |
147. Leu3 transcription factors | (C/G)C(G/T)NNNN(A/C)G(C/G) | Zn(II)2Cys6 | Y
T |
likely active or activable |
148. -35 sequence | TTGACA | ? | Y
T |
likely active or activable, the UTR does overlap the randoms at the random's upper end |
149. Met31ps | AAACTGTG[36] | bZIP | Y
T |
likely active or activable |
150. Metal responsive elements
(MRE) |
TGC(A/G)C(A/C/G/T)C | ? | Y
T |
likely active or activable |
151. Middle sporulation element
(MSE) (Branco) |
ACACAAA | ? | Y
T |
likely active or activable |
152. Midsporulation element
(MSE) (Ozsarac) |
C(A/G)CAAA(A/T) | ? | Y
T |
likely active or activable |
153. Multicopy inhibitor of the GAL1 promoter
(MIG1) |
(C/G)(C/T)GGGG | bZIP | Y
T |
likely active or activable, UTRs may be random |
154. MITF E-box (CAYRTG)
(MITF) |
CA(C/T)(A/G)TG | ? | Y
T |
likely active or activable, negative distals overlap randoms at low end |
155. Musashi binding elements
(MBE1s) |
(G/A)U1AGU | ? | Y
T |
likely active or activable |
156. Musashi binding elements
(MBE2s) |
(G/A)U2AGU | ? | Y
T |
likely active or activable, negative direction distals may be random |
157. Musashi binding elements
(MBE3s) |
(G/A)U3AGU | ? | Y
T |
likely active or activable |
158. MYB ACGT-containing elements
(ACEs) |
CACGT | ? | Y
T |
likely active or activable, positive strand UTR is likely random, negative strand, positive direction distals are likely random |
159. Myeloblastosis recognition element
(MRE) |
A(A/C)C(A/T)A(A/C)C | ? | Y
T |
likely active or activable |
160. Myocyte enhancer factors
(MEFs) |
(C/T)TA(A/T)(A/T)(A/T)(A/T)TA(A/G) | β-Scaffold factors with minor groove contacts | Y
T |
likely active or activable |
161. Nanos/Pumilio response elements
(PREs) |
TGTAAAT | ? | Y
T |
likely active or activable |
162. N-boxes
(Lee) |
CCGGAA | bHLH | Y
T |
likely active or activable |
163. N-boxes
(Bai) |
CACGAG | bHLH | Y
T |
likely active or activable |
164. N-boxes
(Gao) |
CACGGC or CACGAC, CACG(A/G)C | bHLH | Y
T |
likely active or activable |
165. N-boxes
(Leal) |
CACNAG | bHLH | Y
T |
likely active or activable |
166. Non-DiTyrosine 80 transcription factor DNA binding domain
(Ndt80) |
(A/G/T)NC(A/G)CAAA(A/T) | ? | Y
T |
likely active or activable |
167. Nuclear factor of activated T cells
(NFATs) complement and inverse of the Pyrimidine boxes |
GGAAAA | β-Scaffold factors with minor groove contacts | Y
T |
likely active or activable, negative direction distals likely random |
168. NF𝜿B (Sato)
(NF𝜿BSs) |
GAATTC | ? | Y
T |
likely active or activable |
169. Nutrient-sensing response element 1
(NSRE) |
GTTTCATCA | ? | Y
T |
likely active or activable |
170. Oaf1 transcription factor | CGGN3TNAN9-12CCG | ? | Y
T |
likely active or activable |
171. ORESARA1
(ORE1) (Matallana) |
(A/C/G)(A/C)GT(A/G)N5,6(C/T)AC(A/G) | ? | Y
T |
likely active or activable |
172. ORESARA1
(ORE1) (Olsen) |
T(A/G/T)(A/G)CGT(A/G)(A/C/T)(A/G/T) | ? | Y
T |
likely active or activable |
173. p53 response elements | (A/G)(A/G)(A/G)C(A/T)(A/T)G(C/T)(C/T)(C/T) | β-Scaffold factors with minor groove contacts | Y
T |
likely active or activable |
174. p53 response elements
(Long1) |
CAGGCCC | β-Scaffold factors with minor groove contacts | Y
T |
likely active or activable |
175. p53 response elements
(Long2) |
GGGCGTG | β-Scaffold factors with minor groove contacts | Y
T |
likely active or activable |
176. P-box (Mena) | (A/T)AAAG | ? | Y
T |
likely active or activable, the positive direction proximals overlap the randoms |
177. P-box
(Motojima) |
TGAGTTCA | ? | Y
T |
likely active or activable |
178. P-box
(Yu) |
GTAA(T/C) | ? | Y
T |
likely active or activable with some overlapping the randoms |
179. Peroxisome proliferator-activated receptor alpha | CGACCCC | ? | Y
T |
likely active or activable, positive direction distal overlaps upper end of randoms |
180. Phosphate starvation-response transcription factor
(Pho4) (Tang 2020) |
CAC(A/G)T(T/G) | bHLH
purine and histidine biosynthesis pathways |
Y
T |
likely active or activable, positive strands of the UTRs and negative direction distals are in the random range |
181. Pollen1 elements | AGAAA | ? | Y
T |
likely active or activable |
182. Polycomb response elements
(PRE) |
GCCAT | ? | Y
T |
likely active or activable |
183. Pribnow boxes | TATAAT | ? | Y
T |
likely active or activable |
184. Prolamin boxes | TG(A/T)AAAG | ? | Y
T |
likely active or activable |
185. Q elements | AGGTCA | ? | Y
T |
likely active or activable |
186. Quinone reductase response element
(QRDRE) (Yao) |
TCCCCT of TCCCCTTGCGTG | ? | Y
T |
likely active or activable |
187. Rap1 reduced consensus | (A/G)(A/C)ACCC(A/G)N(A/G)C(A/C)(C/T)(A/C) | WD40 repeat family | Y
T |
likely active or activable |
188. Reb1 bound and exact occurrences | TTACCC(G/T) | WD40 repeat family | Y
T |
likely active or activable |
189. Retinoic acid response element
(RARE) |
AG(A/G)TCA | ? | Y
T |
likely active or activable, positive direction distals appear random |
190. Glucose transporter gene repressor
(Rgt1) |
CGG(A/G)(A/T)N(A/T)(A/T) | ? | Y
T |
likely active or activable |
191. classic RORE motif
(RORE) |
A(A/T)NTAGGTCA | ? | Y
T |
likely active or activable |
192. variant RORE motif | C(T/A)(G/A)GGNCA | ? | Y
T |
likely active or activable |
193. R response elements
(RRE) |
CATCTG | ? | Y
T |
likely active or activable |
194. Serum response elements
(SRE) see CArG boxes |
ACAGGATGT | bHLH-ZIP | Y
T |
likely active or activable |
195. Servenius sequences | GGACCCT | ? | Y
T |
likely active or activable |
196. SP1
(Zhang) |
(G/T)GGGCGG(G/A)(G/A)(C/T) | ? | Y
T |
likely active or activable |
197. SP1-box 1
(Motojima) |
GGGGCT | ? | Y
T |
likely active or activable |
198. SP1-box 2
(Motojima) |
CTGCCC | ? | Y
T |
likely active or activable |
199. SP-1
(Sato) |
CCGCCCC | ? | Y
T |
likely active or activable |
200. SP1
(Yao) |
GCGGC | ? | Y
T |
likely active or activable |
201. STAT5 | TTCNNNGAA | β-Scaffold factors with minor groove contacts | Y
T |
likely active or activable |
202. Stress-response elements
(STREs) |
CCCCT | ? | Y
T |
likely active or activable, positive cores overlap randoms
Positive strand, negative direction: CCCCT at 3059 |
203. Sucrose boxes | NNAATCA | ? | Y
T |
likely active or activable |
204. TACTAAC boxes | TACTAA(C/T) | ? | Y
T |
likely active or activable |
205. TAGteams | CAGGTAG | ? | Y
T |
likely active or activable |
206. Tapetum boxes | TCGTGT | ? | Y
T |
likely active or activable |
207. metazoan TATA boxes | TATA(A/T)AA(A/G) | β-Scaffold factors with minor groove contacts | Y
T |
likely active or activable |
208. TATA boxes | TATA(A/T)A(A/T)(A/G) | β-Scaffold factors with minor groove contacts | Y
T |
likely active or activable |
209. TAT Boxes
(Yang) |
TATAAAA | WD40 repeat family | Y
T |
likely active or activable |
210. TAT Boxes
(Fan) |
TATCCAT | WD40 repeat family | Y
T |
likely active or activable |
211. Tbf1 regulatory factors | A(A/G)CCCTAA | General Regulatory Factors | Y
T |
Saccharomyces cerevisiae, likely active or activable |
212. T boxes
(Conlon) |
TCACACCT | bZIP | Y
T |
likely active or activable |
213. T boxes
(Zhang) |
AACGTT | bZIP | Y
T |
likely active or activable |
214. TEA consensus sequences | CATTCY | ? | Y
T |
likely active or activable |
215. Tec1ps | GAATGT | ? | Y
T |
likely random, Ste12p cofactor |
216. Telomeric repeat DNA-binding factors
(TRFs) |
TTAGGG | ? | Y
T |
likely active or activable |
217. Thyroid hormone response elements
(TREs)(THRs) |
AGGTCA | ? | Y
T |
likely active or activable |
218. Transcription factor 3
(TCF3) |
GTCTGGT | ? | Y
T |
likely active or activable |
219. Translational control sequences
(TCSs) |
(A/T)TT(A/G)TCT | ? | Y
T |
likely active or activable |
220. Unfolded protein response element
(URE) (UPRE-1) |
CANCNTG | ? | Y
T |
likely active or activable |
221. Unfolded protein response elements
(UPREs) |
TGACGTG(G/A) | bZIP | Y
T |
likely active or activable |
222. Upstream repressor site 1
(URS1, core) (Sumrada) |
CCGCC | ? | Y
T |
likely active or activable, negative direction proximals are within randoms |
223. Upstream stimulating factors
(USFs) |
GCC(A/T)NN(C/G/T)(A/G) | bHLH-ZIP | Y
T |
likely active or activable, cores overlap lower randoms |
224. UUA rich elements
(Chen) |
TTATTTA(A/T)(A/T) | ? | Y
T |
likely active or activable |
225. V boxes | (A/G)TT(A/T)(C/T) | ? | Y
T |
likely active or activable |
226. Vitamin D response elements
(VDREs) |
(A/G)G(G/T)(G/T)CA | ? | Y
T |
likely active or activable |
227. W boxes | (C/T)TGAC(C/T) | WRKY | Y
T |
likely active or activable |
228. X core promoter elements | (A/G/T)(C/G)G(C/T)GG(A/G)A(C/G)(A/C) | ? | Y
T |
likely active or activable |
229. Xenobiotic response elements
(XREs) |
GCGTG | bHLH
aryl hydrocarbon receptor pathways |
Y
T |
likely active or activable |
230. Yap recognition sequences | TTACTAA | ? | Y
T |
likely active or activable |
231. YY1 binding sites | CCATCTT | Cys 2His 2 |
Y
T |
likely active or activable |
232. Z boxes
NSoSp form |
A(C/T)A(C/G)G(G/T)(A/G/T)T | ? | Y
T |
likely active or activable, negative direction distals within randoms |
233. Z boxes
ZboxG |
A(C/T)A(C/G)GT(A/G)T | ? | Y
T |
likely active or activable |
234. Z boxes
ZboxSp |
CAGGT(A/G) | ? | Y
T |
likely active or activable |
Totals
Of 376 response elements, there are 121 Ns for not present (absent) in either A1BG promoter and 255 Ys for (present) or transcription factors that occur in the promoters on either side A1BG. There are 255 likely active or activable (67.82 %). With 4560 nts considered between ZSCAN22 and A1BG, halfway would be at 2280. Less than 2280 suggests the nearest other gene. In the positive direction, 4445 nts considered between ZNF497 and A1BG, halfway would be 2222 for another nearest gene. Less than 2222 suggests the nearest other gene.
Number of non-degenerate nucleotides per response element
see Non-degenerate nucleotides per response element
Acknowledgements
The content on this page was first contributed by: Henry A. Hoff.
See also
References
- ↑ MeSH (8 July 2008). "Response Elements". U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894: National Institutes of Health, Health & Human Services. Retrieved 2 September 2020.
- ↑ 2.0 2.1 Angelika Bröer; Gregory Gauthier-Coles; Farid Rahimi; Michelle van Geldermalsen; Dieter Dorsch; Ansgar Wegener; Jeff Holst; Stefan Bröer (March 15, 2019). "Ablation of the ASCT2 (SLC1A5) gene encoding a neutral amino acid transporter reveals transporter plasticity and redundancy in cancer cells" (PDF). Journal of Biological Chemistry. 294 (11): 4012–4026. doi:10.1074/jbc.RA118.006378. Retrieved 4 October 2020.
- ↑ 3.0 3.1 Alisa A. Garaeva; Irina E. Kovaleva; Peter M. Chumakov; Alexandra G. Evstafieva (15 January 2016). "Mitochondrial dysfunction induces SESN2 gene expression through Activating Transcription Factor 4". Cell Cycle. 15 (1): 64–71. doi:10.1080/15384101.2015.1120929. PMID 26771712. Retrieved 5 September 2020.
- ↑ 4.0 4.1 Akihito Otsuki; Mikiko Suzuki; Fumiki Katsuoka; Kouhei Tsuchida; Hiromi Suda; Masanobu Morita; Ritsuko Shimizu; Masayuki Yamamoto (February 2016). "Unique cistrome defined as CsMBE is strictly required for Nrf2-sMaf heterodimer function in cytoprotection". Free Radical Biology and Medicine. 91: 45–57. doi:10.1016/j.freeradbiomed.2015.12.005. PMID 26677805. Retrieved 21 August 2020.
- ↑ 5.0 5.1 Sarah E. Lacher; Daniel C. Levings; Samuel Freeman; Matthew Slattery (October 2018). "Identification of a functional antioxidant response element at the HIF1A locus". Redox Biology. 19: 401–411. doi:10.1016/j.redox.2018.08.014. Retrieved 6 October 2020.
- ↑ 6.0 6.1 Ravi P. Misra; Azad Bonni; Cindy K. Miranti; Victor M. Rivera; Morgan Sheng; Michael E.Greenberg (14 October 1994). "L-type Voltage-sensitive Calcium Channel Activation Stimulates Gene Expression by a Serum Response Factor-dependent Pathway" (PDF). The Journal of Biological Chemistry. 269 (41): 25483–25493. PMID 7929249. Retrieved 7 December 2019.
- ↑ 7.0 7.1 Yao EF; Denison MS (June 1992). "DNA sequence determinants for binding of transformed Ah receptor to a dioxin-responsive enhancer". Biochemistry. 31 (21): 5060–7. doi:10.1021/bi00136a019. PMID 1318077.
- ↑ 8.0 8.1 8.2 8.3 8.4 8.5 Matthew J. Rossi; William K.M. Lai; B. Franklin Pugh (21 March 2018). "Genome-wide determinants of sequence-specific DNA binding of general regulatory factors". Genome Research. 28: 497–508. doi:10.1101/gr.229518.117. PMID 29563167. Retrieved 31 August 2020.
- ↑ 9.0 9.1 9.2 Kenneth A. Watanabe; Arielle Homayouni; Lingkun Gu; Kuan‐Ying Huang; Tuan‐Hua David Ho; Qingxi J. Shen (18 June 2017). "Transcriptomic analysis of rice aleurone cells identified a novel abscisic acid response element". Plant, Cell & Environment. 40 (9): 2004–2016. doi:10.1111/pce.13006. Retrieved 5 October 2020.
- ↑ Takayuki Murata; Chieko Noda; Yohei Narita1; Takahiro Watanabe; Masahiro Yoshida; Keiji Ashio; Yoshitaka Sato; Fumi Goshima; Teru Kanda; Hironori Yoshiyama; Tatsuya Tsurumi; Hiroshi Kimura (27 January 2016). "Induction of Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 (LMP1) by Transcription Factors Activating Protein 2 (AP-2) and Early B Cell Factor (EBF)" (PDF). Journal of Virology. doi:10.1128/JVI.03227-15. Retrieved 4 October 2020.
- ↑ 11.0 11.1 11.2 11.3 Bhaskar Sharma; Joemar Taganna (12 June 2020). "Genome-wide analysis of the U-box E3 ubiquitin ligase enzyme gene family in tomato". Scientific Reports. 10 (9581). doi:10.1038/s41598-020-66553-1. PMID 32533036 Check
|pmid=
value (help). Retrieved 27 August 2020. - ↑ 12.0 12.1 Ryuto Maruyama; Makoto Shimizu; Juan Li, Jun Inoue; Ryuichiro Sato (24 March 2016). "Fibroblast growth factor 21 induction by activating transcription factor 4 is regulated through three amino acid response elements in its promoter region". Bioscience, Biotechnology, and Biochemistry. 80 (5): 929–934. doi:10.1080/09168451.2015.1135045. Retrieved 4 October 2020.
- ↑ S Kouhpayeh; AR Einizadeh; Z Hejazi; M Boshtam; L Shariati; M Mirian; L Darzi; M Sojoudi; H Khanahmad; A Rezaei (1 July 2016). "Antiproliferative effect of a synthetic aptamer mimicking androgen response elements in the LNCaP cell line" (PDF). Cancer Gene Therapy. 23: 254–257. doi:10.1038/cgt.2016.26. Retrieved 3 October 2020.
- ↑ Stephen Wilson, Jianfei Qi & Fabian V. Filipp (14 September 2016). "Refinement of the androgen response element based on ChIP-Seq in androgen-insensitive and androgen-responsive prostate cancer cell lines". Scientific Reports. 6: 32611. doi:10.1038/srep32611. Retrieved 3 October 2020.
- ↑ Xu Tao; Anne E. West; Wen G. Chen; Gabriel Corfas; Michael E. Greenberg (2002). "A calcium-responsive transcription factor, CaRF, that regulates neuronal activity-dependent expression of BDNF". Neuron. 33: 383–95. doi:10.1016/S0896-6273(01)00561-X. PMID 11832226. Retrieved 2 September 2020.
- ↑ 16.0 16.1 Jianyin Long; Daniel L. Galvan; Koki Mise; Yashpal S. Kanwar; Li Li; Naravat Poungavrin; Paul A. Overbeek; Benny H. Chang; Farhad R. Danesh (28 May 2020). "Role for carbohydrate response element-binding protein (ChREBP) in high glucose-mediated repression of long noncoding RNA Tug1" (PDF). Journal of Biological Chemistry. 5 (28). doi:10.1074/jbc.RA120.013228. Retrieved 6 October 2020.
- ↑ 17.0 17.1 PA Johnson; D Bunick; NB Hecht (1991). "Protein Binding Regions in the Mouse and Rat Protamine-2 Genes" (PDF). Biology of Reproduction. 44 (1): 127–134. doi:10.1095/biolreprod44.1.127. PMID 2015343. Retrieved 6 April 2019.
- ↑ 18.0 18.1 Young Hun Song; Cheol Min Yoo; An Pio Hong; Seong Hee Kim; Hee Jeong Jeong; Su Young Shin; Hye Jin Kim; Dae-Jin Yun; Chae Oh Lim; Jeong Dong Bahk; Sang Yeol Lee; Ron T. Nagao; Joe L. Key; Jong Chan Hong (April 2008). "DNA-Binding Study Identifies C-Box and Hybrid C/G-Box or C/A-Box Motifs as High-Affinity Binding Sites for STF1 and LONG HYPOCOTYL5 Proteins" (PDF). Plant Physiology. 146 (4): 1862–1877. doi:10.1104/pp.107.113217. PMID 18287490. Retrieved 26 March 2019.
- ↑ Hideharu Hashimoto; Dongxue Wang; John R. Horton; Xing Zhang; Victor G. Corces; Xiaodong Cheng (1 June 2017). "Structural Basis for the Versatile and Methylation-Dependent Binding of CTCF to DNA". Molecular Cell. 66 (5): 711–720.e3. doi:10.1016/j.molcel.2017.05.004. PMID 28529057. Retrieved 28 August 2020.
- ↑ Yan-Hui Li; Gai-Gai Zhang (12 April 2016). "Towards understanding the lifespan extension by reduced insulin signaling: bioinformatics analysis of DAF-16/FOXO direct targets in Caenorhabditis elegans". Oncotarget. 7 (15): 19185–19192. doi:10.18632/oncotarget.8313. PMID 2702736. Retrieved 27 August 2020.
- ↑ 21.0 21.1 Philipp Mracek; Cristina Santoriello; M. Laura Idda; Cristina Pagano; Zohar Ben-Moshe; Yoav Gothilf; Daniela Vallone; Nicholas S. Foulkes (December 6, 2012). "Regulation of per and cry Genes Reveals a Central Role for the D-Box Enhancer in Light-Dependent Gene Expression". PLoS ONE. 7 (12): e51278. doi:10.1371/journal.pone.0051278. Retrieved 10 February 2019.
- ↑ Joshua J. Smith, Eric S. Cole, Daniel P. Romero (15 July 2004). "Transcriptional control of RAD51 expression in the ciliate Tetrahymena thermophila". Nucleic Acids Research. 32 (14): 4313–4321. doi:10.1093/nar/gkh771. PMID 15304567. Retrieved 4 September 2020.
- ↑ Roberta A. Sumrada and Terrance G. Cooper (June 1987). "Ubiquitous upstream repression sequences control activation of the inducible arginase gene in yeast" (PDF). Proceedings of the National Academy of Sciences USA. 84: 3997–4001. doi:10.1073/pnas.84.12.3997. PMID 3295874. Retrieved 6 September 2020.
- ↑ Fumiko Hirose; Masamitsu Yamaguchi; Akio Matsukage (September 1999). "Targeted Expression of the DNA Binding Domain of DRE-Binding Factor, a Drosophila Transcription Factor, Attenuates DNA Replication of the Salivary Gland and Eye Imaginal Disc". Molecular and Cellular Biology. 19 (9): 6020–6028. doi:10.1128/MCB.19.9.6020. PMID 10454549. Retrieved 4 September 2020.
- ↑ Annkatrin Rose, Iris Meier and Udo Wienand (28 October 1999). "The tomato I-box binding factor LeMYBI is a member of a novel class of Myb-like proteins". The Plant Journal. 20 (6): 641–652. doi:10.1046/j.1365-313X.1999.00638.x. Retrieved 8 November 2018.
- ↑ Eiji Yoshihara (18 August 2020). "TXNIP/TBP-2: A Master Regulator for Glucose Homeostasis". Antioxidants. 9 (8): 765–84. doi:10.3390/antiox9080765. PMID 32824669 Check
|pmid=
value (help). Retrieved 5 September 2020. - ↑ 27.0 27.1 27.2 27.3 27.4 Hongting Tang, Yanling Wu, Jiliang Deng, Nanzhu Chen, Zhaohui Zheng, Yongjun Wei, Xiaozhou Luo, and Jay D. Keasling (6 August 2020). "Promoter Architecture and Promoter Engineering in Saccharomyces cerevisiae". Metabolites. 10 (8): 320–39. doi:10.3390/metabo10080320. PMID 32781665 Check
|pmid=
value (help). Retrieved 18 September 2020. - ↑ 28.0 28.1 Liu-Min Fan, Xiaoyan Feng, Yu Wang and Xing Wang Deng (2007). "Gibberellin Signal Transduction in Rice". Journal of Integrative Plant Biology. 49 (6): 731−741. doi:10.1111/j.1744-7909.2007.00511.x. Retrieved 16 October 2018.
- ↑ Nesrin Ozsarac, Melissa J. Straffon, Hazel E. Dalton, and Ian W. Dawes (March 1997). "Regulation of Gene Expression during Meiosis in Saccharomyces cerevisiae: SPR3 Is Controlled by both ABFI and a New Sporulation Control Element". Molecular and Cellular Biology. 17 (3): 1152–9. doi:10.1128/MCB.17.3.1152. PMC 231840. PMID 9032242.
- ↑ Qingliang Li, Rezaul M. Karim, Mo Cheng, Mousumi Das, Lihong Chen, Chen Zhang, Harshani R. Lawrence, Gary W. Daughdrill, Ernst Schonbrunn, Haitao Ji and Jiandong Chen (July 2020). "Inhibition of p53 DNA binding by a small molecule protects mice from radiation toxicity". Oncogene. 39 (29): 5187–5200. doi:10.1038/s41388-020-1344-y. PMID 32555331 Check
|pmid=
value (help). Retrieved 29 August 2020. - ↑ Agata Michalska, Katarzyna Blaszczyk, Joanna Wesoly and Hans A. R. Bluyssen (28 May 2018). "A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses". Frontiers in Immunology. 9: 1135. doi:10.3389/fimmu.2018.01135. Retrieved 18 March 2021.
- ↑ Marilyn Kozak (October 1987). "An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs". Nucleic Acids Research. 15 (20): 8125–8148. doi:10.1093/nar/15.20.8125. PMID 3313277.
- ↑ Takuya Matsumoto; Saemi Kitajima; Chisato Yamamoto; Mitsuru Aoyagi; Yoshiharu Mitoma; Hiroyuki Harada; Yuji Nagashima (9 August 2020). "Cloning and tissue distribution of the ATP-binding cassette subfamily G member 2 gene in the marine pufferfish Takifugu rubripes" (PDF). Fisheries Science. 86: 873–887. doi:10.1007/s12562-020-01451-z. Retrieved 27 September 2020.
- ↑ Robert G. K. Donald and Anthony R. Cashmore (1990). "Mutation of either G box or I box sequences profoundly affects expression from the Arabidopsis rbcS‐1A promoter". The EMBO Journal. 9 (6): 1717–1726. doi:10.1002/j.1460-2075.1990.tb08295.x. Retrieved 8 November 2018.
- ↑ Motoki Kyo, Tae Yamamoto, Hozumi Motohashi, Terue Kamiya, Toshihiro Kuroita, Toshiyuki Tanaka, James Douglas Engel, Bunsei Kawakami, Masayuki Yamamoto (13 February 2004). "Evaluation of MafG interaction with Maf recognition element arrays by surface plasmon resonance imaging technique". Genes to Cells. 9 (2). doi:10.1111/j.1356-9597.2004.00711.x. Retrieved 8 September 2020.
- ↑ 36.0 36.1 Pierre‐Louis Blaiseau and Dominique Thomas (2 November 1998). "Multiple transcriptional activation complexes tether the yeast activator Met4 to DNA". The EMBO Journal. 17: 6327–6336. doi:10.1093/emboj/17.21.6327. Retrieved 4 February 2021.
- ↑ Corine Bertolotto, Roser Buscà, Patricia Abbe, Karine Bille, Edith Aberdam, Jean-Paul Ortonne, and Robert Ballotti (February 1998). "Different cis-Acting Elements Are Involved in the Regulation of TRP1 and TRP2 Promoter Activities by Cyclic AMP: Pivotal Role of M Boxes (GTCATGTGCT) and of Microphthalmia". Molecular and Cellular Biology. 18 (2): 694–702. PMID 9447965. Retrieved 8 December 2018.
- ↑ XIAN-YANG ZHANG, NABILA JABRANE-FERRAT, CLEMENT K. ASIEDU, SANJA SAMAC, B. MATIJA PETERLIN, AND MELANIE EHRLICH (November 1993). "The Major Histocompatibility Complex Class II Promoter-Binding Protein RFX (NF-X) Is a Methylated DNA-Binding Protein" (PDF). MOLECULAR AND CELLULAR BIOLOGY. 13 (11): 6810–8. Retrieved 2017-04-05.
- ↑ Eduardo Moreno, Maša Lenuzzi, Christian Rödelsperger, Neel Prabh, Hanh Witte, Waltraud Roeseler, Metta Riebesell, Ralf J. Sommer (November 2018). "DAF‐19/RFX controls ciliogenesis and influences oxygen‐induced social behaviors in Pristionchus pacificus". Evolution & Development. 20 (6): 233–243. doi:10.1111/ede.12271. Retrieved 9 March 2021.
- ↑ Andrew C. Cuming (5 December 2019). "Evolution of ABA signaling pathways". Advances in Botanical Research. 92: 281–313. doi:10.1016/bs.abr.2019.06.003. Retrieved 15 May 2023.
External links